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ABSTRACT 
 Bovine adenovirus-3 (BAdV-3) a member of genus Mastadenovirus was first isolated in 
England from the eye of seemingly healthy cattle (Darbyshire et al., 1965). The linear double 
stranded genome of BAdV-3 is of 34446 bp in length and is organized into early, intermediate 
and late regions (Reddy et al., 1998). The mRNAs produced from late region are grouped into 
seven families (L1-L7) based upon usage of polyadenylation sites (Reddy et al., 1998).The L6 
region of BAdV-3 encodes pVIII protein a structural protein associated with hexon connecting 
the core with the adenovirus capsid (Reddy et al., 1998,Russell., 2009). The objective of the 
present study was to characterize interaction of pVIII with cellular protein eukaryotic initiation 
factor 6 (eIF6) and to determine the role of pVIII in the life cycle of BAdV-3. 
 Our initial yeast two-hybrid results indicated that pVIII interacts with cellular protein 
eukaryotic initiation factor 6 (eIF6). We validated our yeast two-hybrid results using GST pull-
down assay, co-immunoprecipitation assay and bimolecular fluorescence complementation 
(BiFC) assay. Moreover, BAdV-3 late protein pVIII interacts with eIF6 in transfected and 
BAdV-3 infected cells. Analysis of the interaction of mutant BAdV-3 pVIIIs with eIF6 using co-
immunoprecipitation assay identified amino acids 147 to 174 of BAdV-3 pVIII involved in 
interaction with eIF6. Similar analysis of plasmids expressing mutant eIF6 proteins identified 
amino acids 44 to 97 of eIF6 involved in interaction with BAdV-3pVIII. 
The eukaryotic initiation factor 6 is a 245 amino acid protein that is important both for 
ribosome biogenesis and protein translation (Miluzio et al., 2009). It specifically binds to free 
60S ribosomal subunit and prevents its joining with 40S ribosomal subunit (Gartmann et al., 
2010,Russell & Spremulli., 1979,Valenzuela et al., 1982). Here, we report a novel interaction 
between BAdV-3 pVIII and cellular protein eIF6, which appears to alter the formation of 
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functional 80S ribosomes and may modulate the cellular protein translation. The polysome 
profile analysis of uninfected and BAdV-3 infected MDBK cells indicated that there are more 
free 60S subunits in BAdV-3 infected cells as compared to uninfected cells suggesting the 
inhibition in joining of 40S and 60S ribosomal subunits. Comparison of polysome profiles of 
VIDO GT1 (stable cell line expressing BAdV-3 pVIII) and  VIDO DT1 (not expressing BAdV-3 
pVIII) cells also revealed the presence of more free 60S and free 40S subunits and reduction in 
functional 80S ribosomes in pVIII expressing cells compared to VIDO DT1 cells. These results 
suggest that the presence of pVIII impairs joining of 40S and 60S subunits, which may lead to 
reduction in formation of functional 80S subunits.  
To study the biological significance of pVIII-eIF6 interaction, we constructed a 
recombinant BAdV-3-d147-174, expressing mutant pVIII (containing deletion of domain 
interacting with eIF6). Analysis of the growth kinetics of BAdV-3-d147-174 suggested that 
growth of mutant virus was significantly affected. Moreover, CsCl2 gradient purification and 
TEM analysis revealed the significant decrease in the formation of mature virus particles in 
BAdV-3-d147-174 infected cells. Analysis of viral gene expression revealed that while the 
expression of early gene product (DBP) was not affected, the expression of all the analyzed late 
adenovirus proteins was significantly decreased in the cells infected with BAdV-3-d147-174. 
However, there was no significant difference in the incorporation of analysed structural proteins 
between BAdV-304a and BAdV-3-d147-174. These results indicate that abrogating the 
interaction of pVIII with eIF6 affects expression of adenovirus late proteins, which may result in 
decreased production of progeny virus. We speculate that interaction of pVIII and eIF6 plays a 
major role in preferential translation of adenoviral mRNAs during the late phase of infection.   
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Proteolytic maturation involving cleavage of six structural and one non-structural precursor 
protein is an important aspect of adenovirus life cycle. However, it is not known what role each 
individual cleavage event plays in determining adenovirus particle stability and infectivity. 
Analysis of amino acid sequence of BAdV-3 pVIII identified two potential adenovirus protease 
cleavage sites. Our results suggest that BAdV-3 pVIII is cleaved by adenovirus protease at both 
potential consensus cleavage sites. Further, while abrogation of cleavage at only one site does 
not affect the formation of mature virus, the absence of cleavage at both sites appears lethal for 
the production of progeny virus. Moreover, the cleavage of pVIII at both potential cleavage sites 
is a major contributing factor in producing stable BAdV-3 particles. Together, these studies 
provide evidence that proteolytic maturation of pVIII is essential for correct virus assembly and 
stability of the adenovirus particle. 
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1.0 LITERATURE REVIEW 
1.1 Adenoviruses 
Adenoviruses are large, nonenveloped viruses that have linear double stranded DNA (26 to 
45kb) as their genome (Davison et al., 2003) enclosed in an icosahedral capsid (Berk., 2013). 
Adenoviruses were first isolated in early 1950’s by two distinct groups that were trying to find 
the etiologic agents of acute respiratory infections (Hilleman & Werner., 1954,Rowe et al., 
1953). Although adenoviruses have been isolated from a wide variety of species including 
mammals, birds, reptiles and fishes, their replication is mostly limited to their natural host 
(Shenk., 2001). The in-depth molecular characterization of adenovirus infected cells have 
contributed significantly in understanding various biological processes like  replication of DNA, 
gene expression (both cellular and viral), cell cycle, splicing mechanism and cellular growth 
regulation (Berk., 2013).   
1.1.1 Adenovirus classification 
Adenoviruses are members of family Adenoviridae which is further grouped into five 
genera: Mastadenovirus, Aviadenovirus, Ataadenovirus, Siadenovirus and Ichtadenovirus. The 
genus Mastadenovirus consists of 25 different species of adenovirus that can infect mammals 
only (Brown et al., 2012). Traditionally serology, phylogenetic analyses and more recently 
genome organization has been used to distinguish members of this genus from other genera of 
Adenoviridae family. Distinguishing features of Mastadenoviruses include considerably longer 
(93-371 bp) and more complex ITRs (Brown et al., 2012) and presence of unique genes that code 
for genus specific proteins like core protein V, cementing protein IX  and some of the proteins 
encoded by E1A, E1B, E3 and E4 regions (Davison et al., 2003,Vellinga et al., 2005). Human 
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adenovirus C is the type species for genus Mastadenovirus. The biological properties like 
replication and organization of genome have been studied in great details for some of the isolates 
of Human adenovirus C species (Brown et al., 2012). 
 The genus Aviadenovirus consists of 8 species of adenoviruses that can only infect birds. 
Distinguishing features of aviadenoviruses include considerably larger genomes that range 
between 43804 bp (FAdV-1) (Chiocca et al., 1996) and 45667 (FAdV-4) (Griffin & Nagy., 
2011). The aviadenovirus virion contain two fibers per vertex inspite of the fact that some of 
them have two genes for fiber protein while others have only one gene that encode for fiber 
protein (Brown et al., 2012). Unlike Mastadenoviruses, aviadenoviruses lack the E1 and E3 
region, and genes coding for proteins V and IX (Brown et al., 2012). Compared to other genera 
the E4 region of aviadenoviruses is long (Davison et al., 2003). Though a number of 
transcription units that are exclusive to aviadenoviruses are present on the right end of 
aviadenovirus genome, most of the genes and their products encoded by this region still remain 
uncharacterized. Members of genus Aviadenovirus are pathogenic and are associated with 
diseases in birds like inclusion body hepatitis, bronchitis and hydropericardium syndrome. Fowl 
adenovirus A is the type species for genus Aviadenovirus (Brown et al., 2012). 
The genus Atadenovirus consists of 5 species of adenovirus (Brown et al., 2012). Members 
of genus Atadenovirus have a broad host range and can infect birds, ruminants, marsupial and 
reptiles (Davison et al., 2003). Distinguishing features of Atadenoviruses include high A+ T 
content of the genome, comparatively shorter genome than Mastadenoviruses and absence of 
proteins V and IX (Benkö & Harrach., 1998). All members of the genus Atadenovirus have 
unique structural proteins called p32K (ÉlŐ et al., 2003) and LH3 (Gorman et al., 2005,Pantelic 
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et al., 2008). The LH3 forms knob like structures on surface of virion (Pantelic et al., 2008). 
Ovine adenovirus D is the type species for genus Atadenovirus (Brown et al., 2012).  
The genus Siadenovirus consists of 5 species of adenoviruses. Distinguishing features of 
Siadenoviruses include short genomes and short ITRs (Kovács & Benkő., 2009,Pitcovski et al., 
1998). Siadenoviruses are so named because of their unique feature of encoding sialidase 
enzyme (Davison et al., 2003). Unlike Mastadenoviruses, Siadenovirus genome lacks the E1, E3 
and E4 regions and the genes encoding for proteins V and IX. Frog adenovirus is the type 
species for genus Siadenovirus (Brown et al., 2012). 
The genus Ichtadenovirus consists of only one species of adenovirus known as white 
sturgeon adenovirus 1 (WSAdV-1). The genome of WSAdV-1 is 48395 bp long which makes it 
the longest genome among all known adenoviruses (Brown et al., 2012). 
1.1.2 Human adenovirus 
 Human adenovirus (HAdV) was first isolated from human adenoids in the 1950s (Rowe et 
al., 1953). The extensive characterization of HAdVs for over 6 decades have led to the 
identification of 67 HAdV types (Ghebremedhin., 2014), which are further subdivided into 7 
subgroups (A to G) based on the property of virus to agglutinate the erythrocyte of different 
animals, oncogenecity in animals, transformation of cultured cells, genomic sequencing and 
bioinformatics analysis (Berk., 2013,Ghebremedhin., 2014). 
1.1.2.1 Virion structure 
Adenoviruses are large, non-enveloped double stranded DNA viruses that have a typical 
icosahedral capsid that surrounds a DNA containing core (Fig.1.1.1). The icosahedral AdV 
capsid which has a diameter of approximately 90nm is composed of 13 virion proteins (Berk., 
2013,San Martín., 2012). Hexon protein with 720 copies per virion is the major building block of  
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Figure 1.1.1 Schematic representation of adenovirus structure. Reprinted from (Russell., 
2009) with permission from publisher (Microbiology Society). 
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the capsid. Each capsid has 240 trimers of hexon protein with 12 trimers present at each capsid 
facet. A penton capsomere composed of 5 copies of penton protein is present at each of the 12 
vertices making a complex with a trimer of protruding fiber protein (Russell., 2009,Vellinga et 
al., 2005). Along with these three major capsid proteins, four minor capsid proteins namely 
pIIIa, pVI, pVIII and IX are also present in the virion (Fig.1.1.1). The polypeptide IIIa has a 
copy number of 60 per virion. It is present at the inner surface of the capsid and interacts with 
hexon, protein pVI and protein pVIII (Liu et al., 2010,San Martín., 2012). The polypeptide VI is 
an important protein present at the inner surface of capsid with a copy number of 360 per virion. 
It interacts with proteins IIIA, hexon and V (Moyer et al., 2015,San Martín., 2012,Vellinga et al., 
2005). Polypeptide VIII is another minor protein that is present at the inner surface of capsid. It 
has a copy number of 120 per virion and stabilizes the virion structure by providing a link 
between peripentonal hexons and the rest of the capsid (San Martín., 2012,Vellinga et al., 2005). 
Protein IX with a copy number of 240 is the only minor protein exposed on the outside of the 
capsid (Vellinga et al., 2005). Interactions of these minor proteins with other minor and major 
capsid proteins stabilize the virion structure (Berk., 2013). 
 The adenovirus core is composed of viral DNA genome and core proteins that include 
protein VII, V, Mu (X), IVa2, terminal protein (TP) and adenovirus protease (Fig.1.1.1). 
Polypeptide VII with more than 800 copies per virion is the most abundant core protein (van 
Oostrum & Burnett., 1985). It is highly basic and rich in arginine. Protein V and Mu are the other 
basic and arginine rich components of the core which along with polypeptide VII bind to viral 
DNA and condense it (Chatterjee et al., 1986,Hosokawa & Sung., 1976). Protein V binds to 
genomic DNA and polypeptide VI and thus acts as a bridge between capsid and core (Matthews 
& Russell., 1998a,Reddy & Nemerow., 2014). Core protein IVa2 is present at only one vertex of 
 6 
the icosahedron and is involved in the encapsidation of viral DNA (Christensen et al., 
2008,Ostapchuk et al., 2005,Tyler et al., 2007). The terminal protein present as only two copies 
per virion binds covalently to the 5ʹ ends of the viral DNA (Rekosh et al., 1977). The adenovirus 
protease functions to cleave selected viral precursor proteins during virion maturation (Greber., 
1998).  
1.1.2.2 Virus life cycle 
 Since viruses lack their own metabolic machinery, they depend entirely on living host cell 
to carry out their life-cycle. To take control of the host cell metabolic machinery, they need to 
enter the cell. Initial contact between host cell and a virus involves attachment of the viral 
surface components to the cell surface receptor(s). These initial interactions in many cases are 
non specific and electrostatic, primarily aimed at providing the virus with an opportunity to 
recruit specific receptors that can provide virus entry into the cell (Grove & Marsh., 2011). 
 For adenoviruses, the knob portion of fiber is the surface component responsible for 
establishing the initial contact with the host cell. For HAdV species A, C, D, E and F fiber knob 
interacts with coxsackie and adenovirus receptor (CAR) (Fig.1.1.2) (Arnberg., 2012,Bergelson et 
al., 1997). CAR, a protein that belongs to immunoglobulin family is a trans-membrane protein 
that contains an extracellular domain, a trans-membrane domain and an intracellular domain 
(Coyne & Bergelson., 2005). However, unlike other HAdV’s, species B HAdV can use CD80, 
CD86 or CD46 as their receptor (Marttila et al., 2005,Short et al., 2006). Moreover, sialic acid 
has also been reported as receptor for some species D adenoviruses (Arnberg et al., 2000) In 
addition to these well-known receptors, other host cell factors such as heparin sulfate 
proteoglycans, lactoferrin and coagulation factors have been reported to bind to adenovirus and 
could serve as functional adenovirus receptors (Arnberg., 2009). 
 7 
 
 
 
 
 
Figure 1.1.2 Schematic representation of adenovirus infection pathway. Reprinted from 
(Lenaerts et al., 2008) with permission from John Wiley and Sons (publisher).   
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The interaction of CAR and fiber is mainly involved in attachment of virus to cell receptor 
and has no role in the internalization of adenovirus particles into host cell (Wickham et al., 
1996). For efficient internalization of adenovirus particles into host cell, the interaction involving 
the arginine-glycine-aspartic acid (RGD) motif of penton and integrins present on the cell 
surface is required (Bai et al., 1993,Wickham et al., 1993). This interaction activates the 
phosphoinositide-3-OH kinase, p130CAS and Rho GTPases, which are involved in 
rearrangement of cytoskeleton required for the endocytosis of the virion. This endocytic process 
is mediated by clathrin and requires GTPase, dynamin and the adaptor protein 2 (Li et al., 
1998,Meier & Greber., 2004). After endocytosis, the clathrin coated vesicle mature into the 
endosomes and the pH of endosome becomes more acidic. The increased acidification of the 
endosome triggers dismantling of the capsid, causing the release of penton, hexon and the 
internal capsid proteins IIIa, VI and VIII (Fig. 1.1.2) (Gastaldelli et al., 2008,Greber et al., 
1993). This partial uncoating of the capsid exposes the lytic domain of protein VI which causes 
disruption of the endosomal membrane and subsequent release of partially uncoated virions into 
the cytoplasm (Wiethoff et al., 2005). On reaching the cytoplasm, the partially disassembled 
capsid makes use of microtubule motor protein dynein to reach to the nuclear pore complex 
(NPC). The interaction of hexon with dynein allows the movement of capsid towards the nucleus 
(Bremner et al., 2009,Leopold et al., 2000). The capsid docks at NPC by binding to 
CAN/Nup214 (Trotman et al., 2001). For further disassembly at the NPC, virus uses molecular 
motor kinensin 1(Strunze et al., 2011). After the disassembly at NPC, the viral genome in 
complex with protein VII transports to the nucleus using cellular transport factors such as 
importin,  transportin and histone H1(Hindley et al., 2007,Trotman et al., 2001,Wodrich et al., 
2006). 
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 The transcription of early (E) region of adenovirus genome starts once viral genome 
locates in the nucleus. E1A is the earliest region of viral genome to undergo transcription during 
early phase of infection and encodes two mRNA’s with coterminal 5ʹ and 3ʹ ends. The two major 
E1A protein products termed 289R and 243R have 289 and 243 amino acids, respectively 
(Avvakumov et al., 2004). Two major functions of E1A products are to induce the infected cell 
to enter S phase, making an environment suitable for the replication of virus and to stimulate the 
transcription of other early viral genes (Berk., 2013). 
E1A is an efficient trans-activator and can stimulate transcription from a number of cellular 
and viral promoters by associating to the DNA binding domains of transcription factors (Liu & 
Green., 1994). During early phase of infection, EIA stabilizes p53 by binding to Rb and 
CBP/p300. Deregulation of cell cycle by E1A and stabilization of p53 stimulates apoptosis 
(Gallimore & Turnell., 2001). 
The E1B transcriptional region encodes two proteins, E1B-19K and E1B-55K, which 
counteract the proapoptotic effects of E1A (Berk., 2005,Debbas & White., 1993).  
The E2 early region encodes three proteins namely, DNA binding protein (DBP), DNA 
polymerase (Pol) and pre-terminal protein (pTP) that are essential for viral DNA replication .The 
59kDa DBP is encoded by E2A region and plays a vital role in DNA replication. During 
initiation phase, it stimulates the binding of viral DNA polymerase to viral DNA. During 
elongation phase, it unwinds the viral dsDNA and removes the secondary structures thus 
increasing the efficiency of Pol (Dekker et al., 1997,Lindenbaum et al., 1986,van Breukelen et 
al., 2003). The 80kDa pTP encoded by E2B region binds to the 5ʹ end of each strand of viral 
dsDNA and functions as a primer to initiate the viral DNA replication (Mysiak et al., 2004). 
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After forming heterodimer with Pol, it translocates to the nucleus and starts viral DNA 
replication (Fredman & Engler., 1993). 
The E3 region of adenovirus encodes several proteins that are not essential for viral 
replication but are required for subverting the host immune response. The transcription of E3 
region is regulated by promoter responsive to E1A (Horwitz., 2004).  
The E4 region encodes six proteins that perform a variety of functions during the course of 
viral infection including the cell cycle modulation, DNA repair, late viral protein synthesis, RNA 
processing and counteracting antiviral innate immune response (Greer et al., 2011,O'Shea et al., 
2005,Ullman & Hearing., 2008,Weitzman & Ornelles., 2005).  
Viral DNA replication begins when E2 gene products have accumulated in sufficient 
amounts. The inverted terminal repeats (ITRs) present on each end of viral genome have origins 
of DNA replication where a pre-initiation complex (PIC) composed of viral proteins pTP, AdPol 
and DBP, and cellular proteins NF1 and Oct1 is formed (Bosher et al., 1990,Chen et al., 
1990,Mul et al., 1990). The DNA replication starts after assembly of PIC using pTP as a protein 
primer. First Pol catalyzes the formation of an ester bond between α- phosphoryl group of 
deoxycytidine monophosphate (dCMP) and β-OH of a serine in pTP. The 3ʹ-OH group of the 
newly formed pTP-CMP complex functions as a primer for the production of new strand by Pol. 
Viral proteins Pol and DBP, and the cellular protein topoisomerase (also known as NFII) is 
essential for DNA elongation (Challberg et al., 1980,Lichy et al., 1981,Nagata et al., 1983). The 
production of new viral DNA occurs in 5ʹ to 3ʹ direction using strand displacement mechanism 
(Lechner & Kelly., 1977).  
Viral proteins IVa2 and IX are known as delayed early or intermediate proteins since their 
expression coincides with DNA replication and their transcripts are produced earlier than late 
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proteins. It has been proposed that during initial stages of infection, the cellular transcriptional 
repressors suppress the expression of IVa2 and IX. The cellular protein RBP-2N suppresses the 
expression of protein IX while protein IVa2-RF represses expression of IVa2. As viral DNA 
replication proceeds, the viral genome copy number increases and hence more binding sites for 
cellular repressors become available. Eventually the number of binding sites outnumber the 
cellular repressors, thus relieving the inhibition of protein IX and IVa2 expression (Chen et al., 
1994,Dou et al., 1994,Iftode & Flint., 2004,Lin & Flint., 2000). Protein IVa2 is involved in 
regulating the activity of major late promoter (MLP) and also plays a role in virus assembly 
(Lutz & Kedinger., 1996,Zhang & Imperiale., 2003). Protein IX provides the stability to the 
capsid and is also suggested to play a role in activation of MLP (Lutz et al., 1997,Vellinga et al., 
2005). 
After the onset of viral DNA replication, adenovirus late genes start to be expressed 
efficiently. All late genes are produced from a single transcription unit known as major late 
transcription unit (MLTU) which is processessed by splicing and usage of differential poly A 
sites to generate 20 species of late mRNAs (Nevins & Darnell., 1978,Ziff & Evans., 1978). 
Based on the usage of poly (A) sites these 20 species of late mRNAs are further grouped into 
five families (L1-L5) (Nevins & Darnell., 1978,Ziff & Fraser., 1978). All late mRNAs share a 
common 5ʹ noncoding region known as tripartite leader that helps to increase the translation of 
the late mRNAs (Berget et al., 1977,Chow et al., 1977). Major late promoter (MLP) regulates 
the expression of viral late mRNAs. During early phase of infection, the MLP activity is at very 
low level but it increases several folds at late times post infection because of the stimulation by 
viral proteins including IVa2 (Pardo-Mateos & Young., 2004,Tribouley et al., 1994) and L4-22K 
(Backström et al., 2010,Morris et al., 2010). The products of the late mRNA are mainly viral 
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structural proteins and scaffolding proteins, which regulate the late phase translation and 
assembly of virus particle (Berk., 2013). 
Assembly of the adenovirus particle occurs in the nucleus but the process begins in 
cytoplasm itself where assembly of the hexon trimers and penton capsomeres take place. The 
trimerization of hexon is assisted by L4-100K protein which acts as a scaffold (Hong et al., 
2005,Horwitz et al., 1969,Velicer & Ginsberg., 1970). The assembled hexon and penton 
capsomeres then moves to the nucleus for final assembly process. In the nucleus, the hexon and 
the penton capsomeres associate with each other as well as with other minor capsid proteins to 
form empty capsids (Wodrich et al., 2003). Adenovirus DNA is then packaged in these 
preformed capsids starting with the left end of genome (Hammarskjöld & Winberg., 
1980,Hearing et al., 1987). The left end of adenovirus genome has seven AT-rich repeat 
sequences that are reported to be necessary for the encapsidation of viral DNA (Ostapchuk & 
Hearing., 2003). Adenoviral proteins IVa2, L1 52/55K and L4-22K have been reported to 
interact with packaging sequence and play a vital role in the encapsidation of viral DNA. 
Activated adenovirus protease cleaves the selected precursor proteins thus making the progeny 
virion infectious (Gupta et al., 2004,Mangel et al., 2003,Weber., 1976). 
Although the exact mechanism for the release of adenovirus particle from infected cell is 
not known, several mechanisms have been postulated that help in the release of adenovirus from 
infected cells. First, the cellular cytokeratin is cleaved by activated adenovirus protease during 
the late phase of infection and this destroys the cytoskeleton network of the cell and aids in the 
release of virus from infected host cells (Brown & Mangel., 2004). Secondly, E3 11.6kDa 
protein also known as adenovirus death protein (ADP) has been suggested to play a vital role in 
the lysis of infected cells. While in early phase of infection, ADP is expressed in low quantities 
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from E3 promoter, at late phase of infection it is expressed at high levels by major late promoter.  
The accumulation of high amount of ADP in the infected cells subsequently cause death and 
lysis of the cell (Tollefson et al., 1992,Tollefson et al., 1996). 
1.1.2.3 Human adenovirus pathogenesis 
 Human adenoviruses can cause a variety of infections and most of them are endemic in 
nature. Many of these infections are mild or asymptomatic and result in the development of 
immunity that protect against reinfection with same adenovirus serotype (Walls et al., 2003). 
HAdV’s are commonly associated with infection of respiratory system, gastroenteritis and eye 
infection. They are also associated with urinary tract infection and occasionally can also infect 
other organs such as liver, pancreas, heart and central nervous system (Wold & Ison., 2013). 
 Adenoviruses primarily belonging to group C (HAdV serotypes 1, 2, 5 and 6) and 
occasionally group B (HAdV serotypes 3 and 7) are most commonly associated with upper 
respiratory tract infection especially in children less than 5 years of age. Approximately 7% of 
the cases of pediatric upper respiratory tract infection are because of adenovirus infection 
(Wesley et al., 1993,Wold & Ison., 2013). HAdV primarily belonging to group B (serotypes 3 
and 7) and frequently group C (serotypes 1, 2 and 5) cause pediatric lower respiratory tract 
infections leading to pneumonia and bronchiolitis (Hong et al., 2001,Kim et al., 2003,Pavia., 
2011). 
 Adenoviruses belonging to group B (serotypes 3, 7, 16 and 21) and group E (serotype 4) 
are reported to cause acute lower respiratory tract infection in adults (Wold & Ison., 2013). 
HAdV-4 and HAdV-7 are the primary etiological agents for acute respiratory infection in 
military recruits (Gray et al., 2007,Potter et al., 2012). 
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 HAdV serotypes 3, 7 and 4 can cause mild conjunctivitis. The infection is usually self-
limiting and leads to full recovery (Wadell., 2000). On the other hand, infection of the eye by 
adenoviruses belonging to group D (serotype 8, 9 and 17) can cause severe epidemic kerato-
conjunctivitis (Aoki & Tagawa., 2002,Echavarria., 2009). 
 Enteric adenoviruses HAdV-40 and 41 have been linked with acute gastroenteritis in 
children (Wilhelmi et al., 2003). HAdV-11 and 21 have been reported to be the cause of acute 
haemorrhagic cystitis in boys (Mufson & Belshe., 1976,Numazaki et al., 1973). Several reports 
have implicated adenovirus as a cause for myocarditis in children and adults (Bowles et al., 
2003,Dennert et al., 2008,Lozinski et al., 1994). In addition to this adenoviruses have been 
associated with obesity (HAdV-36) (Atkinson et al., 2005), intussusception (Bines et al., 2006), 
and meningoencephalitis (Chou et al., 1973,Dubberke et al., 2006,Kelsey., 1978). 
 Adenoviruses can frequently infect immune-compromised hosts particularly patients that 
had undergone organ transplant (Bridges et al., 1998,Cames et al., 1992,Michaels et al., 1992) 
and patients with acquired immunodeficiency syndrome (AIDS) (Horwitz et al., 1984,Krilov et 
al., 1990).  Compared to immune-competent host, outcome of adenovirus infection in immune-
compromised host can be much more severe and life threatening (Baldwin et al., 2000,Leen & 
Rooney., 2005).   
1.1.3 Proten-protein interactions in adenovirus lifecycle 
Since viruses do not have their own metabolic machinery, they depend upon host cellular 
machinery for carrying out various functions. As soon as a virus infects a cell, it takes over the 
cellular metabolic machinery by means of various interactions with host factors. Interaction of 
virus and host determines the virus host range and outcome of viral infection.  It is therefore 
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imperative to identify and characterize various virus-host cell interactions to understand the basic 
biology of a virus (Arnberg., 2009,Wang & Li., 2012,Zhou et al., 2009).   
Similarly, adenovirus proteins interact with various host proteins and with other adenovirus 
proteins throughout the viral life cycle to make cellular environment suitable for adenovirus 
multiplication and to counter host defense mechanism. Study of these adenovirus-host cell 
interactions resulted in a better understanding of adenovirus biology. 
1.1.3.1 Protein-protein interactions during adenovirus attachment and internalization 
 Adenovirus infectious cycle starts with interaction of fiber knob of adenovirus with the cell 
surface receptor(s). After attachment of fiber to cell surface receptor, the penton base interacts 
with integrins, which leads to endocytosis of virion (Arnberg., 2009). Interaction of hexon with 
microtubule motor protein dynein is essential for transport of partially uncoated virus to nuclear 
pore complex. At nuclear pore complex (NPC) interaction of hexon with nucleoporin Nup214 is 
essential for nuclear import of viral DNA (Cassany et al., 2015,Trotman et al., 2001). The 
interaction of adenovirus protein IX with kinesin 1 light chain at NPC leads to further 
disassembly of the virus (Strunze et al., 2011). After disassembly at NPC, interaction of pVII 
with cellular transport factors such as importin and transportin and histone H1 regulates transport 
of viral genome into the nucleus (Hindley et al., 2007,Trotman et al., 2001,Wodrich et al., 2006) 
1.1.3.2 Protein-protein interaction of adenovirus early proteins 
 The first region of the adenovirus genome to undergo transcription is E1A, which 
encodes two major proteins namely 289R and 243R. The E1A bind to cellular proteins that 
regulate E2F family of transcription factors namely retinoblastoma (RB) protein and RB related 
proteins p130 and 107. The RB and RB related protein represses E2F transcriptional activation 
by binding to E2F. However, binding of E1A to RB and related proteins displaces them from 
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E2F and hence RB mediated repression of E2F is relieved allowing the cells to enter S phase of 
cell cycle (Berk., 2005). E1A has also been reported to interact with several cellular proteins 
namely p300/CBP, TRRAP/GCN5 and pCAF that are involved in chromatin structure control. 
These interactions of EIA may increase expression of genes regulating the cell cycle by 
increasing DNA and transcription factor binding (Chakravarti et al., 1999,Hamamori et al., 
1999,Lang & Hearing., 2003). Moreover, E1A also binds the CDK inhibitors (CKI) p27 and p21. 
Binding of EIA to CKI’s prevent the CKI mediated inhibition of CDK –cyclin complexes thus 
promoting cell cycling (Chattopadhyay et al., 2001,Mal et al., 1996,Nomura et al., 1998). During 
early phase of infection, E1A stabilizes p53 partly because of its binding to Rb and CBP/p300. 
Deregulation of cell cycle by E1A and stabilization of p53 stimulates apoptosis (Gallimore & 
Turnell., 2001) 
The E1B transcriptional region encoded proteins E1B-19K and E1B-55K interact with host 
\viral proteins to counteract the pro-apoptotic effects of E1A proteins. E1B-55k binds to the p53 
activation domain leading to the stearic hindrance for co-activators to interact with p53. 
Moreover, E1B-55K also has a repressor domain and its binding to p53 converts p53 from gene 
activator to gene repressor (Martin & Berk., 1998,Yew et al., 1994). E1B-55K also causes 
degradation of p53. It forms a complex with viral protein E4orf6 and cellular proteins Elogin B 
and C, Culin5 and RBX1. This complex ubiquitin ligase poly-ubiquinates p53 and thus causes its 
proteosomal degradation (Harada et al., 2002,Querido et al., 2001). E1B-19K, a homologue of 
cellular BCL-2 family of proteins mimics anti apoptotic protein MCL1 and, interacts with pro-
apoptotic proteins BAK and BAX. Binding of E1B-19K to BAK and BAX prevents their 
oligomerization and subsequent pore formation, releasing the apoptosis causing factors from the 
mitochondria (White., 2001). 
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The E2 early region encoded proteins DNA binding protein (DBP), DNA polymerase (Pol) 
and pre-terminal protein (pTP)  interact with each other to regulate viral DNA replication (as 
described in section 1.1.2.2) (Mysiak et al., 2004,van Breukelen et al., 2003). 
 The E3 region of adenovirus encodes several proteins that are not essential for viral 
replication but are required for subverting the host immune response. E3-gp19k, a 19kDa protein 
functions to diminish CTL mediated elimination of adenovirus infected cells. It performs this 
function by two different mechanisms. Firstly, it binds to MHC class I molecule and prevents its 
transport to the cell surface. The gp19k protein contains an ER localization signal that prevents 
transport of MHC class I-gp19k complex to the cell surface (Burgert et al., 1987,Horwitz., 
2004). Secondly, gp19k binds to TAP and prevents the interaction of TAP and Tapasin. 
Interaction of TAP and Tapasin is required for effective presentation of antigen by MHC class I 
molecule. Thus, because of interaction of gp19k and TAP, the cell surface antigen presentation is 
decreased (Bennett et al., 1999,Horwitz., 2004). Moreover, gp19k has been reported to inhibit 
NK cell activation because of its ability to diminish the cell surface expression of NK cell 
activating ligands MHC I chain-related protein A and B (McSharry et al., 2008). The E3-10.4k 
and 14.5k proteins also known as RIDα and RIDβ, respectively together form a complex which 
is called receptor internalization and degradation (RID) complex. The RID complex inhibits 
apoptosis induced by TNF, Fas ligands and TRAIL by removing their receptors from the cell 
surface and increasing their internalization and destruction in lysosome (Chin & Horwitz., 
2006,Shisler et al., 1997,Tollefson et al., 1998).  
The E4 region encoded proteins perform a variety of functions during the course of viral 
infection including cell cycle modulation, DNA repair, late viral protein synthesis, RNA 
processing and counteracting antiviral innate immune response (Greer et al., 2011,O'Shea et al., 
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2005,Ullman & Hearing., 2008,Weitzman & Ornelles., 2005). The E4orf1 protein binds with 
PDZ domain of many cellular proteins and activates PI3K leading to the activation of 
mammalian target of rapamycin (mTOR) (Chung et al., 2007,Frese et al., 2003,O'Shea et al., 
2005). The E4 orf3 facilitates production and accumulation of late viral mRNA by transporting 
components of P-bodies to aggresomes (Greer et al., 2011). The E4orf4 binds to protein 
phosphatase 2A and activates mTOR independently of PI3K (O'Shea et al., 2005). The E4orf6, a 
34kDa protein forms a multifunctional complex with adenovirus E1b55K that is involved in viral 
DNA replication, processing of RNA, nucleo-cytoplasmic shuttling of late viral mRNA and 
inhibiting host protein synthesis during viral infection. It also plays a vital role in 
polyubiquitination and degradation of cellular targets by recruiting cellular factors like Cullin-5, 
Elongin B and Elongin C to E1B55K/E4orf6 complex forming a ubiquitin ligase complex (Boyer 
& Ketner., 2000,Harada et al., 2002,Querido et al., 2001). The E4orf6 can interact with p53 and 
p73 independently of E1b55K, and counteract their inhibitory effects on viral replication 
(Dobner et al., 1996,Higashino et al., 1998,Steegenga et al., 1999). The E4orf6/7 interacts with 
E2F transcription factors and thus increases their binding to E2 promoter (Neill et al., 
1990,Schaley et al., 2000). 
1.1.3.3 Protein-protein interactions of adenovirus intermediate proteins 
 The adenovirus protein IVa2 is a multifunctional protein and plays a significant role in 
capsid assembly (Zhang & Imperiale., 2003), packaging of viral DNA (Ahi et al., 2015,Zhang et 
al., 2001) and  major late promoter activation (Tribouley et al., 1994) by  interacting with 
various other adenoviral protein. Earlier studies have reported that IVa2 interacts with A repeats 
of packaging domain and L152/55k protein suggesting its role in viral DNA encapsidation 
(Ostapchuk et al., 2005,Perez-Romero et al., 2005,Zhang et al., 2001). Moreover, IVa2 also 
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interacts with L4 22K and recruits it to packaging domain. It has been suggested that L4 22K 
also plays an important role in packaging of viral DNA (Ewing et al., 2007,Ostapchuk et al., 
2006,Tyler et al., 2007). Since, IVa2 can bind ATP it has been suggested that it can play the role 
of packaging ATPase. A recent study has reported that ATPase activity of IVa2 is stimulated by 
viral DNA and L4 33K protein (Ahi et al., 2015,Ostapchuk & Hearing., 2008,Ostapchuk et al., 
2011). 
Protein IX a minor capsid protein interacts with PML protein and causes its sequestration 
and thus counteracts the PML mediated antiviral response during late phase of adenovirus 
infection (Rosa-Calatrava et al., 2003).   
1.1.3.4 Protein-protein interactions of adenovirus late proteins 
Adenovirus late proteins regulate the late phase translation and assembly of virus particle 
through their interactions with cellular and other adenovirus protein. 
The HAdV-5 L1 52/55K protein interacts with IVa2 protein and also interacts with 
packaging sequences independent of IVa2 suggesting that it plays a significant role in packaging 
of viral DNA (Perez-Romero et al., 2005). In addition, L1 52/55K interacts with pVII, which 
appears essential for packaging of viral DNA (Zhang & Arcos., 2005). A recent study has 
reported that L1 52/55K is cleaved by AVP during the process of virus maturation causing its 
release from mature virion (Perez-Berna et al., 2014). 
The HAdV-5 L2 pVII is the most abundant core protein. It binds to the viral DNA and 
through its interaction with various cellular transport factors like importin and transportin 
mediates import of viral DNA into nucleus after disassembly of virus particle at NPC (Hindley et 
al., 2007,Wodrich et al., 2006,Zhang & Arcos., 2005). It has been reported that pVII bound to 
adenoviral DNA interacts with cellular protein template activating factor (TAF) 1, which leads to 
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the release of pVII from viral DNA and stimulation of transcription from viral DNA (Gyurcsik et 
al., 2006). Moreover, pVII interacts with adenovirus packaging proteins IVa2 and L1 52/55K, 
which may play a vital  role in packaging of viral DNA (Zhang & Arcos., 2005). 
The HAdV-5 L2 protein V is the second most abundant core protein. Protein V through its 
interactions with capsid protein pVI and core protein pVII acts as a bridge that connects capsid 
and the core (Harpst et al., 1977,Matthews & Russell., 1998a). The protein V interacts with 
cellular proteins nucleolin and B23 and causes their redistribution from nucleolus to the 
cytoplasm (Matthews., 2001). Moreover, protein V interacts with cellular protein p32, which 
might mediate import of viral DNA from the cytoplasm to the nucleus (Matthews & Russell., 
1998b). 
During the process of virion maturation, HAdV-5 L3 protein pVI is cleaved by interacting 
with AVP. The C-terminal 11 amino acids released from pVI then act as cofactor for AVP and 
cause activation of AVP (Mangel et al., 1993,Mangel et al., 2003,Webster et al., 1993,Webster 
& Kemp., 1993). Moreover, pVI interacts with hexon capsomeres and appears to mediate their 
import into the nucleus where assembly of adenovirus virion takes place (Wodrich et al., 2003). 
The HAdV-5 L4 encoded 100K is a multifunctional protein that interacts with various 
cellular and other adenovirus proteins, which play a vital role in adenovirus assembly and 
regulation of late adenoviral protein translation. Earlier studies reported that 100K interacts with 
hexon, which is essential for trimerization of hexon (Cepko & Sharp., 1982,Oosterom-Dragon & 
Ginsberg., 1981) and nuclear import of hexon (Hong et al., 2005). Moreover, 100K interacts 
with both tripartite leader and cellular protein eIF4G and these interactions selectively enhances 
the translation of late adenovirus genes by mechanism of ribosome shunting (Hayes et al., 
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1990,Xi et al., 2004). Another study reported that 100K competes with eIF4E kinase, Mnk1, and 
displaces it from eIF4G thereby inhibiting cellular mRNA translation (Cuesta et al., 2000).  
HAdV-5 L4 33 K protein interacts with other viral proteins and through these interactions 
plays important role in viral DNA packaging and assembly of adenovirus particle. Interaction of 
33K protein with IVa2 (Ahi et al., 2013) and IIIa (Wu et al., 2013) protein have been reported. A 
recent study has reported that 33K is part of packaging motor and acts similar to small terminase 
protein (Ahi et al., 2015). 
HAdV-5 L5 fiber protein interacts with penton base to form penton (Caillet-Boudin., 
1989). The knob domain of fiber interacts with cell surface receptors to facilitate attachment of 
the virus to the cell (Henry et al., 1994,Philipson et al., 1968). 
1.1.4 Bovine adenovirus 
 Isolation of bovine adenovirus (BAdV) was initially reported in 1959 (Klein et al., 1959). 
So far isolation of 14 different serotypes of bovine adenovirus have been reported (Lehmkuhl & 
Hobbs., 2008,Sibley et al., 2011). BAdVs generally cause mild respiratory or gastrointestinal 
tract infections in cattle (Lehmkuhl et al., 1975,Smyth et al., 1996). However, BAdVs have been 
isolated from seemingly healthy animals (Darbyshire et al., 1965). 
1.1.4.1 Classification of bovine adenoviruses 
 Based on various criteria’s including genome length, nucleotide content, presence or 
absence of genus specific antigens and restriction enzyme analysis pattern currently identified 
BAdVs are classified either under the genus Mastadenovirus or the genus Atadenovirus (Benkö 
et al., 1988,Lehmkuhl & Hobbs., 2008,Sibley et al., 2011).  
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1.1.4.2 Bovine adenovirus type 3 
 The isolation of bovine adenovirus 3 (BAdV-3) was first reported from England from the 
eye of seemingly healthy cattle (Darbyshire et al., 1965). Subsequently, its isolation has been 
reported from cattle showing symptoms of respiratory or gastrointestinal disease (Mattson., 
1973a,Mattson., 1973b).  Recently, isolation of BAdV-3 has been reported from sick calves in 
China (Zhu et al., 2011). However, studies involving inoculation of calves with BAdV-3 have 
reported mild or no clinical symptoms in experimentally infected calves (Lehmkuhl et al., 
1975,Mattson et al., 1988,Mittal et al., 1999). 
1.1.4.2.1 Genome organization 
 The double stranded DNA genome of BAdV-3 is of 34446 bp in length. The length of 
BAdV-3 genome and its G+C content (54%) is very similar to that of HAdV-2, HAdV-5 and 
HAdV-12 (Chroboczek et al., 1992,Reddy et al., 1998,Sprengel et al., 1994). Similar to other 
adenoviruses BAdV-3 genome is also flanked by inverted terminal repeats (ITRs) (Morikazu et 
al., 1987). However, 195bp long ITRs of BAdV-3 differ from that of HAdV-2 and HAdV-5 by 
being longer and by having a high G+C content (84%) in the GC-rich region of ITR (Davison et 
al., 2003,Reddy et al., 1998). Similar to other adenoviruses the BAdV-3 packaging domain is 
present at the left end of genome with a number of A repeats located between nucleotide 225 and 
310 (Reddy et al., 1998). However, a distinct feature of BAdV-3 is that a portion of E1A coding 
sequence is reported to be essential for BAdV-3 genome packaging. Moreover, it has been 
reported that the E1A promoter is situated in the left ITR region (Xing & Tikoo., 2006). Similar 
to other members of the genus Mastadenovirus, the genome of BAdV-3 is also structured into 
early, intermediate and late regions. However, unlike HAdV-5 genome (Chroboczek et al., 1992) 
the late genes of BAdV-3 genome are divided into 7 regions (Fig.1.1.3) (Reddy et al., 1998).  
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Figure 1.1.3 Schematic representing transcription map and genome organization of BAdV-
3. Figure and figure legend reprinted from (Reddy et al., 1998) with permission from American 
Society for Microbiology (publisher). (a) Summary of transcriptional analysis of BAdV-3. The 
schematic diagram of the BAV-3 genome (34,446 bp) is divided into 100 m.u. Arrows above and 
below the central line represent mRNAs from the r and l strands, respectively. Solid lines 
represent sequences found in mRNA, broken lines indicate introns, and arrowheads represent 
poly (A) sites and show the direction of transcription. Each mRNA in L1 to L7 has a TPL spliced 
to its 5′ terminus (•). (b) Summary of the genomic organization of BAV-3. Genes are named as 
homologs of HAV-2. Arrows show the positions of the ORFs for the indicated proteins.  
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1.1.4.2.2 Early genes 
 The E1 region of BAdV-3 genome encodes for E1A and E1B. Unlike HAdV (Berk & 
Sharp., 1978), BAdV-3 E1A and E1B are encoded by a single transcription unit sharing the 
polyadenylation site (Reddy et al., 1999). Using alternative splicing E1A region of BAdV-3 
encodes six transcripts that encode three small proteins of 211, 115 and 100 amino acids (Reddy 
et al., 1999). Similar to HAdV, BAdV-3 E1 proteins are necessary for replication of virus and 
transactivation of other viral genes (Reddy et al., 1999,Zheng et al., 1994,Zhou et al., 2001a) . 
The E1B region of BAdV-3 is reported to produce two distinct overlapping mRNAs that encodes 
two different proteins 420R and 157R (Reddy et al., 1999). One of the studies has reported that 
420R is essential for BAdV-3 replication while requirement of 157R for viral replication is 
dependent on cell type (Zhou et al., 2001a). 
The E2 region is divided into two transcriptional units E2A and E2B encoding proteins 
essential for replication of viral DNA (Reddy et al., 1998). The 432 amino acid long DNA 
binding protein (DBP) is the only protein encoded by E2A. The amino acid sequence of BAdV-3 
DBP shows 18 to 47% sequence identities with DBP of other adenoviruses (Reddy et al., 1998). 
Like other adenoviruses, DBP of BAdV-3 also consists of a variable amino-terminal region and a 
highly conserved carboxy terminal region. The highly conserved carboxy terminal region of 
HAdV DBP has been reported to be involved in DNA binding and viral replication, and also 
activation of the MLP (Kitchingman., 1985). Similar to HAdVs, the amino terminal region of 
BAdV-3 DBP consists of many serine and threonine amino acids, which may function as sites 
for phosphorylation (Reddy et al., 1998). Similar to HAdVs, a number of basic amino acids 
containing motifs are present in the amino-terminal region of BAdV-3 DBP including 
29
PRKK
32
, 
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35
RKRR
38
 and 
53
KRAK
56
. These potential NLS could serve to import DBP into the nucleus 
(Reddy et al., 1998). 
Like HAdVs, the viral DNA polymerase (Pol) protein and the preterminal protein (pTP) 
are encoded by BAdV-3 E2B region. The BAdV-3 Pol protein consists of 1023 amino acids and 
shows 59-60% homologies with Pol protein of other members of genus Mastadenovirus. The 
BAdV-3 pTP protein is composed of 649 amino acids and shows 58-60% homologies to pTP 
protein of other mastadenoviruses (Baxi et al., 1998,Reddy et al., 1998). It has been reported that 
a YSRLRYT motif present in pTP is essential for protein primed initiation of DNA replication 
by pTP (Hsieh et al., 1990). The BAdV-3 pTP also contains this motif in form of YSRLVYR 
(Baxi et al., 1998). Unlike HAdV-2 pTP which has three potential protease cleavage sites, 
BAdV-3 pTP has only two potential protease cleavage sites (Baxi et al., 1998,Webster et al., 
1994). 
Compared to other adenoviruses, the 1591 bp long E3 region of BAdV-3 is relatively 
small.  However, similar to other adenoviruses, its location has been mapped to be between the 
genes coding for pVIII and fiber protein (Idamakanti et al., 1999,Reddy et al., 1998). The 
transcripts generated from E3 region code for four proteins with 284 (284R), 121 (121R), 86 
(86R) and 82 (82R) amino acids respectively. The 284R protein identified as a glycoprotein does 
not show any homology to E3 region encoded gp19 glycoproteins of HAdVs (Idamakanti et al., 
1999). Although, BAdV-3 121R protein shows limited homology with the 14.7K protein of 
HAdV-5 (Mittal et al., 1992), they appear to be functionally similar (Zakhartchouk et al., 2001).  
The E3 region of BAdV-3 is not required for viral replication in cultured cells (Zakhartchouk et 
al., 1998a). 
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Like other HAdVs, E4 region of BAdV-3 has been mapped to the right end of the genome 
(Lee et al., 1998,Reddy et al., 1998). The 3004 bp E4 region of BAdV-3 produces 7 transcripts 
that encode 5 open reading frames. Out of these five ORFs three ORFs 1, 2 and 4 do not have 
any homologs in other adenoviruses and thus appear to be unique to BAdV-3. However, ORFs 3 
and 5 have been reported to share homology with E4orf6 proteins of HAdVs (Baxi et al., 
1999,Baxi et al., 2001). Mutational analysis of E4 regions has reported that individual ORFs of 
E4 region are dispensable for viral replication in cultured cells as well as cotton rats (Baxi et al., 
2001).  
The genome of HAdV-2 also contains genes for encoding two non coding RNAs known as 
virus-associated (VA) RNAs (Reich et al., 1966). They counteract the host viral defense 
mechanism by inhibiting the PKR mediated phosphorylation of eukaryotic initiation factor 2 
(eIF2α) (Kitajewski et al., 1986,O'Malley et al., 1986). Moreover, recent studies have reported 
that VA RNA inhibits cellular miRNA biogenesis (Andersson et al., 2005,Bennasser et al., 
2011). The location of genes for VA RNAs has been mapped between the 52/55K and pTP 
encoding genes. However, unlike HAdV-2, so far genes encoding for VA RNAs have not been 
located in BAdV-3 genome (Reddy et al., 1998). Since genes coding for BAdV-3 52/55K and 
pTP do not have any space between them, it has been speculated that either VA RNA genes are 
absent from BAdV-3 genome or are located at a different location in genome (Reddy et al., 
1998). 
1.1.4.2.3 Intermediate gene 
 Similar to HAdVs, BAdV-3 also encodes two intermediate proteins named IVa2 and IX. 
The BAdV-3 structural protein IVa2 is shorter compared to IVa2 protein of other adenoviruses 
and is 376 amino acid long (Baxi et al., 1998,Morrison et al., 1997,Vrati et al., 1996). The 
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BAdV-3 intermediate protein IVa2 shows 29 to 69% identical amino acids when matched to 
amino acid sequence of IVa2 protein of other adenoviruses (Baxi et al., 1998,Reddy et al., 
1998). In HAdV-2 (Berk & Sharp., 1978) the IVa2 transcript is 3ʹ co terminal with either pTP or 
DNA Pol transcripts however, this is not the case with BAdV-3 IVa2. The BAdV-3 intermediate 
protein IX is shorter than protein IX of HAdV-2 and is 125 amino acid long (Baxi et al., 
1998,Zheng et al., 1994). When compared to amino acid sequence of other adenoviruses protein 
IX of BAdV-3 shows 16 to 28% similar amino acids (Reddy et al., 1998). In BAdV-3 infected 
cells protein IX can be detected as 14 kDa protein (Reddy et al., 1999). Similar to protein IX of 
other HAdVs (Akalu et al., 1999,Dmitriev et al., 2002), C-terminus of  protein IX of BAdV-3 is 
also exposed on the surface of viral capsid, which has been exploited for insertion of peptides for 
targeting of adenovirus vectors to different cells (Akalu et al., 1999,Dmitriev et al., 
2002,Zakhartchouk et al., 2004). 
1.1.4.2.4 Late genes 
 Similar to HAdVs, the BAdV-3 MLP is located at 16.2 map units (Reddy et al., 1998, 
Song et al., 1996). However, unlike HAdVs in which the late transcription unit gives rise to five 
families (L1-L5) of late mRNAs (Fraser et al., 1982) the BAdV-3 late transcription unit is 
processed into mRNAs that has been grouped into seven families (L1-L7) based upon usage of 
polyadenylation sites (Reddy et al., 1998). Similar to HAdV-2, BAdV-3 late mRNAs transcribed 
from MLP contains non coding tripartite leader (TPL) sequence, which in BAdV-3 is 205nt in 
length. The three parts of TPL are 40nt, 78nt and 87nt in length respectively (Chow et al., 1977, 
Reddy et al., 1998). 
 Unlike HAdVs in which L1 region encodes for only two proteins (52/55K and pIIIa) the 
L1 region of BAdV-3 encodes for four late proteins 52K, IIIA, III and pVII (Reddy et al., 
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1998,Sussenbach., 1984).The 52K protein of BAdV-3 is 331 amino acids long and shows 61.6% 
amino acid identities with its homolog in HAdV-2 (Reddy et al., 1998). The BAdV-3 52K is 
detected as 40kDa protein in infected cells, which localizes predominantly in the nucleus 
(Paterson et al., 2012). The three basic residues 
105
RKR
107
 of the identified NLS (amino acids 
102 to 110) of BAdV-3 52K appear critical for nuclear localization (Paterson et al., 2012). 
Furthermore, BAdV-3 52K interacts with and uses cellular importin α3 of the classical importin 
α/β pathway for it is transport to the nucleus (Paterson et al., 2012). The BAdV-3 52K also 
interacts with cellular protein NFκB-binding protein (NFBP) and causes its redistribution from 
the nucleolus to nucleus. The report also suggests that BAdV-3 52K interacts with viral protein 
pVII (Paterson., 2010).  
 The 568 amino acid long BAdV-3 IIIa protein shows 25 to 75% amino acid identities to its 
homologs in other adenoviruses. It has a potential protease cleavage site (LRGT↓G) which is 
located 19 amino acids away from C-terminus (Reddy et al., 1998). 
 The 482 amino acid long BAdV-3 penton base protein (protein III) shows 44 to 64% 
identities with amino acid sequences of its homologs in other  adenoviruses (Reddy et al., 1998). 
Unlike HAdV-5 (Neumann et al., 1988), the penton base protein of BAdV-3 lacks RGD motif, 
which is required for interacting with integrins (Reddy et al., 1998). Moreover, it also lacks the 
LDV motif present in penton base protein of HAdVs but instead contain a MDV motif 
(Komoriya et al., 1991,Reddy et al., 1998). Similar to HAdVs (Caillet-Boudin., 1989), the 
penton base of BAdV-3 also interacts with fiber protein using the conserved interacting domain 
located at amino acids 241 to 253 (Caillet-Boudin., 1989,Reddy et al., 1998). 
 The BAdV-3 major core protein pVII is 171 amino acids long and shows 29 to 53% amino 
acid identities to amino acid sequence of its homologs in other adenoviruses (Morrison et al., 
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1997,Reddy et al., 1998). The BAdV-3 pVII is highly basic and contains a potential adenovirus 
protease cleavage site (MYGG↓A) located close to its N-terminus (Reddy et al., 1998). It has 
been reported that BAdV-3 pVII localizes to mitochondria, increasing mitochondrial ATP and 
Ca+ production thus inhibiting apoptosis by preventing the loss of mitochondrial membrane 
potential (Anand et al., 2014). 
 Unlike L2 region of HAdV-2, which codes for three proteins, the L2 region of BAdV-3 
produces a single transcript that encodes protein V (Reddy et al., 1998,Sussenbach., 1984). The 
protein V is unique to the genus Mastadenovirus (Davison et al., 2003). The BAdV-3 protein V 
is 410 amino acids long and shows 28 to 40% amino acid identities to amino acid sequence of 
protein V of other Mastadenovirus (Morrison et al., 1997,Reddy et al., 1998). Recent report 
(Zhao., 2016) suggests that BAdV-3 protein V detected as 55kDa protein in infected cells, 
localizes to both nucleus and nucleolus of infected cells. Furthermore, BAdV-3 protein V 
contains three nuclear localization signals (amino acids 80-120, 190-210 and 380-389) and 
preferentially interacts with importin α-3 for its nuclear localization (Zhao., 2016). Moreover, it 
has been reported that BAdV-3 protein V contains two nucleolar localization signals (NoLs) that 
have been mapped to amino acids 21-50 and 380-389. Further it has been reported that these 
NoLs are necessary for viral replication (Zhao., 2016). It has also been reported that protein V is 
indispensable for viral replication and deletion of protein V from viral genome leads to decrease 
in viral late protein expression, reduced viral assembly and increased thermolability of progeny 
virions (Zhao., 2016). 
  Unlike HAdV-2, the L3 region of BAdV-3 encodes pX protein (Reddy et al., 
1998,Sussenbach., 1984). Similar to HAdV-2, BAdV-3 pX protein is 80 amino acid long and 
shows 38 to 64% amino acid identities to amino acid sequence of its homologs in other 
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adenoviruses (Anderson et al., 1989,Reddy et al., 1998). The BAdV-3 pX protein is also rich in 
basic amino acids and contains a bipartite NLS (Anderson et al., 1989,Reddy et al., 1998). 
Moreover, BAdV-3 pX also contains 2 potential protease cleavage sites (
27LRGG↓S31) and 
(
47LRGG↓F51) (Reddy et al., 1998,Russell & Kemp., 1995,Weber., 1995). 
 Unlike HAdV-2, the L4 region of BAdV-3 encodes pVI protein (Reddy et al., 
1998,Sussenbach., 1984). The BAdV-3 pVI is 263 amino acids long and shows 15 to 38% amino 
acid identities to amino acid sequence of its homologs in other adenoviruses (Reddy et al., 1998). 
The BAdV-3 pVI contains two potential adenovirus protease cleavage sites (Reddy et al., 
1998,Russell & Kemp., 1995,Weber., 1995). Since there is substantial amino acid sequence 
homology between the C-terminal fragment of pVI protein of HAdV-2 and BAdV-3 it is likely 
that the C-terminal fragment of BAdV-3 pVI protein may function as cofactor for BAdV-3 
protease (Reddy et al., 1998). 
 Unlike HAdV-2, the L5 region of BAdV-3 encodes two proteins namely hexon and 
protease (Reddy et al., 1998,Sussenbach., 1984). The 204 amino acid long BAdV-3 protease 
shows 30 to 65% amino acid identities with amino acid sequence of its homologs in other 
adenoviruses (Cai et al., 1990,Reddy et al., 1998). The potential BAdV-3 protease cleavage sites 
are conserved in all the precursor proteins (Reddy et al., 1998). The major capsid protein hexon 
is 910 amino acids long in BAdV-3 and shows 45 to 70% amino acid identities to amino acid 
sequence of hexon protein of other adenoviruses (Hu et al., 1984,Reddy et al., 1998). In BAdV-3 
infected cells hexon can be detected as a 98 kDa protein (Kulshreshtha et al., 2004). 
 The L6 region of BAdV-3 genome  encodes three non structural proteins namely 100K, 
22K and 33K and one structural protein pVIII (Reddy et al., 1998). The 850 amino acid long 
BAdV-3 100K protein shows 27 to 52% amino acid identities with amino acid sequence of its 
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homologs in other adenoviruses (Reddy et al., 1998). A recent report suggested that BAdV-3 
100K acts as a substrate for adenovirus protease and is cleaved at two consensus protease 
cleavage sites. However, cleavage of BAdV-3 100K protein appears dispensable for virus 
replication (Makadiya et al., 2015). Further, it has been reported that the cleaved C-terminus 
fragment of 100K contains a nuclear localization signal (amino acids 789-811) which helps to 
localize the C-terminus of BAdV-3 100K in the nucleus (Makadiya et al., 2015). The BAdV-3 
100K also interacts with adenovirus protein 33K and cellular protein dynein light chain 
(DYNLT) 1 (Makadiya., 2013).  
BAdV-3 33K and 22K proteins are products of splicing of a single transcript and both 
share N-terminus 138 amino acids (Kulshreshtha., 2009). Interaction of 33K with adenovirus 
proteins 100K and protein V and cellular protein bovine presenilin-1-associated 
protein/mitochondrial carrier homolog 1 (BoPSAP/BoMtch1) has also been reported 
(Kulshreshtha., 2009,Kulshreshtha & Tikoo., 2008). A recent study has reported that 33K protein 
uses both importin-α5 and transportin-3 for its nuclear transport. Moreover, it has been reported 
that conserved arginines of RS repeats that are present at C-terminus of 33K are indispensable 
for nuclear transport of 33K as well as virus replication (Kulshreshtha et al., 2014). 
The 274 amino acid long BAdV-3 22K protein is the unspliced form of 33K mRNA. It has 
been suggested that the 97 amino acids located at N-terminus of 33K/22K may play a vital role 
in encapsidation of DNA (Kulshreshtha et al., 2004). 
 The hexon associated protein pVIII is the only structural protein that is encoded by the L6 
region of BAdV-3. The BAdV-3 pVIII is 216 amino acids long and shows 19 to 56% amino acid 
identities with amino acid sequence of its homologs in other adenoviruses (Reddy et al., 
1998,Sussenbach., 1984,Vrati et al., 1995). Two potential adenovirus protease cleavage sites 
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(
108IAGG↓G112) and (143LGGG↓S147) are present in pVIII protein of BAdV-3 (Reddy et al., 
1998). 
 Unlike HAdV-2, the L7 region of BAdV-3 genome encodes for fiber protein (Reddy et al., 
1998,Sussenbach., 1984). The 976 amino acid long BAdV-3 fiber protein shows 17 to 26% 
amino acid identities with amino acid sequence of its homologs in other adenoviruses (Reddy et 
al., 1998). The BAdV-3 fiber protein also contains the conserved hydrophobic sequence motif 
that is responsible for interacting with penton base protein (Caillet-Boudin., 1989,Reddy et al., 
1998). Moreover, BAdV-3 fiber protein also contains a conserved TLWT motif at the junction of 
head and shaft (Chroboczek et al., 1995,Reddy et al., 1998). Since the tropism of BAdV-3 can be 
altered by changing the knob region of BAdV-3 fiber protein with knob region of HAdV-5 fiber 
protein, it is suggested that the knob region of BAdV-3 fiber is responsible for the initial 
interaction of virus to cellular receptor (Wu & Tikoo., 2004). 
1.1.5 Adenovirus protease and its role in adenovirus life cycle 
 Early studies reported that cleavage of some adenovirus precursor proteins is essential for 
infectivity of progeny adenovirus (Amin et al., 1977,Anderson et al., 1973,Edvardsson et al., 
1976,Weber., 1976). Subsequent studies reported that proteolytic activity observed during 
adenovirus infection is because of virus encoded protease protein packaged in adenovirus virion 
(Bhatti & Weber., 1979,Bhatti & Weber., 1978). 
 Adenovirus protease, a product of L3 transcription unit, has a molecular weight of 23 kDa 
in HAdV-5. The gene for AVP is highly conserved in all adenoviruses that have been sequenced 
to date (Davison et al., 2003,Webster & Kemp., 1993). Protease protein is packaged into mature 
virus particle with an estimated copy number ranging between 10 and 50 per virion (Anderson., 
1990,Brown et al., 1996). 
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Earlier studies reported that protease activity of adenoviral protease expressed in E. coli is 
inhibited by cysteine protease inhibitor and hypothesized that conserved cysteine residues at 
position 104 and 122 are crucial for the protease activity (Tihanyi et al., 1993). Later analysis of 
the crystal structure of HAdV-2 protease in complex with C-terminal 11 amino acids of pVI 
revealed that like papain, adenovirus protease also uses a catalytic triad of H54, E71 and C122 
for its activity. These findings lead to the classification of AVP as the earliest member of a novel 
class of cysteine proteases (Ding et al., 1996). 
Using synthetic peptides as substrates and by analyzing cleavage of the precursor viral 
proteins during adenovirus infection, it has been determined that AVP recognizes and cleaves at 
two consensus cleavage motifs (M/I/L)XGX-G and( M/I/L)XGG-X (where X is any amino acid) 
(Webster et al., 1989). However, some of the studies have reported AVP mediated cleavage at 
sites other than the consensus cleavage motif suggesting that the specificity requirements for the 
cleavage motif can be relaxed (Makadiya et al., 2015,Perez-Berna et al., 2014,Webster et al., 
1997). 
Observations that recombinant AVP produced in bacteria or insect cells has no cleavage 
activity together with the observation that the protease activity of recombinant AVP can be 
restored by incubation with disrupted virus led to the conclusion that some adenovirus encoded 
cofactors are required for AVP activity. Further studies suggested that the C-terminal 11 amino 
acid of protein pVI and viral DNA act as the cofactors required for the optimal AVP activity 
(Mangel et al., 1993,Webster & Kemp., 1993,Webster et al., 1993). 
 Adenoviral proteins that act as substrate for adenovirus protease include three minor 
capsid proteins (pIIIa, pVI and pVIII ) and three core proteins (pVII, pμ and pTP) (Challberg & 
Kelly., 1981,Mangel et al., 1996,Weber., 1976). Apart from these six structural proteins two 
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nonstructural proteins L1 52/55k (Perez-Berna et al., 2014) and 100K (Makadiya et al., 2015) 
have been recently reported to be the substrates of adenoviral protease. Studies involving a 
temperature sensitive mutant adenovirus also known as ts1 has provided invaluable information 
on role of AVP in maturation of adenovirus and its effect on the infectivity (Mangel & San 
Martín., 2014). The ts1 mutant when propagated at 39°C failed to incorporate AVP in the viral 
particle. Moreover, though progeny virions contained all AVP target proteins in precursor form, 
the virions were not infectious. These results suggested that AVP is essential for the maturation 
and subsequent infectivity of progeny adenovirus (Imelli et al., 2009,Rancourt et al., 
1995,Weber., 1976,Yeh-Kai et al., 1983). 
Newly synthesized AVP is in its inactive state to protect precursor proteins from being 
cleaved prematurely. The packaging of AVP in immature particle and its binding to viral DNA 
leads to its partial activation (Bajpayee et al., 2005,Gupta et al., 2004,Mangel et al., 
1993,McGrath et al., 2001). When partially activated AVP comes in contact with DNA bound 
pVI, it cleaves pVI at both N-terminus and C-terminus generating 11 amino acids peptide 
cofactor pVIc. The released pVIc then binds to AVP bound to DNA leading to its full activation 
(Baniecki et al., 2001,Graziano et al., 2013,McGrath et al., 2002). Fully activated AVP cleaves 
six structural proteins and a non structural 52/55k protein causing its release from the virion 
(Mangel et al., 1997,Perez-Berna et al., 2014). AVP mediated cleavage of adenoviral proteins 
thus results in a mature metastable adenovirus particle (Perez-Berna et al., 2012).  
After the lysis of the infected cells, newly assembled viruses are released into the 
extracellular environment. The oxidizing conditions of the extracellular environment inactivate 
the AVP. To infect a new cell, after initial attachment of adenovirus fiber knob with the primary 
cellular receptor, the penton base interacts with integrins receptors on cell surface and virus 
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particles are subsequently endocytosed. Interaction of integrins and penton base causes a 
conformational change that exposes the previously hidden protease cleavage sites of pVI protein 
(Greber et al., 1996). Exposure to reducing environment of endosomes reactivates the AVP and 
leads to degradation of pVI protein and this starts the uncoating of adenovirus particle. The 
degradation of pVI protein is blocked and disassembly of virus particle is suspended at nuclear 
envelop if protease activity is blocked by use of protease inhibitors (Greber., 1998,Greber et al., 
1996).  
It has been reported that late in infection, AVP causes cleavage of cytokeratin 18 at two 
consensus cleavage sites causing destruction of cytokeratin network of the cell (Chen et al., 
1993). The actin was identified as a cofactor that can activate AVP in cytoplasm in the absence 
of other viral proteins (Brown et al., 2002).  Presence of two AVP consensus cleavage sequences 
in β-actin suggested that it can also be a substrate for AVP. Incubation of AVP with actin lead to 
the cleavage of actin at consensus cleavage site confirming that indeed actin acts as a substrate 
for AVP (Mangel et al., 2003). These reports indicated that during the course of adenovirus 
infection, AVP causes destruction of the cytoskeletal network and thus promotes lysis of 
adenovirus infected cell, which is essential for the release of progeny virions (Chen et al., 1993). 
Thus, adenovirus protease plays a vital role in maturation, uncoating and release of adenovirus 
from the infected cells. 
1.2 mRNA translation in eukaryotes 
 mRNA translation in eukaryotes is an essential, multistep, multiprotein, complex process 
that requires comprehensive biological machinery (Hershey., 1991,Hershey & Merrick., 2000). 
This elegant process of deciphering a polypeptide sequence from an mRNA transcript can be 
divided into four stages: translation initiation, elongation, translation termination and recycling 
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(Kapp & Lorsch., 2004,Sonenberg & Hinnebusch., 2009). In initiation stage, an active 80S 
ribosome, consisting of 40S and 60S ribosomal subunits, is assembled at the 5ʹ end of mRNA. 
The elongation stage follows initiation stage and involves movement of 80S ribosome along 
mRNA in a 5ʹ to 3ʹ direction adding amino acid to polypeptide chain. Termination occurs when a 
stop codon is encountered in mRNA by the translating ribosome. The newly synthesized 
polypeptide chain is then released from translating ribosome. In the recycling stage, the 80S 
ribosome is dissociated into 40S and 60S subunits which can again take part in another round of 
initiation (Kapp & Lorsch., 2004). Since protein synthesis is central to the cell survival and well 
being a large proportion of cellular resources and energy is devoted towards translation and its 
regulation. Although all stages of translation are tightly regulated, the regulation of translation 
initiation is most critical (Mathews et al., 2007,Preiss & W Hentze., 2003,Sonenberg & 
Hinnebusch., 2009).  
1.2.1 Translation initiation  
 Translation initiation is the process of assembly of protein synthesis machinery on an 
mRNA transcript and involves structural elements of mRNA and several coordinated mRNA-
protein and protein-protein interactions (Preiss & W Hentze., 2003). A number of proteins that 
play important role in translation initiation are present in limiting amounts in cells, therefore 
translation initiation is the critical step for protein synthesis (Preiss & W Hentze., 2003,Sachs & 
Varani., 2000).  
1.2.1.1 Structural elements of eukaryotic mRNA 
 Since cellular nucleases can easily access and target the 5ʹ and 3ʹ ends of newly 
synthesized mRNA transcript, the ends of mRNA must be protected from this nuclease mediated 
degradation. This is accomplished by addition of a 5ʹ 7-methylguanosine cap structure at time of 
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transcription and a 50-300 nucleotide long 3ʹ poly A tail immediately after transcription (Hall., 
2002,Schoenberg & Maquat., 2009,Wilusz et al., 2001). These structural elements not only 
protect the mRNA transcript but also regulate processing, export from nucleus to cytoplasm and 
translation of mRNA transcript (Wilusz et al., 2001). 
 The 5ʹ cap structure plays an important role in regulating the important features of mRNA 
biology including RNA splicing, export from nucleus and translation (López‐Lastra et al., 2010). 
During the process of translation initiation, the cap structure through its interaction with 
eukaryotic initiation factor (eIF) 4E recruits the 40S ribosomal subunit to the mRNA transcript 
(described in section 1.2.1.2). 
 The presence of a poly (A) tail at the 3ʹ end of mRNA transcript is also important for 
providing stability to mRNA transcript. Except histone mRNAs, majority of the mammalian 
mRNA transcripts have a poly (A) tail ranging from 50-300 nucleotides long (Dominski & 
Marzluff., 2007). Poly (A) - binding protein (PABP), which has high affinity for polyadenylated 
mRNA, binds to poly A tail (Mangus et al., 2003). Moreover, PABP also interacts with 5ʹ end 
bound eIF4G leading to the circularisation of mRNA transcript.  This circular conformation 
increases the stability of mRNA transcript and protects 3ʹ and 5ʹ ends of mRNA by blocking the 
access to nucleases and decapping enzymes (Amrani et al., 2008,Sachs & Varani., 2000). 
1.2.1.2 Cap dependent translation initiation 
Translation initiation is a process involving a number of steps that require orderly 
interactions of at least 12 well defined initiation factors (Pestova et al., 2007). Since, translation 
initiation necessitates dissociated ribosomal subunits, the first step in the initiation process is 
building the pool of 40S and 60S ribosomal subunits. This is accomplished by blocking 
physiologically favourable joining of dissociated 40S and 60S subunits by tight binding of three 
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initiation factors eIF1A, eIF3 and eIF6 to dissociated subunits (Jackson et al., 2010,Pestova et 
al., 2007).  eIF6 interacts with 60S subunit (Valenzuela et al., 1982) while eIF1A and eIF3 bind 
tightly to 40S subunit (Thomas et al., 1981). Once a pool of 40S subunit is established, the next 
step is the recruitment of initiator tRNA, Met-tRNAi and formation of a ternary complex 
consisting of eIF2, GTP and Met-tRNAi. The eIF2 first binds GTP and subsequently eIF2-GTP 
complex binds Met-tRNAi to produce the ternary complex (Erickson & Hannig., 1996,Kapp & 
Lorsch., 2004). The ternary complex then interacts with 40S subunit to form the 43S preinitiation 
complex (PC). The 40S subunit bound factors eIF1, eIF1A and eIF3 facilitate interaction of the 
ternary complex and the 40S subunit (Majumdar et al., 2003,Trachsel et al., 1977). 
 The 43S PC is then recruited to the mRNA using the 5ʹ cap structure of the mRNA as a 
recruitment site. This recruitment of the 43S PC to the 5ʹcap is facilitated by the eIF4F complex. 
The eIF4F is a multiprotein complex consisting of cap binding protein eIF4E, RNA helicase 
eIF4A and the scaffolding protein eIF4G (Pestova et al., 2007).  
 The cap binding protein eIF4E has a baseball glove like structure made up of eight 
stranded anti parallel beta sheets and three long helices. The concave region of the eIF4E formed 
between two tryptophan residues provide binding site for the cap structure of mRNA whereas 
convex surface of the protein provides binding site for eIF4G (Marcotrigiano et al., 1997,Matsuo 
et al., 1997,von der Haar et al., 2004). Once eIF4E binds to the cap structure of a mRNA, it 
facilitates the interaction of eIF4A and eIF4G to the 5ʹ end of mRNA (Pestova et al., 2007). 
 The eIF4A, a protein that belongs to DEAD-box protein family, is a 46 kDa protein with 
both RNA helicase and RNA dependent ATPase activity. Although, eIF4A has a weak inherent 
helicase activity, its activity is significantly enhanced by eIF4B and by incorporation into the 
eIF4F complex (Rogers et al., 2001,Rozen et al., 1990). It has been suggested that the increased 
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helicase activity of eF4A-eIF4B complex plays a role in unwinding complex secondary 
structures in the 5ʹ UTR of mRNA and aids in recruitment of 43S PC (Rogers et al., 
1999,Sonenberg., 1996). 
 The 176 KDa eIF4G is the largest member of eIF4F complex. It binds to eIF4E, eIF4A, 
eIF3 and PABP and thus acts as a scaffold for the formation of an active translation initiation 
complex (Keiper et al., 1999,Prévôt et al., 2003). The attachment site for eIF4E is present at the 
N-terminus whereas the middle and C-terminal presents site for eIF4A binding (Imataka & 
Sonenberg., 1997,Mader et al., 1995). Because of its binding with eIF3 (part of 43S PC), the 
eIF4G acts as a bridge between mRNA and 40S ribosome (Gingras et al., 1999,Sachs et al., 
1997). Moreover, by binding to PABP, the eIF4G links 3ʹ poly A tail and 5ʹcap structure and thus 
causes circularization of mRNA (Kahvejian et al., 2001). 
 Once 43S PC is positioned near mRNA, it moves in 5ʹ to 3ʹ direction along the mRNA 
scanning for the AUG initiation codon (Kozak., 1978). The first AUG sequence in an optimal 
sequence context for initiation (GCC(G/A)CCAUG) is the initiation codon (Kozak., 
1986,Kozak., 1987). Once an appropriate initiation codon is identified, the base pairing of the 
AUG initiation codon and the CAU anticodon of Met-tRNAi leads to the production of 48S 
initiation complex (Pestova et al., 1998). After formation of 48S initiation complex the 40S 
bound initiation factors (eIF1A and eIF3) are removed from 40S subunit to allow joining of 60S 
subunit. This is facilitated by eIF5, which causes hydrolysis of GTP in ternary complex eIF2-
GTP-Met-tRNAi that leads to the release of eIF2-GDP. This is followed by release of eIF3 from 
48S complex. Subsequently, eIF5B mediates the release of eIF1, eIF1A, remaining eIF2-GDP 
and joining of 60S subunit resulting in generation of functional 80S ribosome (Pestova et al., 
2000,Unbehaun et al., 2004). 
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1.2.1.3 Cap independent translation initiation 
 The majority of protein synthesis in the eukaryotic cells is reliant on the cap structure 
present at 5ʹ terminus of mRNA. However, some cellular and viral RNAs do not have a cap 
structure and are translated by an alternative mechanism that involves 5ʹ untranslated region 
(UTR) that have extensive secondary structure, known as internal ribosome entry site (IRES) 
(Hellen & Sarnow., 2001). The first IRES sequences were discovered in picornavirus mRNAs 
(Jang et al., 1988,Pelletier & Sonenberg., 1988) and later on IRES sequence was discovered in a 
cellular mRNA (Macejak & Sarnow., 1991). Subsequently, the  IRES sequence has been found 
in a number of cellular mRNAs including oncogene c-myc, fibroblast growth factor-2 (FGF-2), 
eIF4GII, heat shock protein 70 (HSP 70), and X-linked inhibitor of apoptosis protein (XIAP) 
(Byrd et al., 2005,Holcik et al., 1999,Rubtsova et al., 2003,Stoneley et al., 2000,Vagner et al., 
1995). The mRNAs that contain IRES sequences are normally expressed at low levels, however; 
they are expressed more efficiently if cap dependent translation is inhibited or down regulated 
(i.e. due to stress or viral infection) (Merrick., 2004,Qin & Sarnow., 2004). A number of viruses 
including coronaviruses, flaviviruses, picornaviruses, retroviruses and herpesviruses have been 
reported to contain IRES sequence in their mRNA (López‐Lastra et al., 2010). 
1.2.2 Viral inhibition of cellular mRNA translation 
Viruses do not have their own metabolic machinery so they depend completely on their 
host for translation of their transcripts. Viruses must therefore compete with host cell for protein 
synthesis machinery. However, it is difficult for the virus to compete because viral transcripts are 
outnumbered by large number of cellular transcripts (Mohr et al., 2007,Schneider & Mohr., 
2003). The majority of protein synthesis in the eukaryotic cells is reliant on the cap structure 
present at 5ʹ terminus of mRNA. This absolute dependence of host cellular mRNA on cap 
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initiation complex has provided viruses with the unique opportunity to compete with host. The 
easiest way for the virus to acquire host protein synthesis machinery is to inhibit host protein 
synthesis by targeting the process of cap dependent translation and at the same time develop 
specific translation mechanisms for itself that bypasses this requirement. Thus, viruses have 
developed sophisticated alternative means for mRNA translation. These specialized mechanisms 
reduce their dependence on cap dependent translation or provide them an edge for competing 
with the cellular transcripts. Many viruses globally interfere with the host translation by 
inhibiting cap dependent ribosome recruitment to host mRNA (Firth & Brierley., 2012,Gale et 
al., 2000). Viruses can target initiation, elongation or termination stage of translation (Walsh & 
Mohr., 2011). Since translation initiation is the most critical step for eukaryotic translation, most 
of the viruses target the translation initiation factors to inhibit cap dependent translation (Gale et 
al., 2000). 
1.2.2.1 Inhibition of protein synthesis by targeting eIF4F   
The eIF4F is a multisubunit complex formed by three important proteins i) eIF4G-the 
scaffold protein, ii) eIF4E- the cap binding protein and iii) eIF4A-the RNA helicase (Gingras et 
al., 1999) The eIF4F proteins perform several key functions at the time of cap dependent 
translation in eukaryotes such as recognition of the 5ʹcap, recruitment of 40S ribosomal subunit 
and unwinding of RNA secondary structure. Thus, it is not unexpected that several viruses target 
eIF4F to shut off the host protein synthesis by making eIF4F subunit non functional or by 
altering the eIF4F binding proteins (Walsh & Mohr., 2011). 
1.2.2.1.1 Targeting of eIF4G by viral proteases 
The eIF4G acts as a scaffold protein and interacts with several proteins essential for the 
recruitment of the ribosome to 5ʹ end of mRNA. It interacts with eIF4E, eIF3, PABP and the 
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MAPK integrating kinase (Mnk), for forming an active translation initiation complex (Prévôt et 
al., 2003). Because of its central role in translation initiation, several viruses encode proteases to 
target eIF4G.  Poliovirus, rhinovirus and retroviruses cleave eIF4G by using virus encoded 
proteases (Etchison et al., 1982,Haghighat et al., 1996,Ventoso et al., 2001). This cleavage of 
eIF4G by viral proteases separates the eIF4E binding amino terminal region from eIF3 and 
eIF4A associated carboxy terminal fragment. This prevents formation of a functionally active 
eIF4F complex, thus inhibiting the cap dependent cellular proteins synthesis. This inhibition of 
host cap dependent protein synthesis does not inhibit viral mRNA translation because the viral 
mRNA of these viruses contains IRES sequences that mediate cap independent protein synthesis 
(Walsh & Mohr., 2011). 
1.2.2.1.2 Modulation of eIF4E availability 
The eIF4E protein is a key translation initiation factor. The eIF4E binds to the 5ʹ cap 
structure of an mRNA, eIF4A and eIF4G. In comparison to other translation factors, eIF4E is 
present in limited quantities in the cell, which helps to regulate formation of eIF4F complex by 
controlling availability of eIF4E by 4E binding proteins (4EBP)(Matsuo et al., 1997,Sonenberg., 
1996). The 4EBP’s are low molecular weight proteins, which can act as translation repressors by 
preventing the formation of eIF4F complex. The 4EBP’s binds tightly to eIF4E in the same 
region where eIF4G binds to eIF4E (Gingras et al., 1999,Gingras et al., 2001b). The interaction 
of 4EBP and eIF4E is regulated by phosphorylation of 4EBP’s. In their hypophosporylated form, 
the 4EBP’s binds to eIF4E, eliminating its binding to eIF4G and hence inhibiting the cap 
dependent translation. The phosphorylation of 4EBP reduces its affinity for eIF4E and hence 
increasing the availability of eIF4E for incorporation into eIF4F (Gingras et al., 2001a,Lin et al., 
1994,Svitkin et al., 2005). Several viruses target this process for inhibiting cap dependent 
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translation. Hypophosphorylation of 4EBP in encephalomyocarditis virus (EMCV) infected cell 
leads to inhibition of cellular protein synthesis (Gingras et al., 1996). Viral mRNA translation is 
not inhibited because of IRES elements that are able to recruit ribosomes in absence of a cap and 
eIF4E. This mechanism of inhibition of cellular protein synthesis is also seen during vesicular 
stomatitis virus (VSV) where Akt-signaling is suppressed by viral M protein leading to 
prevention of mTORC1 facilitated inactivation of 4EBP1 (Dunn & Connor., 2011). Similarly,In 
SV40 infection, small T-antigen associates with cellular protein phospahatase 2A (PP2A) leading 
to dephosphorylation of 4EBP1 (Yu et al., 2005). The accumulation of hypophosphorylated 
4EBP to inhibit eIF4F assembly is also demonstrated in Dengue virus, Sindbis virus and cricket 
paralysis virus infected cells (Garrey et al., 2010,Mohankumar et al., 2011,Villas-Bôas et al., 
2009).  
Interestingly, enterovirus infection leads to increased production of cellular miRNA mir-
141 which decreases the expression of its target gene eIF4E thus resulting in inhibition of cap 
dependent protein synthesis (Ho et al., 2011). 
1.2.2.1.3 Modulation of eIF4E activity by phosphorylation 
  The eIF4G associated kinases Mnk1 and Mnk2 causes phosphorylation of eIF4E. 
However, effect of Mnk1 and Mnk2 mediated phosphorylation of eIF4E on translation initiation 
is not clear (Pyronnet et al., 1999,Scheper & Proud., 2002,Scheper et al., 2001). Reduction in the 
level of phosphorylation of eIF4E has been suggested to be responsible for inhibition of mRNA 
translation in mammalian cells infected with several viruses including adenovirus and influenza 
virus (Cuesta et al., 2000,Cuesta et al., 2004,Feigenblum & Schneider., 1993). The cellular 
protein synthesis is inhibited at late time in adenovirus infected cell because of virus induced 
under phosphorylation of eIF4E. Adenoviral 100K protein binds to C-terminus of eIF4G and 
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prevents binding of Mnk1 to eIF4G thereby blocking phosphorylation of eIF4E (Cuesta et al., 
2004). 
1.2.2.2 Inhibition of protein synthesis by targeting Poly (A) binding protein  
The PABP1 is an essential protein and plays a vital role in mRNA stability and translation 
initiation. The poly (A) tail of majority of the transcripts is covered with multiple copies of 
PABP1 (Gorgoni & Gray., 2004,Mangus et al., 2003). The PABP interacts with eIF4G bridging 
5ʹ and 3ʹ termini of mRNA causing circularization of the translation initiation complex. This 
circulariztion of translation initiation complex increases efficiency of translation by stabilizing 
assembled initiation factors (Sachs et al., 1997,Svitkin et al., 2001). Several viruses target PABP 
and disrupt its function. In enteroviruses or coxsackievirus infected cells, the PABP is cleaved by 
viral encoded protease 2A (Joachims et al., 1999,Kerekatte et al., 1999). Similarly, in poliovirus 
infected cells, the PABP is cleaved by virus encoded protease 3C (Kuyumcu-Martinez et al., 
2004b). However, in calcivirus infected cells, the virus encoded 3C like protease cleaves PABP 
(Kuyumcu-Martinez et al., 2004a). The Inhibition of host cap mediated translation in rotavirus 
infected cells occurs by blocking the function of PABP.  Rotavirus mRNA’s have a 5ʹcap 
structure but lack 3ʹ poly (A) tail. The 3ʹ untranslated region of rotavirus mRNA contain a 
conserved tetranucleotide sequence, which is recognized by viral protein NSP3. The NSP3 also 
binds to eIF4G through its C- terminal domain and assumes the role of PABP in translation of 
rotavirus mRNA. Moreover, eIF4G has more affinity for viral NSP3 than for PABP. This leads 
to the disruption of interaction between eIF4G and PABP leading to reduced efficiency of host 
mRNA translation (Groft & Burley., 2002,Piron et al., 1998,Vende et al., 2000) 
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1.2.2.3 Inhibition of protein synthesis by altering the distribution of translation initiation 
factors 
Several viruses inhibit protein synthesis by altering the local abundance of translation 
initiation factors. Vaccinia virus and African swine fever virus replicate in dedicated 
compartments in cytoplasm. They cause redistribution of eIF4E and eIF4G to these dedicated 
compartments (Castelló et al., 2009,Katsafanas & Moss., 2007,Walsh et al., 2008). Poliovirus 
causes redistribution of eIF4E (Sukarieh et al., 2010). Several viruses including bunyavirus, 
rotavirus, herpes simplex virus (HSV)-1 and Kaposi sarcoma herpes virus (KSHV) cause 
redistribution of PABP to the nucleus (Blakqori et al., 2009,Clyde & Glaunsinger., 2010,Harb et 
al., 2008,Salaun et al., 2010). 
1.2.2.4 Inhibition of protein synthesis by targeting mRNA 
Several viruses target 5ʹ Cap structure of host mRNA to interfere with cellular protein 
synthesis.  Influenza virus and hantavirus encode  a viral endonuclease to steal caps along with 
10-18 nucleotide segment from host mRNA (Mir & Panganiban., 2008,Mir et al., 2008,Plotch et 
al., 1981). Poxviruses and asfarviruses produce decapping enzyme that remove the 5ʹ cap from 
host mRNA resulting in the inhibition of cap dependent protein synthesis (Parrish et al., 
2007,Parrish & Moss., 2007).  
1.2.3 Eukaryotic initiation factor 6 (eIF6) 
Eukaryotic translation initiation factor 6 (eIF6) is an important protein that is necessary 
for 60S ribosome biogenesis and assembly (Basu et al., 2001,Valenzuela et al., 1982). It was 
initially isolated independently from both wheat germ and calf liver extract (Russell & 
Spremulli., 1979,Valenzuela et al., 1982). The eIF6 is highly conserved from yeast to mammals 
(Biffo et al., 1997). The human eIF6 is 245 amino acids long and shows  77% identity to its 
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homolog in yeast cells (Si et al., 1997,Si & Maitra., 1999). The eIF6 is expressed as 25 kDa 
protein at varying levels within the tissues. The brain and epithelia have high levels of eIF6 
expression while muscles show low level of eIF6 expression. Within an organ, eIF6 expression is 
high in stem cells and dividing cells (Donadini et al., 2001).  However, it is still not known how 
expression of eIF6 is regulated at molecular level. 
Earlier studies involving yeast cells reported that depletion of Tif6 (yeast eIF6 homologue) 
results in rapid reduction of 60S ribosomal subunits compared to 40S subunit. This effect could 
be reversed if human eIF6 is supplemented (Sanvito et al., 1999,Si & Maitra., 1999,Wood et al., 
1999) indicating that eIF6 plays an important role in ribosome biogenesis. However, there is no 
study that can provide a direct evidence for role of eIF6 in ribosome biogenesis in mammalian 
cells (Miluzio et al., 2009).   
It was found that eIF6 can bind to immature 60S subunit, which prevents joining of 40S 
ribosomal subunit with 60S subunits and thus 80S initiation complex is not formed (Valenzuela 
et al., 1982). Since translation initiation necessitates availability of separated 40S and 60S 
ribosomal subunits, and eIF6 because of its ability to prevent joining of 40S and 60S ribosomal 
subunit was thought to play a major role in providing a pool of separated ribosomal subunits, it 
was classified as a translation initiation factor (Biswas et al., 2012). For initiation of translation, 
the release of eIF6 from 60S subunit is essential (Ceci et al., 2003). Recent studies have reported 
that 40S and eIF6 bind to same site of 60S and thus presence of eIF6 on 60S subunit presents a 
stearic hindrance for 40S subunit thus modulating the joining of 40S to 60S subunit (Gartmann et 
al., 2010,Klinge et al., 2011).    
The eIF6 is localized in the nucleus as well as in the cytoplasm of both mammalian and 
yeast cells (Horsey et al., 2004,Lebreton et al., 2006,Sanvito et al., 1999).  eIF6 is found bound 
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to immature 60S ribosomal subunit in the nucleolus. During pre 60S maturation, eIF6 is found in 
the nucleus and it then moves to the cytoplasm along with pre 60S ribosomal subunit. After  
maturation of 60S subunit in cytoplam, eIF6 is released from the mature 60S subunit in the 
cytoplasm, which allows joining of 60S and 40S subunits leading to the formation of functional 
80S ribosome (Fig. 1.2.1) (Ceci et al., 2003,Horsey et al., 2004,Miluzio et al., 2009,Si & 
Maitra., 1999). 
 It has been reported that eIF6 is a nucleo-cytoplasmic shuttling protein, which is 
regulated by phosphorylation and dephosphorylation of eIF6 (Basu et al., 2003,Biswas et al., 
2011). The CK1 mediated phosphorylation of Ser-174 and Ser-175 residues of pre-60S bound 
eIF6 are essential for its export from the nucleus (Basu et al., 2003). Moreover, following its 
release from 60S ribosomal subunit in the cytoplasm, the phosphorylated eIF6 is 
dephosphorylated by calcium dependent phosphatase calcineurin and this dephosphorylated form 
of eIF6 is imported back into the nucleus by some yet unknown mechanism (Biswas et al., 
2011). 
The mechanism of release of eIF6 from 60S subunit is still not clear and two different 
mechanisms have been proposed. First, protein kinase C (PKC)-RACK1 (receptor for activated 
kinase C) complex in mammalian cells mediates phosphorylation of eIF6 at Ser-235 that leads to 
the release of eIF6 from 60S subunit (Ceci et al., 2003). However, studies involving yeast cell 
reported that release of eIF6 from 60S subunit is caused by co-operative action of GTPase 
elongation factor-like1 (Efl 1 p) and Sdo1 (yeast orthologue of mammalian Shwachman-Bodian- 
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Figure 1.2.1 Nucleocytoplasmic shuttling of eIF6 and its anti-association activity. Reprinted 
from (Miluzio et al., 2009) with permission from John Wiley and Sons (publisher). 
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Diamond syndrome protein) (Bécam et al., 2001,Menne et al., 2007,Senger et al., 2001). One of 
the recent in vitro studies have reported that purified recombinant SBDS and EFL1 proteins 
when incubated with eIF6 bound 60S subunits can cause release of eIF6 from the 60S subunit 
(Finch et al., 2011). A recent cryo –EM study have suggested that binding of EFL1 to 60S 
ribosome causes repositioning of SBDS on 60S ribosome, which facilitates a conformational 
change in EFL1. The EFL1 then compete with eIF6 for a corresponding binding site on 60S 
ribosome causing release of eIF6 from 60S ribosome (Weis et al., 2015).    
A number of studies have tried to identify the role of eIF6 in cancer biology. The eIF6 
expression has been found to be upregulated in certain cancer types including colorectal cancer, 
lung metastasis, head and neck cancer, malignant mesothelioma and acute promyelocytic 
leukemia. However, no study has been able to establish the etiologic role of eIF6 in cancer (Biffo 
et al., 1997,Harris et al., 2004,Martín et al., 2008,Rosso et al., 2004,Sanvito et al., 2000). 
1.1.6 The polypeptide pVIII 
 The polypeptide pVIII is one of the minor capsid proteins that is present at the inner 
surface of the capsid and connects capsid to the core (Reddy et al., 1998,Rohn et al., 1997). The 
polypeptide pVIII is produced and present in immature capsid in precursor form (Takahashi et 
al., 2006, Vellekamp et al., 2001). However, only the cleaved fragments of pVIII can be detected 
in mature virus particles (Vellekamp et al., 2001).  
 The pVIII encoded by L4 region of HAdV-5 is 227 amino acids long (Chroboczek et al., 
1992) and contains three potential adenovirus protease cleavage sites (Diouri et al., 1996). 
Earlier mass spectrometry studies involving purified HAdV-5 virions reported presence of 
amino- terminal 112 amino acids  (Liu et al., 2003), carboxy-terminal 70 amino acids (Takahashi 
et al., 2006) or both amino-terminal 112 amino acids and carboxy-terminal 70 amino acids of 
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pVIII in mature virions (Blanche et al., 2001,Chelius et al., 2002). However, a cryoEM study has 
confirmed the presence of both amino-terminus (112 amino acids) and carboxy-terminus (70 
amino acids) fragments of pVIII in mature virus particles (Liu et al., 2010). Further studies have 
reported that two structurally different copies of pVIII (named A and B) bind to the hexons. The 
VIII-A is a member of V-VI-VIII ternary complex. This ternary complex provides stability to 
peripentonal hexons while VIII-B is a part of a binary complex VIII-B- VIB that contributes to 
stabilization of group of nine hexons (GONs) (Reddy & Nemerow., 2014). Thus, localization of 
polypeptide VIII points to its role in the stabilization of virion particle. One of the studies has 
reported that mutation in pVIII affects the stability of the adenovirus and makes them more 
thermolabile (Liu et al., 1985). 
 The BAdV-3 pVIII encoded by the L6 region of the genome is 216 amino acids long and 
shows 19 to 56% amino acid identities with amino acid sequence of its homologs in other 
adenoviruses (Reddy et al., 1998,Sussenbach., 1984). Two potential adenovirus protease 
cleavage sites [(
108IAGG↓G112) and (143LGGG↓S147)] are present in pVIII protein of BAdV-3. 
Recent report (Ayalew., 2015) suggest that BAdV-3 pVIII  detected as 24kDa protein in infected 
cells localizes to both nucleus and cytoplasm of infected cells. Moreover, BAdV-3 pVIII 
contains a nuclear localization signal (amino acids 57-72) and preferentially interacts with 
importin α-3 for its nuclear import (Ayalew et al., 2014). Moreover, it has been reported that 
BAdV-3 pVIII interacts with cellular DEAD-box protein 3 (DDX3) and this interaction leads to 
inhibition of cap dependent mRNA translation (Ayalew., 2015). 
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2.0 HYPOTHESIS AND OBJECTIVES 
 Although adenoviruses have been studied extensively, there is still paucity of information 
regarding the role of structural proteins in the infectious cycle particularly, with respect to the 
interaction between viral structural proteins and cellular factors. Among all the adenovirus 
structural proteins, minor capsid protein pVIII is least characterized (San Martín., 2012). The L4 
region encoded HAdV-2 pVIII (Chroboczek et al., 1992) connects the inner surface of the capsid 
to core and plays a significant role in providing stability to the virion.  
 Unlike HAdV-pVIII, BAdV-3 pVIII encoded by the L6 region of the genome is 216 amino 
acids long. Two potential adenovirus cleavage sites (
108IAGG↓G112) and (143LGGG↓S147) are 
present in pVIII protein of BAdV-3 (Reddy et al., 1998). Apart from pVIII, other adenoviral 
structural proteins that are substrate for adenovirus protease include minor capsid proteins pIIIa 
and pVI and core proteins pVII, pμ and pTP (Challberg & Kelly., 1981,Mangel et al., 
1996,Weber., 1976). Adenovirus protease mediated cleavage of these proteins is essential for 
maturation and subsequent infectivity of adenovirus. However, importance of each independent 
cleavage in virion stability and infectivity is still lacking. Moreover, the role of pVIII and its 
cleavage in the life cycle of adenovirus is still not clear. To understand the role of cleavage of 
each precursor protein, mutational studies involving mitigation of cleavage site are required.  
Viral proteins interact with host cellular proteins to create a favorable environment for 
virus multiplication. To understand the basic biology of a virus it is necessary to study these 
virus host interactions. Results of our recent yeast two hybrid experiments indicated that BAdV-
3 pVIII interacts with cellular protein eIF6. The eIF6 is a highly conserved protein that is 
essential for ribosome biogenesis and assembly and possesses a unique anti-association activity 
that keeps immature 60S and 40S ribosome separated (Miluzio et al., 2009). 
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 Taking all these points in consideration we hypothesize that pVIII of BAdV-3 is a 
multifunctional protein that interacts with cellular protein eIF6 and adenovirus protein protease 
and through these interactions play an important role in virus replication, virus assembly, 
stability and infection. 
The specific objectives of this work are: 
1. Confirmation of interaction of pVIII with eIF6 
2. Identification of interacting region of pVIII and eIF6 
3. Determining the biological significance of interaction of pVIII and eIF6 
4. Study the role of cleavage of pVIII in adenovirus life cycle 
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3.0 BOVINE ADENOVIRUS-3 pVIII ASSOCIATES WITH EUKARYOTIC INITIATION 
FACTOR-6 DURING INFECTION 
3.1 Introduction 
 Adenoviruses are large, nonenveloped viruses that have linear double stranded DNA (26 to 
45kb) as their genome (Davison et al., 2003) enclosed in an icosahedral capsid (Berk., 2013). 
Adenoviruses are members of family Adenoviridae which is further divided into five genera: 
Mastadenovirus, Aviadenovirus, Ataadenovirus, Siadenovirus and Ichtadenovirus. Members of 
Mastadenovirus genus including bovine adenovirus (BAdV) -3 encode genus specific protein 
named pVIII, a structural protein associated with hexon connecting the core with the adenovirus 
capsid (Reddy et al., 1998,Russell., 2009). 
 Viruses depend absolutely on translational machinery of their host cells for production of 
various proteins essential for their replication and progeny production. Viruses must therefore 
compete with cellular mRNAs for limited translation factors that are present in the eukaryotic 
cells. The majority of protein synthesis in eukaryotic cells is reliant on cap structure present at 5ʹ 
terminus of mRNA. This absolute reliance of host cellular mRNA on cap initiation complex has 
provided viruses with excellent opportunity to develop sophisticated translation mechanism that 
help them circumvent this requirement (Gale et al., 2000,Smith & Gray., 2010,Walsh et al., 
2013). Although a number of mechanisms have been reported for selective translation of viral 
mRNAs (Firth & Brierley., 2012,López‐Lastra et al., 2010,Mohr et al., 2007,Walsh & Mohr., 
2011), most of the viruses target translation initiation factors to inhibit cap dependent translation  
and then use the resources and host translation machinery for synthesis of their own proteins 
(Gale et al., 2000,López‐Lastra et al., 2010,Schneider & Mohr., 2003,Smith & Gray., 
2010,Walsh & Mohr., 2011,Walsh et al., 2013). 
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 Eukaryotic initiation factor 6 (eIF6) is one of the important initiation factors that plays an 
important role both in ribosome biogenesis and protein translation. It is a 25 kDa 
nucleocytoplasmic shuttling protein that is present bound to immature 60S unit in the nucleolus 
and the nucleus. In the cytoplasm, it is bound to free 60S ribosomal subunit (Horsey et al., 
2004,Russell & Spremulli., 1979,Valenzuela et al., 1982). The nucleocytoplasmic shuttling of 
eIF6 is controlled by its dephosphorylation and phosphorylation by cellular kinases (Biswas et 
al., 2011,Ceci et al., 2003). The presence of eIF6 on the 60S ribosomal subunit presents a steric 
hindrance in joining of 40S and 60S subunits. Only after complete maturation of 60S subunit, 
eIF6 is released from the 60S subunit so that the 40S subunit can join the 60S subunit to form a 
functional 80S ribosome (Gartmann et al., 2010). 
 Although it is known that adenovirus inhibit cap dependent translation during late times 
post infection identity of adenoviral protein involved in inhibiting cap dependent translation and 
exact mechanism is still not completely known (Huang & Schneider., 1991). Here, we report that 
BAdV-3 pVIII protein interacts with eIF6 and this interaction might prevent release of eIF6 from 
60S subunit thereby preventing joining of 40S and 60S subunit resulting in impairment in the 
formation of functional 80S ribosome.  
3.2 Materials and methods 
3.2.1 Cell line and Viruses 
Madin Darby Bovine Kidney (MDBK) cells (Kulshreshtha et al., 2004), cotton rat lung 
(CRL) cells (Papp et al., 1997) and VIDO DT1 cells (cotton rat lung fibroblasts expressing I-
SceI protein) (Du & Tikoo., 2010) were grown in minimum essential medium (MEM; Sigma 
Aldrich) supplemented with 10% fetal bovine serum. Human embryo kidney (HEK) 293T cells 
(ATCC
®
 CRL-3216
TM) were propagated in Dulbecco’s Modified Eagle medium (DMEM) 
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supplemented with 10% FBS. BAV304a (contains BAdV-3 genome from which E3 region is 
deleted and is replaced by EYFP gene which is under CMV promoter) (Du & Tikoo., 2010) and 
mutant BAdV-3 were propagated in MDBK cells in MEM supplemented with 2% fetal bovine 
serum.  
3.2.2 Antibodies 
Polyclonal anti-pVIII serum (Ayalew et al., 2014), BAdV-3 DNA binding protein (DBP) 
(Zhou et al., 2001b), BAdV-3 pVII (Anand et al., 2014), BAdV-3 protein V (Kulshreshtha & 
Tikoo., 2008) BAdV-3 hexon (Patel & Tikoo., 2006) and BAdV-3 100K (Makadiya et al., 2015) 
specific antibodies have been described.  Monoclonal antibody (Mab) specific to eIF6 (BD 
transduction laboratories),  Alexa Fluor 680 conjugated goat anti-rabbit antibody (Invitrogen), 
anti-β-actin monoclonal antibody, MAb specific to HA (Sigma-Aldrich), IRDye800 Conjugated 
goat anti-mouse antibody (Rockland), Alexa Flour 546 goat anti-mouse IgG antibody (Molecular 
probes), Alexa Flour 488 goat anti-rabbit IgG antibody, AP-conjugated goat anti-mouse antibody 
and Alkaline phosphatase (AP)-conjugated goat anti-rabbit IgG (Jackson ImmunoResearch) were 
purchased. 
3.2.3 Plasmid construction 
 Plasmid GC.linker, plasmid GN.linker and Plasmid pcDNA.3HA has been describrd earlier 
(Ayalew et al., 2014). Construction of plasmids pEY.VIII, pGB.VIII,  pGA.VIII, pGST.pVIII, 
pGN.VIII and pGC.DDX3 has been described earlier (Ayalew et al., 2014). Following plasmids 
were constructed using standard DNA manipulation techniques. 
i. pc3HA-eIF6- PCR was done using primers eIF6-Fwd and eIF6-Rev (Table 3.2.1) and 
plasmid pGAD-eIF6 DNA as a template to amplify a 762bp DNA fragment containing 
eIF6 gene. Restriction enzymes EcoRI and XhoI were used to digest the PCR product. 
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The digested PCR product was ligated to EcoRI and XhoI digested plasmid pcDNA.3HA 
creating plasmid pc3HA-eIF6. 
ii. pDS-eIF6- PCR was done using primers DS- eIF6-Fwd and DS- eIF6-Rev (Table 3.2. 1) 
and plasmid pGAD-eIF6 DNA as a template to amplify a 759bp DNA fragment 
containing eIF6 gene. Restriction enzymes EcoRI and XhoI were used to digest the PCR 
product. The digested PCR product was ligated to EcoRI and XhoI digested plasmid 
pDsRed-Monomer-C1 creating plasmid pDS-eIF6. 
iii. pGC-eIF6- PCR was done using primers GC- eIF6-Fwd and GC- eIF6-Rev (Table 3.2.1) 
and plasmid pGAD-eIF6 DNA as a template to amplify a 767bp DNA fragment 
containing eIF6 gene. Restriction enzymes XmaI and NotI were used to digest the PCR 
product. The digested PCR product was ligated to XmaI and NotI digested plasmid GC-
linker in frame with the C-terminus of GFP gene creating plasmid pGC-eIF6. 
iv. pC-pVIII- PCR was done using primers pVIII-Fwd and pVIII-Rev (Table 3.2.1), and 
plasmid pFBAV302 (Zakhartchouk et al., 1998b) to amplify a 672bp DNA fragment 
containing pVIII gene. Restriction enzymes EcoRI and XhoI were used to digest the PCR 
product. The digested PCR product was ligated to EcoRI and XhoI digested plasmid 
pcDNA3.1 (-) (Invitrogen) creating plasmid pC-pVIII. 
v. pC-pVIII-tn1- PCR was done using primers pVIII-d1Fwd and pVIII-d1Rev (Table 
3.2.1), and plasmid pC-pVIII DNA as a template to amplify a 417bp DNA fragment 
containing pVIII gene. Restriction enzymes EcoRI and XhoI were used to digest the PCR 
product. The digested PCR product was ligated to EcoRI and XhoI digested plasmid pC-
cmyc creating plasmid pC-pVIII-tn1. 
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vi.  pC-pVIII-tn2- PCR was done using primers pVIII-d2Fwd  and pVIII-Rev (Table 3.2.1), 
and plasmid pC-pVIII DNA as a template  to amplify a 279bp DNA fragment containing 
pVIII gene. Restriction enzymes EcoRI and XhoI were used to digest the PCR product. 
The digested PCR product was ligated to EcoRI and XhoI digested plasmid pC-cmyc 
creating plasmid pC-pVIII-tn2. 
vii. pC-pVIII-d3- First round of PCR was performed with primer pairs pVIII-Fwd- pVIII-
d3R  and pVIII-d3F-pVIII-Rev to generate 426 and 160 bp products, respectively using 
plasmid pC-pVIII as template. PCR products of first round were mixed and used as 
templates with primers pVIII-Fwd and pVIII-Rev to amplify 543bp product by PCR. 
Restriction enzymes EcoRI and XhoI were used to digest the PCR product. The digested 
PCR product was ligated to EcoRI and XhoI digested plasmid pC-cmyc creating plasmid 
pC-pVIII-d3. 
viii. pC-pVIII-d4- PCR was performed using primers pVIII-Fwd  and pVIII-d4R (Table 
3.2.1), and plasmid pC-pVIII DNA as a template to amplify a 549bp DNA fragment 
containing pVIII gene. Restriction enzymes EcoRI and XhoI were used to digest the PCR 
product. The digested PCR product was ligated to EcoRI and XhoI digested plasmid pC-
cmyc creating plasmid pC-pVIII-d4. 
ix. pC-pVIII-d5 - First round of PCR was performed with primer pairs pVIII-Fwd- pVIII-
d5R  and pVIII-d5F-pVIII-Rev to generate 425 and 242 bp products, respectively using 
plasmid pC-pVIII as template. PCR products of first round were mixed and used as 
templates with primers pVIII-Fwd and pVIII-Rev to amplify 627 bp product by PCR. 
Restriction enzymes EcoRI and XhoI were used to digest the PCR product. The digested 
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PCR product was ligated to EcoRI and XhoI digested plasmid pC-cmyc creating plasmid 
pC-pVIII-d5. 
x. pC-pVIII-d6- First round of PCR was performed with primer pairs pVIII-Fwd- pVIII-
d6R  and pVIII-d6F-pVIII-Rev to generate 470 and 158 bp products, respectively using 
plasmid pC-pVIII as template. PCR products of first round were mixed and used as 
templates with primers pVIII-Fwd and pVIII-Rev to amplify 588 bp product by PCR. 
Restriction enzymes EcoRI and XhoI were used to digest the PCR product. The digested 
PCR product was ligated to EcoRI and XhoI digested plasmid pC-cmyc creating plasmid 
pC-pVIII-d6. 
xi. pC-3HAeIF6-tn1- PCR was performed using primers eIF6-d1F and eIF6-d1R (Table 
3.2.1) and plasmid pC-3HAeIF6 DNA as a template to amplify a 414bp DNA fragment 
containing eIF6 gene. Restriction enzymes EcoRI and XhoI were used to digest the PCR 
product. The digested PCR product was ligated to EcoRI and XhoI digested plasmid 
pcDNA.3HA creating plasmid pc3HA-eIF6-tn1. 
xii. pC-3HAeIF6-tn2- PCR was performed using primers eIF6-d2F and eIF6-d2R (Table 
3.2.1) and plasmid pC-3HAeIF6 DNA as a template to amplify a 432bp DNA fragment 
containing eIF6 gene. Restriction enzymes EcoRI and XhoI were used to digest the PCR 
product. The digested PCR product was ligated to EcoRI and XhoI digested plasmid 
pcDNA.3HA creating plasmid pc3HA-eIF6-tn2. 
xiii. pC-eIF6-del3- PCR was performed using primers eIF6-d3F and eIF6-d2R (Table 3.2.1) 
and plasmid pC-3HAeIF6  DNA as a template to amplify a 606bp DNA fragment 
containing eIF6 gene. Restriction enzymes EcoRI and XhoI were used to digest the PCR 
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product. The digested PCR product was ligated to EcoRI and XhoI digested plasmid 
pcDNA.3HA creating plasmid pC-eIF6-del3. 
xiv. pC-eIF6-del4- First round of PCR was performed with primer pairs eIF6-Fwd – eIF6-
d4R and eIF6-d4F-eIF6-Rev (Table 3.2.1) to generate 186 and 480 bp products, 
respectively using plasmid pC-3HAeIF6 as template. PCR products of first round were 
mixed and used as templates with primers eIF6-Fwd and eIF6-Rev to amplify 624 bp 
product by PCR. Restriction enzymes EcoRI and XhoI were used to digest the PCR 
product. The digested PCR product was ligated to EcoRI and XhoI digested plasmid 
pcDNA.3HA creating plasmid pC-eIF6-del4. 
xv. pC-eIF6-del5- First round of PCR was performed with primer pairs eIF6-Fwd – eIF6-
d5R and eIF6-d5F-eIF6-Rev (Table 3.2.1) to generate 324 and 351bp products, 
respectively using plasmid pC-3HAeIF6 as template. PCR products of first round were 
mixed and used as templates with primers eIF6-Fwd and eIF6-Rev to amplify 633 bp 
product by PCR. Restriction enzymes EcoRI and XhoI were used to digest the PCR 
product. The digested PCR product was ligated to EcoRI and XhoI digested plasmid 
pcDNA.3HA creating plasmid pC-eIF6-del5. 
xvi. pC-eIF6-del-6- PCR was performed using primers eIF6-d6F and eIF6-d2R (Table 3.2.1) 
and plasmid pC-3HAeIF6  DNA as a template to amplify a 630bp DNA fragment 
containing eIF6 gene. Restriction enzymes EcoRI and XhoI were used to digest the PCR 
product. The digested PCR product was ligated to EcoRI and XhoI digested plasmid 
pcDNA.3HA creating plasmid pC-eIF6-del6. 
xvii. pC-eIF6-del7- First round of PCR was performed with primer pairs eIF6-Fwd – eIF6-
d7R and eIF6-d7F-eIF6-Rev (Table 3.2.1) to generate 164 and 575 bp products, 
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respectively using plasmid pC-3HAeIF6 as template. PCR products of first round were 
mixed and used as templates with primers eIF6-Fwd and eIF6-Rev to amplify 693 bp 
product by PCR. Restriction enzymes EcoRI and XhoI were used to digest the PCR 
product. The digested PCR product was ligated to EcoRI and XhoI digested plasmid 
pcDNA.3HA creating plasmid pC-eIF6-del7. 
xviii. pC-eIF6-del8- First round of PCR was performed with primer pairs eIF6-Fwd – eIF6-
d8R and eIF6-d8F-eIF6-Rev (Table 3.2.1) to generate 230 and 479bp products, 
respectively using plasmid pC-3HAeIF6 as template. PCR products of first round were 
mixed and used as templates with primers eIF6-Fwd and eIF6-Rev to amplify 669bp 
product by PCR. Restriction enzymes EcoRI and XhoI were used to digest the PCR 
product. The digested PCR product was ligated to EcoRI and XhoI digested plasmid 
pcDNA.3HA creating plasmid pC-eIF6-del8. 
xix. pMCS+pVIII- Restriction enzymes MfeI and SpeI were used to isolate a 7361 bp DNA 
fragment of plasmid pUC304a+ (Du & Tikoo., 2010). The isolated DNA fragment was 
then ligated to MfeI-NheI digested plasmid pMCS (Thanbichler et al., 2007) creating 
plasmid pMCS+pVIII. 
xx. pMCS-minus-pVIII- First round of PCR was performed  and a 453 bp PCR fragment 
was amplified using primer pairs (FWD –Reco-p8-del \  Rev –Reco-p8-del-OE; Table 
3.2.1) and plasmid pMCS+pVIII DNA as a template. Similarly, a 672 bp PCR fragment 
was amplified using primers (FWD –Reco-p8-del - FWD –Reco-p8-del-OE; Table 3.2.1) 
and plasmid pMCS+pVIII DNA as a template. The two PCR products were mixed and 
used as DNA templates with primers (FWD –Reco-p8-del + FWD –Reco-p8-del; Table 
3.2.1) to amplify 1022 bp product by PCR. Restriction enzymes AscI and AfeI were used 
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to digest the PCR product. The digested PCR product was then ligated to AscI and AfeI 
digested plasmid pMCS+pVIII creating plasmid pMCS-minus-pVIII. 
xxi. pMCS-pVIIIdel-Kana- A 1240bp fragment was isolated from plasmid pUC4K (Taylor & 
Rose., 1988) by digesting it with SbfI  and ligated to SbfI digested plasmid pMCS-minus-
pVIII creating plasmid  pMCS-pVIIIdel-Kana. 
xxii. pUC304a.dVIII - Restriction enzyme XcmI was used to isolate a 6127 bp DNA fragment 
of plasmid pMCS-pVIIIdel-Kana. The isolated 6127bp DNA fragment was recombined 
with plasmid pUC304a+ DNA in E. coli BJ5183 to generate plasmid pUC304-pVIII-
deleted-Kana. Finally, plasmid pUC304-pVIII-deleted-Kana was digested with restriction 
enzyme SbfI and large fragment was self-ligated to generate plasmid pUC304a.dVIII. 
xxiii.  pMCS-d147-174- using primer pairs (FWD –Reco-p8-del  - p8-del9-OE-Rev; Table 
3.2.1) and plasmid pMCS+pVIII DNA as a template to amplify a 883 bp DNA fragment. 
Similarly, PCR was performed using primers (Rev-Reco-p8-del - p8-del9-OE-Fwd) and 
plasmid pMCS+pVIII DNA as template to amplify a 793 bp DNA fragment. The two 
PCR products were mixed and used as templates with primers (FWD –Reco-p8-del + 
Rev-Reco-p8-del; Table 3.2.1) to amplify 1636 bp product by PCR. Restriction enzymes 
AscI and AfeI were used to digest the PCR product. The digested PCR product was then 
ligated to AscI and AfeI digested plasmid pMCS+pVIII creating plasmid pMCS-d147-
174. 
xxiv. pUC304a-pVIII-d147-174- Restriction enzyme XcmI was used to isolate a 5446 bp DNA 
fragment from plasmid pMCS-d147-174.  The isolated DNA fragment was used with SbfI 
digested plasmid pUC304a+ DNA for homologous recombination in E. coli BJ5183 to 
generate plasmid pUC304a-pVIII-d147-174. 
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Table 3.2.1 List of primers  
Primer Name Primer sequence 
eIF6-Fwd ATTGGTGAATTCATGGCGGTCCGTGCGTCGTTC 
eIF6-Rev GCCAATCTCGAGTCAGGTGAGGCTGTCAGTGAG 
DS-eIF6-Fwd ATTCTCGAGTTATGGCGGTCCGTGCGTCGTTCGAG 
DS- eIF6- Rev GCCGAATTCTACAGGTGAGGCTGTCAGTGAGGGAATC 
GC- eIF6-Fwd AATATATACCCCGGGATGGCGGTCCGTGCGTCGTTC 
GC- eIF6-Rev ATTAACGCGGCCGCTCAGGTGAGGCTGTCAGTGAG 
pVIII-Fwd GGCGCGGAATTCATGAGCAAAGAAATTCCCACACC 
pVIII-Rev GTCCTCGAGTCAGCTATAACCGCTCACAGAG 
pVIII-d1Fwd   GGCGCCGAATTCATGAGCAAAGAAATTCCCACAC 
pVIII-d1Rev   TATCTCGAGGGCGGTGAGCGGGATAAGGGTTC 
pVIII-d2Fwd   GCGACAGAATTCGCCTCCTGCTTAAGACCAGATG 
pVIII-d3F TCGAACCCTTATCCCGTTAACCAGGCAGTTTGTAGAGGAATTTGT 
pVIII-d3R AAATTCCTCTACAAACTGCCTGGTTAACGGGATAAGGGTTCGAGC 
pVIII-d4R ACTGACCTCGAGTCAGGATCCTATGCCCCCGTGGCGCGGTCTG 
pVIII-d5F GAACCCTTATCCCGCTCACCTCGCGTTCATCTTTCAACCC 
pVIII-d5R GGGTTGAAAGATGAACGCGAGGTGAGCGGGATAAGGGTTC 
pVIII-d6F TCTTTCAACTAGGAGGAGGCAGGCAGTTTGTAGAGGAATT 
pVIII-d6R AATTCCTCTACAAACTGCCTGCCTCCTCCTAGTTGAAAGA 
eIF6-d1F ACTTTGGAATTCATGGCGGTCCGTGCGTCGTTCGAG 
eIF6-d1R CGAAGTCTCGAGAGCCAGGATCTCTTCTGTTTC 
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eIF6-d2F ACTGACGAATTCTGCAATGACTATGTGGCCTTAGTCC 
eIF6-d2R ATTCTCGAGTCAGGTGAGGCTGTCAGTGAG 
eIF6-d3F ACTGACGAATTCTCCATCGCCGGCTGCCGCATC 
eIF6-d4F ACCATCCCCGTAGTGCACGCTGAGGAACGGCTCTCAGCCCTG 
eIF6-d4R CAGGGCTGAGAGCCGTTCCTCAGCGTGCACTACGGGGATGGT 
eIF6-d5F AGCGTGCAGATCCGGAGGGTGAAAGTGGCTGACCAGGTGCTG 
eIF6-d5R CAGCACCTGGTCAGCCACTTTCACCCTCCGGATCTGCACGCT 
FWD–Reco-p8-del TGACCAAAACCGCCACTCAGAGCAAAAAGAGC 
FWD–Reco-p8-del-OE GACCCGCCTAAACTCTCAGCCCTGCAGGGATAAGCCCTAATAGTAATC 
Rev–Reco-p8-del CGACTGCAGAATTCGAAGCTTGAGCTCGAGATC 
Rev–Reco-p8-del-OE GATTACTATTAGGGCTTATCCCTGCAGGGCTGAGAGTTTAGGCGGGTC 
p8-del9-OE-Fwd TCTTTCAACTAGGAGGAGGCAGGCAGTTTGTAGAGGAATT 
p8-del9-OE-Rev AATTCCTCTACAAACTGCCTGCCTCCTCCTAGTTGAAAGA 
Q adeno Fwd CAGGTGCCAGTCAAGATTAC 
Q adeno Rev ATGGCCGACTGAGTCATAAG 
Actin Fwd CTAGGCACCAGGGCGTAATG 
Actin Rev CCACACGGAGCTCGTTGTAG 
  
3.2.4 Yeast two-hybrid assay 
Initially, the interaction between pVIII and eIF6 was detected using the Matchmaker two-
hybrid system3 using Saccharomyces cerevisiae (Clonetech) as described (Kulshreshtha & 
Tikoo., 2008). The plasmid DNA from indicated plasmids was used to cotransform yeast AH109 
cells (Clontech). The transformed cells were then plated on to selective dropout medium plates 
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as described in (Makadiya., 2013) and the plates were then incubated at 30
°
C in a humidified 
environment for a duration of 5-7 days and observed for growth and development of color.  
3.2.5 GST-pull down assay 
 The Escherichia coli BL21(D3E) pLysS (Promega) cells were used for expression of the 
recombinant GST-fusion proteins as described (Zhou & Tikoo., 2001). Purification of 
Glutathione S-transferase (GST) and GST-pVIII fusion proteins has already been described 
(Ayalew., 2015). The Bradford assay was used for measuring concentrations of the proteins. 
GST binding buffer (Ayalew., 2015) was used to wash and prepare glutathione sepharose beads 
for use in GST-pull down assay. Radio-labeled eIF6 was synthesized in-vitro by using plasmid 
pC -3HA-eIF6 DNA (1 μg) in an in-vitro transcription and translation reaction. The in-vitro 
transcription and translation reaction was carried out using a TNT T7 Coupled Reticulocyte 
Lysate System (Promega) and 30Ci of [35S]-methionine (Perkin Elmer). Equal amount of GST 
or GST-pVIII fusion protein was mixed with 15μl of in vitro synthesized eIF6 and 40 μl of 
glutathione sepharose beads and incubated at 4
°
C overnight on a nutator. After the incubation, 
GST binding buffer was used to wash the beads three times. The beads were then boiled in 40 μl 
of Laemmli's sample buffer for 5 minutes.  A 12% SDS-PAGE was run to separate the proteins. 
After the run was over the proteins in the gel were fixed using fixative solution for 30min. The 
gel was then dried using a geldryer (Bio-Rad Model 583). Finally, the dried gel was exposed to a 
phosphor screen (Kodak) for 16 hrs and visualized using Molecular Imager FX and Quantity One 
software (Bio-Rad). 
3.2.6 Co-immunoprecipitation assay  
 293T cells were co-transfected with 4μg of each indicated plasmid DNA. At 48 hrs post 
transfection the cells were lysed in NP-40 lysis buffer and indicated protein specific antibodies 
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were used for immunoprecipitation of proteins from cell lysates. Subsequently, the proteins were 
run on 12% SDS-PAGE, transferred to PVDF membrane and probed by Western blot using 
indicated protein specific antibodies as described (Kulshreshtha & Tikoo., 2008). Similarly 
monolayer of MDBK cells grown in one well of 6 well plate were infected with BAdV-3 at an 
MOI of 5. At 48 hrs post infection the cells were lysed and processed as described above.  
3.2.7 Bimolecular fluorescence complementation assay (BiFC) 
 Yeast S288c cells (A kind gift from Dr. Troy Harkness, University of Saskatchewan) 
were co-transformed, using the lithium acetate method (Gietz et al., 1992, Schiestl & Gietz., 
1989) with indicated plasmid DNAs. The cells were then plated on to a selective drop out 
medium without urease and histidine and incubated at 30
°
C in a humidified environment. After 
3-4 days of incubation, single colonies were picked, spread and fixed on a slide, mounted on a 
mounting medium containing DAPI (Vectashield) and examined using Zeiss LSM 5 laser 
scanning con-focal microscope.   
3.2.8 Generation of stable cell line expressing BAdV-3 pVIII 
For generation of lentivirus 293T cells in one well of 6 well plate were transfected with 
three plasmids pTrip-pVIII, pXPAX2 and pMD2.G. After 48 hours of transfection medium was 
collected, centrifuged at 1500 rpm for 5 min and then supernatant was filtered using 0.45μm 
filter and stored at -80°C. For transduction, VIDO DT1 cells in one well of 6 well plate were first 
treated with 8μg/ ml of polybrene for 15 minutes and then were either mock transduced or  
transduced with 500 μl of lentivirus. After 24 hours of transduction the media was changed to 
selection media (MEM with 2% fetal bovine serum and 10 μg/ml of puromycin). The selection 
media was changed every 48 hours until puromycin resistant clones begin to appear. The 
expression of pVIII in selected clones was confirmed by Western blot. 
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3.2.9 Polysome profile assay 
MDBK cells in 100 mm culture dishes were either mock infected or infected with BAdV-3 
virus at MOI of 2. After 40 hrs post infection, cyclohexamide (final concentration 50 μg per ml) 
was added to the medium and the cells were again incubated at 37
°
C for 30 minutes. After 
incubation, cold PBS was used to wash the cells two times. The cells were then scraped with a 
cell scrapper and collected in 2 ml tubes.  Cells were then lysed by addition of polysome 
extraction buffer and incubation on ice. After incubating the cells on ice for 10 minutes, the cells 
were spun for 10 seconds to pellet the nuclei. Supernatant was collected and OD was taken at 
260 nm. Equal OD units of individual cell lysates were applied to separate ultracentrifuge tubes 
containing 5%- 50% linear sucrose gradients. These tubes were then centrifuged in an 
ultracentrifuge (Beckman) at 4
°
C at 36000 rpm for 2 hours 30 minutes. From each tube, fractions 
of approximately 550μl were collected manually.  The OD was measured from each fraction at 
260nm and plotted on a graph against the fraction number. From each fraction total RNA was 
extracted using Trizol LS reagent (Invitrogen) following manufacturer’s instructions. The 
Agilent 2100 Bioanalyser instrument was then used to analyse the extracted RNA.  
For polysome profile analysis of pVIII expressing cell line, 70-80% confluent VIDO GT1 
(Constitutively expressing BAdV-3 pVIII) and VIDO DT1 (Du & Tikoo., 2010) cells in 100 mm 
culture were processed as described above. Proteins were also extracted from top 1 to 16 
fractions. Immunoblotting analysis of gradient fractions was performed using antibodies against 
eIF6 and BAdV-3 pVIII. Whole cell lysate was used as control.  
3.2.10 Western blotting 
MDBK cells were infected with either wild-type or mutant BAdV-3 at an MOI of 1. After 
24 hrs, cell lysate was collected and viral proteins were detected by Western blotting using 
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protein specific rabbit antisera. Alexa Fluor 680 conjugated goat anti-rabbit antibody 
(Invitrogen) was used as secondary antibody. β-actin was used as loading control and was probed 
by Western blot using mouse anti-β-actin monoclonal antibody (Sigma-Aldrich) as primary 
antibody and IRDye800 Conjugated goat anti-mouse antibody (Rockland) as secondary 
antibody. Finally, viral protein expression was analyzed by using the Odyssey infrared imaging 
system. 
3.2.11 Isolation of mutant BAdV-3 
Monolayers of VIDO DT1 cells in six well plates were transfected with 4-6μg of 
individual plasmid DNA using Lipofectamine 2000 reagent (Invitrogen). At 4hrs post-
transfection, the medium was replaced with fresh MEM containing 2% FBS. The cells were 
observed daily for appearance of any cytopathic effect (CPE). The cells showing CPE were 
collected, freeze thawed three times and used to purify the virus. 
3.2.12 CsCl gradient centrifugation 
Monolayers of MDBK cells were infected with individual virus. When more than 80% 
cells showed CPE, the cells were collected, pelleted by centrifugation and re-suspended in 5ml 
medium. The cell lysate was freeze thawed 5 times and subjected to CsCl density gradient 
centrifugation at 35000 rpm for 1hr at 4°C. The band containing virus was collected and used for 
a second round of CsCl density gradient centrifugation at 35000 rpm for 16 hrs at 4°C. The virus 
was collected, dialyzed against three changes of dialysis buffer to remove traces of cesium 
chloride and stored in small aliquots at -80°C. 
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3.2.13 Virus growth kinetics 
MDBK cells in 24-well plates were infected with either BAdV304a or BAdV-3-d147-174 
at MOI of 1. Infected cells were then collected at different time points (0, 6, 12, 24, 36, 48 h) 
post-infection, freeze-thawed 3 times and virus in cell lysate was titrated by TCID50 in MDBK 
cells as described (Kulshreshtha et al., 2004). 
3.2.14 Viral genome replication 
Viral genome replication was measured as described in (Wu et al., 2012) with minor 
modifications. Briefly, MDBK cells were infected with either BAdV-304a or BAdV-3-d147-174 
virus and harvested at indicated time points. Cells were pelleted and washed one time with 
phosphate-buffered saline (PBS). The cell pellet was then resuspended in isotonic buffer. Cell 
lysates were incubated on ice for 10 minutes and nuclei were then pelleted by centrifugation at 
2000 × g at 4°C for 5 min and then 200 μl PBS was added for resuspension. DNA was then 
extracted using a DNeasy blood and tissue kit (Qiagen) and following manufacturer’s 
instruction. Finally, the DNA was resuspended in double distilled water and subjected to 
quantitative PCR using Bio-Rad real time PCR system. The two sets of primers used for 
quantitative PCR were primer pair Q adeno Fwd and Q adeno Rev and primer pair Actin Fwd 
and Actin Rev (Table 3.2.1). Genome replication was calculated as the value of viral genome 
copy number divided by actin copy number. For comparison, the value of each virus was 
normalized to that of BAV304a at 6hpi and shown as relative viral genome copy number.  
3.2.15 Transmission electron microscopy 
The 300 mesh grids (Ted Pella, cat# G300) covered with 0.25% formvar and coated with  
carbon  (Denton Vacuum Inc.) were suspended for 2 min on to a twenty microliter droplet of 
virus particles purified using CsCl gradient and fixed with 5% electron microscopy grade 
 69 
glutaraldehyde (catalogue number 16316-10; Electron Microscopy Sciences). After 3 washes 
with water, the grids were suspended on a droplet of 0.5% Phosphotungstic Acid (J.B. Em 
Services Inc. Dorval QC) for 1 minute.  The excess solution was removed and grids are allowed 
to dry. The grids with negatively stained virus particles were examined on an HT7700 
transmission electron microscope (Hitachi Inc.) at 80 kv. 
Monolayer of MDBK cells were infected with either BAdV-304a or BAdV-3-d147-174. At 
48 hrs post-infection, the cells were harvested and fixed in 2.5% glutaraldehyde in 0.1 M sodium 
cacodylate buffer at 4°C. Following fixation cells were pelleted in 1% Low melting point 
agarose, post fixed at room temperature in 1% OsO4 in 0.1M sodium cacodylate buffer and en-
bloc stained with saturated Uranyl Acetate in 70% Ethanol. Dehydration was carried out with a 
graded ethanol series and finalized in propylene oxide (Electron Microscopy Sciences 
cat#20401). Dehydrated cells were infiltrated with Epon812/Araldite embedding medium by 
gradually increasing concentration in propylene oxide, and then polymerized in molds with pure 
Epon/araldite at 60C for 24 hrs. Finally, the pellet was sectioned with a Reichert ultracut 
ultramicrotome, each section stained with Reynolds lead citrate and 2% Uranyl acetate and 
viewed on a HT7700 transmission electron microscope (Hitachi Inc.) at 80 kv. 
3.2.16 Infectivity assay 
MDBK cells grown in 12 well plates were infected with equal number of virus (TCID50). 
After 18 hrs 5 random fields were chosen from each well and GFP positive cells were counted 
for each well using fluorescent microscope. The average number of GFP positive cells were 
quantified as fluorescent focus unit (FFU) per field. 
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3.2.17 Statistical analysis 
  All data were analyzed using GraphPad Prism version 6 (GraphPad Software, Inc., La 
Jolla, CA, USA). Statistical differences among the groups were calculated using unpaired t-test. 
Differences were considered significant at * p<0.05, ** p<0.01 and *** p<0.001. 
3.3 Results 
3.3.1 Interaction of BAdV-3 pVIII with cellular protein eIF6 in-vitro 
 Initially, results of yeast two-hybrid screen carried out using PCR amplified gene coding 
for BAdV-3 pVIII cloned into plasmid vector pGBKT7 in frame with GAL4 DNA binding 
domain as bait and plasmid vector pGADT7 (clontech) containing bovine retina cDNA library 
fused to GAL4 activation domain as prey, indicated that BAdV-3 pVIII interacts with cellular 
protein eIF6 (Patel and Tikoo unpublished results). To further confirm these findings, pVIII gene 
was cloned in frame to GAL4 activation domain (pGA.VIII) and used as prey. Similarly, eIF6 
gene was cloned in frame to GAL4 DNA binding domain (pGB.eIF6) and used as bait. Yeast 
AH109 cells co-transformed using bait and prey vectors were screened for interaction as 
described earlier (Kulshreshtha & Tikoo., 2008). As seen in Fig.3.3.1 (panel A), yeast AH109 
cells co-transformed with plasmid pGA.VIII and pGB.eIF6 DNAs revealed bluish green colonies 
suggestive of positive interactions. No such colonies were detected when AH108 cells were co-
transformed with plasmid pGA.VIII and pGBKT7.  
To confirm our initial yeast two-hybrid results, we performed the GST-pull down assay. 
Equal amount of purified GST or GST.pVIII fusion protein was individually mixed with 
sepharose beads and in-vitro transcribed and translated radiolabeled [
35
S] eIF6 in an eppendorf 
tube and incubated at 4°C on a nutator. After washing the beads three times with washing buffer, 
the bound proteins were separated on 12% SDS-PAGE and analysed using Molecular Imager FX  
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Figure 3.3.1 Interaction of BAdV-3 pVIII with eIF6. (A). Yeast two hybrid analysis. 
Plasmid DNA from pGA.VIII and pGB.eIF6 or pGA.VIII and pGBKT7 was used to co-
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transform the AH109 yeast cells.  The transformed yeast cells were streaked on a selective 
medium containing X--gal but devoid of Leu, Trp, Ade and His (B). GST pull-down assay.  
In-vitro translated [35S] methionine labeled HA tagged eIF6 was incubated with equal amount of 
either purified GST or GST.pVIII fusion protein immobilized on Glutathione-Sepharose 4B 
beads. The beads were washed three times and bead bound proteins were separated by 12% SDS-
PAGE and detected by autoradiography. (C). Co-immunoprecipitation assay in transfected 
cells. Cell lysate was prepared from 293T cells co-transfected with either plasmid pC-pVIII and 
pc3HA-eIF6 DNA or plasmid pCDNA3 and pc3HA-eIF6 DNA. Proteins were 
immunoprecipitated from prepared cell lysate using anti-pVIII serum or anti-Rabbit IgG,  run on 
12% SDS-PAGE,  transferred to PVDF membrane and probed in Western blot using anti-HA 
MAb. (D). Co-immunoprecipitation assay in transfected cells. Cell lysates were prepared 
from 293T cells co-transfected with either plasmid pC-pVIII and pc3HA-eIF6 DNA or plasmid 
pC-pVIII and pCDNA3HA DNA. Proteins were immunoprecipitated from prepared cell lysates 
using anti-HA MAb, run on 12% SDS-PAGE and transferred to PVDF membrane and probed in 
Western blot using anti-pVIII serum. (E). Bimolecular fluorescence complementation. Yeast 
S288c cells were co-transformed with indicated plasmids, plated on to a selective drop out 
medium and analyzed using Zeiss LSM 5 laser scanning confocal microscope as described in 
materials and methods. (F). Co-immunoprecipitation assay in BAdV-3 infected cells. Cell 
lysates were prepared from mock infected and BAdV-3 infected cells. Proteins from the prepared 
lysates were immunoprecipitated with anti-pVIII serum, run on 12% SDS-PAGE, transferred to 
PVDF membrane and probed in Western blot using anti-eIF6 MAb. Molecular weight markers 
(MW) are shown on the left of the panel.  
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and Quantity One software (Bio-Rad). As seen in Fig.3.3.1 (panel B), the radiolabeled eIF6 
protein interacted with GST.pVIII fusion protein (lane 1) but not with GST protein alone (lane 
2). 
Next we validated these interactions in plasmid DNA transfected 293T cells by co-
immunoprecipitation coupled with Western blot using protein specific antibodies. 293T cells 
were co-transfected with 4μg of each indicated plasmid DNA. At 48 hrs post transfection the 
cells were lysed and immuno-precipitated with indicated protein specific antibodies. 
Subsequently, the proteins were run on 12% SDS-PAGE, transferred to PVDF membrane and 
probed by Western blot using indicated protein specific antibodies. As seen in Fig.3.3.1 (panel 
C), eIF6 specific protein could be detected when proteins from the lysates of cells co-transfected 
with plasmid pC-pVIII + pc3HA-eIF6 DNAs were immuno-precipitated with anti-pVIII serum 
and probed in Western blot with anti-HA MAb (lane 3).  No such protein could be detected when 
proteins from the lysates of cells co-transfected with plasmid pC-pVIII + pc3HA-eIF6 DNAs 
were immuno-precipitated with normal rabbit IgG and probed in Western blot with anti-HA 
MAb (lane 2). Similarly, no protein could be detected when proteins from the lysates of the cells 
co-transfected with plasmid pc3HA-eIF6 DNAs + pcDNA3 DNAs were immuno-precipitated 
with normal rabbit IgG (lane 5) or anti-pVIII sera (lane 6) and probed in Western blot with anti-
HA Mab. 
Similarly, pVIII specific protein (Fig.3.3.1. panel D) could be detected when proteins from 
the lysates of the cells co-transfected with plasmid pC-pVIII + pc3HA-eIF6 DNAs were 
immuno-precipitated with anti-HA MAb and probed in Western blot with anti-pVIII serum 
(Lane 2). No such protein could be detected in lysates of the cells co-transfected with plasmid 
pc3HA-eIF6 DNAs + pcDNA3 DNAs immuno-precipitated with anti—HA serum (lane 4).   
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3.3.2 Interaction of pVIII with eIF6 in cultured cells 
 Initially, we performed bimolecular fluorescence complementation assay. Indicated 
plasmid DNAs were used to co-transform yeast S288c cells. The transformed cells were plated 
on to a selective drop out medium without urease and histidine and incubated at 30
o
C in a 
humidified environment. After 3-4 days of incubation, single colonies were picked, spread and 
fixed on a slide, mounted on a mounting medium containing DAPI and examined using con-
focal microscope. As expected green fluorescence could be detected in yeast cells co-
transformed with plasmid pGC.DDX3 + pGN.VIII DNAs (Ayalew., 2015). Similarly, green 
fluorescence could also be detected in yeast cells co-transformed with plasmid pGC.eIF6 + 
pGN.VIII DNAs (Fig.3.3.1. panel E). However, no green fluorescence could be detected in yeast 
cells co-transformed with plasmid pGN.VIII + pGC.linker, pGC.eIF6 + pGN.linker or 
pGN.linker + pGC.linker DNAs. 
Finally, the interaction of viral pVIII with cellular eIF6 was verified in BAdV-3 infected 
cells.  Monolayer of MDBK cells grown in one well of 6 well plates were infected with BAdV-3. 
At 48 hrs post infection, the cells were lysed, immuno-precipitated with anti-pVIII serum and 
probed in Western blot with anti -eIF6 MAb. As seen in Fig.3.3.1 (panel F), eIF6 protein could 
be detected in Western blots of mock infected (lane 1) or BAdV-3 infected (lane 3) cells using 
anti-eIF6 MAb. Similarly, eIF6 protein could be detected in the lysates of MDBK cells immuno-
precipitated with anti-pVIII serum and probed in Western blot with anti eIF6 MAb (lane 4). No 
such protein could be detected in mock infected cells immuno-precipitated with anti-pVIII serum 
and probed in Western blot with anti-eIF6 MAb (Lane 2).  
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3.3.3 BAdV-3 pVIII domain interacting with eIF6 
 To further delineate the region of pVIII interacting with eIF6, we constructed a panel of 
plasmids expressing mutant pVIII proteins. Western blot analysis confirmed the expression of 
mutant proteins in transfected cells (Fig. 3.3.2.). Next, 293T cells were co-transfected with 
plasmid pc3HA-eIF6 and individual plasmid expressing mutant pVIII protein and analyzed by 
co-immunoprecipitation /Western blot analysis using protein specific antibodies. As seen in 
Fig.3.3.3. anti-pVIII serum co-immunoprecipitated eIF6 from the cells co-transfected with 
plasmid pc3HA-eIF6 + pC-pVIII-tn2 (panel B, lane 5) DNAs. Similarly, anti-pVIII serum co-
immunoprecipitated eIF6 from the cells co-transfected with plasmid pC.pVIIId4+ pc3HA-eIF6 
(panel C, lane 4) and plasmid pC-pVIII-d5 + pc3HA-eIF6 (panel D, lane 2) which could be 
detected in Western blot using anti-HA MAb. No eIF6 specific protein could be co-
immunoprecipitated with anti-pVIII sera from the cells co-transfected with plasmid pc-3HA-eIF6 
+ pC-VIII-tn1 (panel B, lane 4), pC-pVIII-d3 + pc3HA-eIF6 (panel C, lane 2), pC-pVIII-d6 + 
pc3HA-eIF6 (panel C, lane 4). Detection of eIF6 (panel B, lane 3; panel C, lane 1 and lane3, 
panel D, lanes 1, lane 3, lane 5) represents input (10 %) protein.  
3.3.4 eIF6 domain interacting with BAdV-3 pVIII  
To identify the domain of eIF6 interacting with BAdV-3 pVIII, we constructed a panel of 
plasmids expressing mutant eIF6. Western blot analysis confirmed the expression of mutant 
proteins in transfected cells (Fig. 3.3.4.). Next, 293T cells were co-transfected with plasmid pC-
pVIII and individual plasmid expressing mutant eIF6 proteins and analyzed by co-
immunoprecipitation /Western blot analysis using protein specific antibodies. As seen in 
Fig.3.3.5 (panel B-D), anti-pVIII sera co-immunoprecipitated eIF6 mutant protein from the cells  
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Figure 3.3.2 Expression of mutant proteins in transfected cells. Cell lysates were prepared 
from 293T cells transfected with indicated plasmid DNAs. Proteins from prepared lysates were 
run on 12% SDS-PAGE, transferred to PVDF membrane and probed using anti-pVIII serum. 
Molecular weight marker (MW). Mock transfected (Mo). 
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Figure 3.3.3 Identification of BAdV-3 pVIII domain interacting with eIF6. (A) Schematic 
diagram of plasmids. Thick line represents BAdV-3 pVIII gene. Thin lines represent deleted 
regions. The amino acid numbers of pVIII are indicated on the top. The name of the plasmid is 
depicted on the right of the panel.  (B-D) Western blot.  Cell lysates were prepared from 293T 
cells transfected with indicated plasmid DNAs. Proteins from the prepared cell lysates were 
immunoprecipitated with anti-pVIII serum (Ayalew et al., 2014), run on 12 % SDS-PAGE 
transferred to PVDF and probed using anti-HA MAb (B-D). Immunoprecipitation (IP), 
Molecular weight makers (MW). 
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Figure 3.3.4 Expression of mutant proteins in transfected cells. Cell lysates were prepared 
from 293T cells transfected with indicated plasmid DNAs. Proteins from the prepared lysates 
were run on 12 % SDS-PAGE, transferred to PVDF membrane and probed using anti-HA Mab. 
Molecular weight marker (MW). Mock transfected (Mo). 
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Figure 3.3.5 Identification of eIF6 region interacting with BAdV-3 pVIII. (A). Schematic 
representation of plasmids. Thick line represents eIF6 gene. Thin lines represent deleted 
regions. The amino acid numbers of eIF6 are depicted on the top. The name of the plasmid is 
depicted on the right of the panel. (B-D). Western blot. Cell lysates were prepared from 293T 
cells co-transfected with indicated plasmid DNAs. Proteins from prepared cell lysates were 
immunoprecipitated with anti-pVIII serum, run on 12% SDS-PAGE, transferred to PVDF 
membrane and probed using anti-HA MAb (B-D). Immunoprecipitation (IP), Molecular weight 
makers (MW). 
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co-transfected with plasmid pC.pVIII + pC.3HA-eIF6-tn1 (panel B, lane 2), pC-pVIII + 
pC.3HA-eIF6-d5 (panel C, lane 6) and pC-pVIII + pC.3HA-eIF6-d6 (panel D, lane 2) DNAs.  
No such  protein could be co-immunoprecipitated from cells co-transfected with plasmid 
pC.pVIII  + pc3HA-eIF6-tn2 (panel B, lane 4), pC-pVIII + pC3HA-eIF6-d3 (panel C, lane 2), 
pC-pVIII + pC3HA-eIF6-d4 (panel C, lane4 ), pC-pVIII + pc3HA-eIF6-d7  (panel D, lane 4), 
pC-pVIII + pc3HA-eIF6-d8 (panel D, lane 6) or pC-pVIII +pcDNA3 (panel C lane 8, panel D 
lane 8) Detection of eIF6 (panel B, lanes 1,3; panel C and D, lanes 1,3,5) represent input (10%) 
protein.   
3.3.5 Analysis of polysome profiles 
 To determine if polysome profile is altered in BAdV-3 infected cells, we performed  
polysome profiling. MDBK cells were mock infected or infected with BAdV-3 at a MOI of 2. 
After 40 hrs post infection, cycloheximide was added to the medium. After further incubating at 
37
°
C for 30 min, the polysome extraction buffer was added to lyse the cells and extract 
polysomes. Equal OD units of individual cell lysates were applied to ultracentrifuge tubes 
containing 5%- 50% linear sucrose gradients. These tubes were then centrifuged in an 
ultracentrifuge. From each tube, fractions of 550μl were collected manually.  Total RNA was 
extracted from each fraction and the efficient generation of gradient and polysome separation 
were confirmed by analyzing extracted RNA by Agilent 2100 Bioanalyser instrument. As seen 
in Fig. 3.3.6, only 5S RNA is visible in top fractions (lanes 1 - 3) followed by fractions where 
only 18S RNA was present (lanes 4-7), followed by fractions in which both 18S RNA and 28S 
RNA were visible (lanes 8-21). Fractions 8 to 11 represent 60S ribosomal subunit, fractions 12 to 
15 represent 80S ribosome and fractions 16 to 21 contained polysomes thus confirming efficient  
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Figure 3.3.6 RNA analysis. Total RNA was extracted from each gradient fraction from (A) 
mock infected and (B) BAdV-3 infected MDBK cells using Trizol LS reagent (Invitrogen) and 
extracted RNA was by analyzed by Agilent 2100 Bioanalyser instrument.  Fraction numbers 
(from top to bottom) are depicted on top.  
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Figure 3.3.7 Polysome profile analysis. (A-C). Polysome profile analysis of mock infected or 
BAdV-3 infected MDBK cells. Cytoplasmic extracts were prepared from BAdV-3 infected or 
mock infected MDBK cells and subjected to 5 -50 % sucrose gradient centrifugation. Total RNA 
extracted from each gradient fraction was analysed by Agilent 2100 Bioanalyser instrument.  The 
OD was measured at 260 nm for each fraction obtained from mock infected (panel A) or BAdV-
3 infected cells (Panel B) and plotted on a graph against the fraction number. Polysomal profile 
of mock infected and BAdV-3 infected cells was compared (panel C). The monosomal (40S, 60S 
and 80S) and polysomal fractions are indicated. (D-E). Western blot. Proteins from the 
individual gradient fractions were run on 12% SDS-PAGE, transferred to PVDF and probed 
using protein specific antibodies. The number of the gradient fraction is depicted on the top of 
the panel. The name of the protein is depicted on the right of the panel.The data is representative 
of two independent experiments. Molecular weight marker (M).   
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generation of gradient. From each fraction OD was measured at 260nm and plotted on a graph 
against the fraction number (Fig.3.3.7. panels A-C).  As seen in Fig.3.3.7 (panel C), compared to 
uninfected cells, polysomal peaks were smaller in infected cells. Moreover, while peak for free  
60S was higher in infected cells, the free 40S peak was much smaller in infected cells. Proteins 
were extracted from each fraction and analysed by Western blotting using protein specific 
antisera. RPL5 (anti-RPL5 antibody) and RSP14 (anti-RPS14 antibody) proteins were used as 
marker for 60S ribosomes and 40S ribosomes, respectively. As seen in Fig 3.3.7, (panel D and 
panel E),  RPL5 localized in the soluble fractions (Lane 1-3) and the fractions enriched in 60S 
ribosome (lanes 9-13 panel D and lanes 8-13 panel E), However, RPS 14 localized in the soluble 
fractions as well as in the fractions enriched in both 40S and 60S ribosome (Lanes 1-13 panel D 
and E) Similarly, pVIII localized in soluble fractions as well as fractions enriched in 40S 
ribosomes and 60S ribosomes (Lanes 1-13 panel E).  
3.3.6 Isolation of lentivirus expressing pVIII 
The VSV pseudotyped lentivirus expressing pVIII named TRIP.pVIII was isolated as 
described previously (Du & Tikoo., 2010). Briefly, 293T cells in 100 mm culture dishes were 
transfected with three plasmids pTrip-pVIII, pXPAX2 and pMD2.G. After 48 hours of 
transfection medium containing lentivirus was collected Generation of lentivirus was confirmed 
by using Lenti-X™ GoStix™ (Clonetech) following manufacturer’s protocol. 
3.3.7 Generation of stable cell line expressing BAdV-3 pVIII 
 To determine the effect of pVIII on polysome profile, we developed a stable cell line 
expressing BAdV-3 pVIII.  Briefly, subconfluent VIDO DT1 cells (cotton rat lung fibroblasts 
expressing I-SceI protein) (Du & Tikoo., 2010) were transduced with lentivirus TRIP.pVIII.  
After 24 hrs of transduction, the media was changed to selection media (MEM with 2% fetal 
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bovine serum and 10 μg/ml of puromycin). The selection media was changed every 48 hours 
until puromycin resistant clones begin to appear. The puromycin resistant clones were expanded 
and analyzed by Western blotting. As seen in Fig.3.3.8, anti-pVIII sera detected pVIII specific 
protein in puromycin resistant cells (lanes 2 and 3) and BAdV-3 infected VIDO DT1 cells (lane 
1). No such protein could be detected in VIDO DT1 cells (lane 4). The pVIII expressing cell line 
(clone1) designated as VIDO GT1 was used in the present study. 
3.3.8 Ribosomal subunit association in pVIII expressing cells 
 To determine the effect of pVIII on polysomal profile, we compared the polysome profile 
of VIDO GT1 (expressing pVIII) and VIDO DT1 (not expressing pVIII) cells. As seen in Fig. 
3.3.9 only 5S RNA is visible in lanes 1 to 3), 18S RNA is present in lanes 4 to 8, followed by 
fractions in which both 18S RNA and 28S RNA were visible, polysomes are present in fractions 
14 to 21 thus confirming the efficient generation of the gradient. From each fraction OD was 
measured at 260nm and plotted on a graph against the fraction number (Fig.3.3.10, panels A-C).  
As seen in panel C, peaks for free 40S and free 60S were higher in VIDO GT1 (expressing 
pVIII) cells as compared to that in VIDO DT1 (not expressing pVIII) cells.  In contrast, peaks of 
80S and polyribosome were lower in VIDO GT1 cells as compared to VIDO DT1 cells. 
Next we analysed proteins in the gradient fractions by Western blot using protein specific 
antibodies (Fig.3.3.10, panel D). As expected, anti-eIF6 MAb detected eIF6 in fractions enriched 
in 60S ribosome subunit of both VIDO DT1 and VIDO GT1 cells. However, anti-pVIII serum 
detected BAdV-3 pVIII protein in fractions enriched in 40S ribosome subunit as well as in 
fractions enriched in 60S ribosomal subunit of VIDO GT1 cells. In contrast, anti-pVIII serum did 
not detect BAdV-3 pVIII protein in polysomes of both VIDO DT1 and VIDO GT1 cells.  
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Figure 3.3.8 Analysis of pVIII expression in VIDO GT1 cells. Proteins from the cell lysates 
prepared from BAdV-3 infected VIDO DT1 cells (lane1), VIDO GT1 cells (lane 2 and 3) or 
VIDO DT1cells (lane 4)  were run on 12 % SDS-PAGE, transferred to PVDF membrane and 
probed using anti-pVIII serum (Ayalew et al., 2014). 
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Figure 3.3.9 RNA analysis. Total RNA was extracted from each gradient fraction from (A) 
VIDO GT1 cells and (B) VIDO DT1 cells using Trizol LS reagent (Invitrogen) and extracted 
RNA was by analyzed by Agilent 2100 Bioanalyser instrument.  Fraction numbers (from top to 
bottom) are depicted on top.  
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Figure 3.3.10 Polysome profile analysis. (A-C). Polysome profile analysis of VIDO DT1 cells 
and VIDO GT1 cells (cells expressing BAdV-3 pVIII).   The cytoplasmic extract prepared 
from VIDO DT1 (Du & Tikoo., 2010)  and VIDO GT1 (VIDO DT1 cells expressing BAdV-3 
pVIII) cells was subjected to 5 -50 % sucrose gradient centrifugation. Total RNA extracted from 
each gradient fraction was analysed by Agilent 2100 Bioanalyser instrument. The OD 260 value 
was measured for each fraction obtained from VIDO GT1 (A) or VIDO DT1 (B) and plotted 
versus fraction numbers. Polysome profile of VIDO DT1 cells and VIDO GT1 cells was 
compared (C). (D-E) Western blot. Proteins from the individual gradient fractions were run on 
12% SDS-PAGE, transferred to PVDF membrane and probed using protein specific antibodies.  
VIDODT1 (D), VIDO GT1 (E). The number of the gradient fraction is depicted on the top of the 
panel. The name of the protein is depicted on the right of the panel. Molecular weight marker 
(M), Whole cell lysate from respective cells was used as control (C). 
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3.3.9 Construction of mutant BAdV-3  
A plasmid pUC304a-pVIII-d147-174 containing full length BAV304a (contains BAdV-3 
genome from which E3 region is deleted and is replaced by EYFP gene  under CMV promoter) 
(Du & Tikoo., 2010) genomic DNA with deletion of the region encoding BAdV-3 pVIII amino 
acid 147 to 174  was constructed and used to transfect VIDO DT1 cells (cotton rat lung 
fibroblasts expressing I-SceI protein) (Du & Tikoo., 2010)  The cells showing CPE and increased 
expression of GFP were harvested 25 day post transfection,  freeze thawed three times and 
propagated in MDBK cells. The identity of mutant named BAVd147-174 was confirmed by 
sequencing of genomic DNA and by detection of recombinant protein in virus infected cells by 
Western blot using anti-pVIII sera (Fig.3.3.11A). As seen in Fig. 3.3.11A, anti-pVIII detected a 
24 kDa protein in BAV304a infected cells (lane 1). In contrast, anti-pVIII serum detected a 
protein of 21 kDa in BAV.d147-174 infected cells (lane 2). No such protein could be detected in 
mock infected cells (lane 3). 
3.3.10 Growth kinetics of BAdV-3-d147-174  
To determine if the deletion of BAdV-3 pVIII domain interacting with eIF6 affects BAdV-3 
replication in MDBK cells, we compared the growth kinetics of BAdV-304a and BAdV-3-d147-
174. MDBK cells in 24-well plates were infected with either BAdV304a or BAdV-3-d147-174 at 
MOI of 1. At 0, 6, 12, 24, 36, 48 hrs post-infection, the cells were collected, freeze-thawed 3 
times and virus in cell lysate was titrated by TCID50 in MDBK cells. As seen in Fig.3.3.11B, 
BAdV304a grew to a titer of 10
8.5 
TCID50/ml while BAdV-3-d147-174 could only grow to a titer 
of 10
6
 TCID50/ ml. 
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Figure 3.3.11 Characterization of mutant BAdV-3. (A). Western blot. Proteins from the 
lysates of BAdV-3 infected MDBK cells (lane 1), BAdV-3 d147-174 infected MDBK cells (lane 
2) or mock infected MDBK cells (lane 3) were separated by 4-20% SDS-PAGE, transferred to 
PVDF membrane and probed using anti-pVIII serum (Ayalew et al., 2014). The size of the 
molecular Weight markers (M) in kDa are depicted on the left of the panel.  (B). Virus growth 
kinetics. MDBK cells were infected with BAdV304a or BAdV-3-d147-174 at MOI of 1. At 
different times post infection, the infected cells were collected, freeze-thawed 3 times and virus 
in cell lysate was titrated by TCID50 in MDBK cells. Values represent averages from two 
independent experiments and error bars indicate the standard deviations. (C). Virus infectivity.  
The MDBK cells were infected with equivalent amounts of infectious particles of indicated 
virus. The infected cells were visualized for the expression of GFP at 18 hrs post infection by 
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fluorescent microscope TCS SP5 (Leica). (D). Viral genome replication. The MDBK cells were 
infected with equivalent amounts of infectious particles of indicated virus in triplicate. At 
indicated times post infection, the infected cells were collected, and genomic DNA was isolated. 
The viral genome copy number was determined by quantitative PCR and divided by actin copy 
number for normalization. For comparison the normalized genome copy number values for each 
virus at each time point were compared to that of wild-type virus at 6hpi.   
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3.3.11 Virus Infectivity and genome replication  
To test the virus infectivity, MDBK cells were infected with equal amount of BAV304a or 
BAdV-3-d147-174 and FFU were quantified from 5 random fields in each well. As seen in 
Fig.3.3.11C, there was no significant difference in the average number of FFU per field between 
BAV304a and BAdV-3-d147-174.  
Viral DNA replication was analysed in MDBK cells infected with either BAdV-304a or 
BAdV-3-d147-174 using quantitative real time PCR. As seen in Fig.3.3.11D, there is not much 
difference in genome copy number during 6-12 hrs post infection. However, at 24 -48 hrs post 
infection, the genome copy number showed marginal difference (2 fold) between BAdV-3-d147-
174 and BAV304a infected cells. 
3.3.12 Analysis of protein expression in BAdV-3-d147-174 infected cells 
To analyze the expression of viral proteins, MDBK cells infected with BAdV-304a or 
BAdV-3-d147-174 were collected, lysed and the lysates were used to detect the viral proteins by 
Western blotting using protein specific rabbit antisera. As seen in Fig.3.3.12A, there is no 
significant decrease in the expression of DBP (early protein) in the cells infected with BAdV-3-
d147-174. However, there is significant decrease in the expression of analyzed BAdV-3 late 
proteins particularly hexon, pV and pVII in the cells infected with BAdV-3-d147-174. 
3.3.13 Analysis of protein incorporation in BAdV-3-d147-174 viral particles 
To analyse the incorporation of viral protein in the progeny virions, proteins from the 
purified virions were separated by 4-20% SDS-PAGE, transferred to PVDF membrane and 
probed in Western blot using viral protein specific serum. As seen in Fig.3.3.12B, no significant 
difference in the incorporation of the viral proteins in purified BAV304a or BAdV-3-d147-174 
could be observed. Inspite of our repeated events we could not detect pVIII by western blotting 
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Figure 3.3.12 Analysis of viral proteins. (A). Analysis of protein expression in infected cells. 
Proteins from the lysates of MDBK cells were separated by 4-20% gradient SDS-PAGE, 
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transferred to PVDF membranes and probed by Western blot using anti-DNA binding protein 
(DBP) (Zhou et al., 2001b), anti-100K (Makadiya et al., 2015) anti-pV (Kulshreshtha & Tikoo., 
2008),anti- hexon (Patel & Tikoo., 2006) and pVII (Anand et al., 2014) sera followed by Alexa 
Fluor 680 conjugated goat anti-rabbit antibody (Invitrogen). β-actin was detected by Western 
blot using mouse anti-β-actin monoclonal antibody (Sigma-Aldrich) followed by IRDye800 
conjugated goat anti-mouse antibody (Rockland). The name of the proteins is depicted on the 
right of the panel. DBP (DNA binding protein). The results were analyzed by using Odyssey 
Infrared Imaging System and are presented as bar diagram. Values represent averages from two 
independent repeats and error bars indicate the standard deviations. (B). Analysis of viral 
protein incorporation in purified virions. Proteins from purified BAdV304a, or BAdV-3-
d147-174 were separated by 4-20% gradient SDS-PAGE, transferred to PVDF membrane and 
probed in Western blot using protein specific antisera. The name of the detected protein is 
depicted on the right. The results were analyzed by using Odyssey Infrared Imaging System and 
are presented as bar diagram. Values represent averages from two independent repeats and error 
bars indicate the standard deviations. 
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Figure 3.3.13 Analysis of BAdV-3-d147-174 assembly. (A). CsCl2  purification. Virus was 
purified from infected cell lysates by CsCl2 density gradient purification. Mature virion bands 
after double density-gradient centrifugation. (B). Electron microscopic analysis of purified 
virus. Purified BAV304a (panel 1), BAdV-3-d147-174 (panel 2) (Magnification 100000×).  (C). 
Electron microscopic analysis of virus infected cells. BAV304a infected (panel 1) or BAdV-3-
d147-174 (panel 3) infected MDBK cells (Magnification 10000×). The arrows depict the 
enlargement of selected boxed region of panel 1 (panel2) and panel 3 (panel 4) (Magnification 
30000×). 
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of purified BAdV-3-d147-174 this may be because the size of C-terminal cleaved fragment of 
pVIII is small and it might pass through the membrane during transfer from gel to membrane. 
3.3.14 Analysis of BAV-3-d147-174 assembly  
To assess whether deletion of amino acid 147-174 of pVIII has any effect on the virus 
structure, the BAV304a or BAV-3-d147-174 were propagated in MDBK cells and purified by 
CsCl density gradient as described (Tollefson et al., 2007). The number of MDBK cells used to 
purify BAV-3-d147-174 was three times more than that used for purifying BAV304a. As seen in 
Fig.3.3.13A, the amount of mature virions present in BAdV3-d147-174 infected cells appears 
lower than the amount detected in BAV304a infected cells. The negative-staining electron 
microscopy revealed that like BAV304a, the BAdV-3-d147-174 particles appeared icosahedral 
in shape (Fig.3.3.13B).  However, unlike BAV304a, more BAV-3-d147-174 virus particles 
appeared disrupted (Fig.3.3.13B). 
To further assess whether deletion of BAdV-3 pVIII amino acids numbered 147-174 has 
any effect on virus assembly, transmission electron microscopy was performed on MDBK cells 
infected with BAdV304a or BAdV-3-d147-174. As seen in Fig.3.3.13C, TEM images of virions 
suggested no observable defect in the assembly of virus particles. However, unlike BAV304a, 
few virus particles with darkly staining core were detected in BAV-3-d147-174 infected cells. 
3.4 Discussion 
 Protein-protein interactions influence every cellular process. Since, the interaction of 
viral proteins with host cell proteins is essential for virus growth and survival, identifying the 
interactions and determining the consequence of such interactions is important in understanding 
the virus –host interactions (Phizicky & Fields., 1995). Earlier, we demonstrated that BAdV-3 
pVIII is expressed as 24 kDa protein in BAdV-3 infected as well as BAdV-3 pVIII transfected 
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cells and is transported to nucleus by interacting preferentially with α3 importin (Ayalew et al., 
2014). We also demonstrated that pVIII interacts with cellular factor DDX3 and inhibits cap 
dependent translation (Ayalew., 2015). Here, we report a new interaction between BAdV-3 pVIII 
and cellular protein eIF6, which appear to alter the formation of functional 80S ribosomes and 
may modulate cellular protein translation. Moreover, pVIII domain interacting with eIF6 appears 
to be important for efficient replication of BAdV-3. 
 The eukaryotic initiation factor 6 is a 245 amino acid extremely conserved protein (Si et 
al., 1997,Si & Maitra., 1999), which is important for ribosome biogenesis and protein translation 
(Miluzio et al., 2009). Several lines of evidence suggest that pVIII and eIF6 interact during 
BAdV-3 infection. First, yeast two hybrid experiments indicated that pVIII interacts with eIF6. 
Secondly, pVIII-eIF-6 interaction was demonstrated using GST pulled down assay. Thirdly, 
bimolecular fluorescence complementation assay suggested that pVIII and eIF6 interact in- vivo.  
Finally, using co-immunoprecipitation and Western blot assays, we demonstrated that cellular 
eIF6 interact with pVIII synthesized in BAdV-3 infected cells. Deletion analysis revealed that C-
terminus of pVIII (amino acids 147-174) appear to interact with N-terminus of eIF6 (amino acids 
44-97).  
  Earlier studies involving yeast cells reported that depletion of Tif6 (yeast eIF6 homologue) 
results in rapid reduction of 60S ribosomal subunits compared to 40S subunit. (Sanvito et al., 
1999,Si & Maitra., 1999,Wood et al., 1999). Moreover, the eIF6 also specifically binds to free 
60S ribosomal subunit and prevents premature association of pre-40S and pre-60S subunits in 
absence of mRNA joining with 40S ribosomal subunit (Gartmann et al., 2010,Russell & 
Spremulli., 1979,Valenzuela et al., 1982). For initiation of translation, eIF6 is released from the 
60S subunit in the cytoplasm (Ceci et al., 2003), which allows joining of 60S and 40S subunits 
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resulting in the formation of active, translating 80S complex (Ceci et al., 2003,Horsey et al., 
2004,Si & Maitra., 1999). Our results support the suggestion that interaction of eIF6 with pVIII 
alters the release of eIF6 from the 60S subunit in infected \ transfected cells, which lead to the 
reduction in the formation of functional 80S subunits. First, there are more free 60S ribosomal 
subunits and less 80S ribosomal subunits in BAdV-3 infected cells than mock infected cells. 
Second, there are more free 60S ribosomal subunits and less 80S ribosomal units in cells 
expressing BAdV-3 pVIII compared to control cells.  
Earlier report demonstrated that reduction of 40S ribosomal subunit modulates the 
hepatitis C virus IRES-mediated translation but not host specific translation (Huang et al., 2012). 
Analysis of BAdV-3 infected cell polysomes revealed the reduction in 40S ribosomal subunits in 
infected cells. Although the role of such reduction in 40S ribosomal subunits in BAdV-3 infected 
cells is not yet clear, the absence of such reduction in 40S ribosomal subunits in pVIII expressing 
cell line suggests that pVIII is not involved in this process.  
A number of viruses are known to target initiation factors and translation initiation step to 
inhibit host mRNA translation (Bushell & Sarnow., 2002,Schneider & Mohr., 2003). Some of 
the strategies used by viruses to target translation initiation and inhibit host protein synthesis 
includes, modification of activity of eukaryotic initiation factors (Feigenblum & Schneider., 
1993), targeting PABP and sequestering it (Ilkow et al., 2008,Smith & Gray., 2010), cleavage of 
eIF4G and/ or de-phosphorylation of 4EBP1 (You et al., 1999), modulating  activity of eIF4E 
(Burgui et al., 2007,Connor & Lyles., 2002) or excluding 4EBP1 from mRNA cap binding 
complex (Aoyagi et al., 2010) by direct interaction of viral proteins with eIFs. 
 The cellular mRNA translation is also inhibited in adenovirus infected cells at late times 
post infection (Huang & Schneider., 1991). Earlier report suggested that interaction of 
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adenovirus 100K protein with eIF4G and consequent displacement of mnk-1 from eIF4G leading 
to under-phosphorylation of eIF4E  results in altering cellular mRNA translation (Cuesta et al., 
2000,Cuesta et al., 2004). Recent report has suggested that the cellular mRNA translation may 
also be interfered by altering the availability of eIFs for cap binding protein complex due to 
interaction of pVIII with DDX3 (Ayalew., 2015). We speculate that this impairment of formation 
of functional 80S unit, because of inhibition of release of eIF6 from 60S subunit may be yet 
another mechanism of altering the translation of cellular mRNAs at late times post BAdV-3 
infection and helping the preferential translation of late viral mRNAs by ribosome shunting 
mechanism (Yueh & Schneider., 1996). In ribosome shunting mechanism, the 40S ribosomal 
subunit binds to the cap structure and scans a short linear non structured region of mRNA. It then 
shunts all the structured region having secondary structure and hairpin loops and lands to a site 
several hundred nucleotides downstream. Since the structured region is not scanned the 
secondary structure of shunted region remains preserved (López‐Lastra et al., 2010). All 
adenovirus late mRNAs have tripartite leader spliced to them. The tripartite leader which acts as 
a shunting element has a proximal linear non structured region which is followed by highly 
structured region which has complex secondary structures and hairpin loops (Yueh & Schneider., 
1996,Yueh & Schneider., 2000). At late time points post adenovirus infection when host cap 
dependent protein synthesis is inhibited adenovirus late mRNAs are preferentially translated by 
ribosome shunting mechanism (Xi et al., 2004). Thus, it appears that inhibition of cellular 
mRNA translation at late times post infection may be mediated by multiple mechanisms 
involving different adenovirus late proteins. However, it is not clear if different mechanisms of 
inhibition of cellular mRNA translation in adenovirus infected cells at late times post infection 
act synergistically or act separately at different times post infection. 
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Domain of BAdV-3 pVIII (amino acid 147-174) interacting with eIF6 (amino acid 44 to 
97) appears dispensable for the production of progeny virus. Although formation of mature 
BAdV-3-d147-174 virus occurs, the mutant virus yield and production of mature virus particles 
(Fig.3.3.11 panel B; Fig.3.3.13, panel A, B, C) appears affected. Both BAdV-3-d147-174 and 
BAV304a showed comparable infectivity and viral genome replication. Moreover, deletion of 
eIF6 interacting domain of pVIII (amino acid 147-174) does not affect the structure of the capsid 
of mature BAdV-3-d147-174 as it does not make it thermolabile.  However, analysis of BAdV-3-
d147-174 gene expression revealed that while the expression of DBP (early gene) is not affected, 
the expression of late viral proteins was significantly decreased in BAdV-3-d147-174 infected 
cells. However, there was no significant difference in the incorporation of analyzed structural 
proteins between BAdV-3-d147-174 and BAV304a. These results indicate that abrogating the 
interaction of pVIII and eIF6 affect the expression of adenovirus late proteins, which may lead to 
decrease in the production of mature virus particles. We suggest that absence of interaction of 
pVIII and eIF6 in BAdV-3-d147-174 allows the formation of 80S ribosomal subunit required for 
efficient translation of cellular mRNAs, thus modulating the preferential translation of adenoviral 
mRNAs during late phase of infection in BAV304a infected cells.  
In conclusion, our results suggest that C- terminus (amino acid 147 to 174) of pVIII 
interact with N- terminus (amino acids 44 to 97) of eIF6, which causes impairment of the 
formation of 80S ribosomes and may lead to modulation of cellular mRNA translation at late 
times post BAdV-3 infection.  We speculate that this impairment of ribosomal subunit joining is 
a consequence of inhibition of release of eIF6 from 60S subunit by pVIII. Moreover, we have 
demonstrated that abrogation of this interaction affects the formation of mature BAdV-3 virions 
and virus yield by modulating the translation of BAdV-3 mRNAs at late times post infection.   
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4.0 TRANSITION FROM SECTION 3.0 TO SECTION 5.0 
Protein-protein interactions are integral part of virus life cycle. Viral proteins often interact 
with host cell proteins and other viral proteins to perform their functions. So far, I analysed the 
interaction of pVIII with one of the cellular protein eIF6 and determined the biological 
significance of this interaction. In the next section, I studied the interaction of pVIII with BAdV-
3 protease. The following section describes characterization of adenovirus protease mediated 
cleavage of pVIII and the role of proteolytic cleavage of pVIII in virus assembly, stability and 
infection. 
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5.0 ROLE OF PROTEOLYTIC CLEAVAGE OF BOVINE ADENOVIRUS-3 ENCODED 
PVIII IN BAdV-3 INFECTION 
5.1 Introduction 
Adenoviruses are complex, large, non-enveloped viruses that have a linear double stranded 
DNA genome (Martin et al., 2007). The in-depth molecular characterization of human 
adenoviruses and their properties like ease of genome manipulation, broad tropism, transgene 
carrying capacity of up to 30kb and rapid growth to high titers in tissue culture have made 
adenoviruses a popular tool for gene transfer into mammalian cells (Campos & Barry., 
2007,Tatsis & Ertl., 2004) . However, despite being extensively studied for more than 5 decades 
some aspects of adenovirus biology such as assembly and final maturation are not fully 
understood. Moreover, localization of some of minor capsid proteins and their role(s) in 
adenovirus lifecycle is not clear yet (Condezo et al., 2015). 
Like many other viruses and bacteriophages, proteolytic maturation is a key step in the 
life cycle of adenoviruses. The key player in adenovirus maturation is adenovirus protease which 
recognizes and cleaves at two consensus cleavage motifs (M/I/L)XGX-G and( M/I/L)XGG-X 
(where X is any amino acid) (Webster et al., 1989). Adenoviral proteins that are substrate for 
adenovirus protease include three minor capsid proteins (pIIIa, pVI and pVIII) and three core 
proteins (pVII, pμ and pTP) (Challberg & Kelly., 1981,Mangel et al., 1996,Weber., 1976). Apart 
from these six structural proteins two nonstructural proteins L1 52/55k (Perez-Berna et al., 2014) 
and 100K (Makadiya et al., 2015) have been recently reported to be substrates of adenoviral 
protease.  
One of the substrate for adenoviral protease is pVIII. The pVIII is a minor capsid protein 
that is present on the inner surface of the capsid and connects the core with the capsid (Rohn et 
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al., 1997). As pVIII is one of the least characterized adenoviral protein, very little is known 
about the function of pVIII in adenovirus life cycle. Earlier work suggested that HAdV-5 pVIII 
encoded by L4 region is 227 amino acids long (Chroboczek et al., 1992) and is present in  
precursor form in immature virus particles and in cleaved form in mature virions  (Chelius et al., 
2002,Liu et al., 2010,Takahashi et al., 2006). Crystallographic studies could identify amino acids 
31-90 fragment 1 (aa 1-111) and amino acids 163-215 of fragment 2 (aa 158-227) of HAdV-5 
pVIII in mature virions (Reddy & Nemerow., 2014).    
Recently, we have reported that BAdV-3 pVIII, a protein of 216 amino acids encoded by 
L6 region (Reddy et al., 1998) is localized to the nucleus of the infected cells by binding of pVIII 
(amino acid 52-72) with importin -3 (Ayalew et al., 2014). The pVIII is expressed as 24 kDa 
(precursor form) and 8 kDa (cleaved form) proteins in BAdV-3 infected cells. Moreover, while 
the precursor form (24 kDa) could be detected in empty capsids, the cleaved form (8 kDa) could 
be detected in mature capsids (Ayalew et al., 2014) suggesting that BAdV-3 pVIII appears to be 
cleaved at potential cleavage site 
143LGGG↓S147 (Ayalew et al., 2014). 
Although proteolytic maturation involving cleavage of some structural and  non-
structural precursor protein is an important aspect of adenovirus life cycle (Mangel & San 
Martín., 2014,Moyer et al., 2015),  it is not known what role each individual cleavage event 
plays in determining adenovirus particle stability and infectivity (Mangel & San Martín., 
2014,Moyer et al., 2015). The present study was initiated to determine the role of proteolytic 
cleavage of pVIII in virus assembly, stability and infection. Here, we report that BAdV-3 pVIII 
is cleaved by adenovirus protease at both potential consensus protease cleavage sites. The 
cleavage at one consensus protease cleavage sites of pVIII appears essential for the production of 
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infectious progeny virus. Moreover, cleavage of pVIII at both potential protease cleavage sites is 
a major contributing factor in determining the stability of adenovirus particles. 
5.2 Materials and methods 
5.2.1 Cell line and Viruses 
Madin Darby Bovine Kidney (MDBK) cells (Kulshreshtha et al., 2004), cotton rat lung 
(CRL) fibroblast cells (Papp et al., 1997) and VIDO DT1 cells (cotton rat lung fibroblasts 
expressing I-SceI protein) (Du & Tikoo., 2010) were grown in minimum essential medium 
(MEM; Sigma Aldrich) supplemented with 10% fetal bovine serum. Human embryo kidney 
(HEK) 293T cells (ATCC
®
 CRL-3216
TM) were propagated in Dulbecco’s Modified Eagle 
medium (DMEM) supplemented with 10% FBS. BAV304a (contains BAdV-3 genome from 
which E3 region is deleted and is replaced by EYFP under CMV promoter)  (Du & Tikoo., 2010) 
and mutant BAdV-3s were propagated in MDBK cells in MEM supplemented with 2% fetal 
bovine serum.  
5.2.2 Antibodies 
Polyclonal anti-pVIII serum recognizes a protein of 24 kDa and 8 kDa in BAdV-3 infected 
cells (Ayalew et al., 2014). Production and characterization of sera recognizing DNA binding 
protein (DBP) (Zhou et al., 2001b), pVII (Anand et al., 2014), protein V (Kulshreshtha & 
Tikoo., 2008), hexon (Patel & Tikoo., 2006) and 100K (Makadiya et al., 2015) of BAdV-3 have 
been described.  Anti-GFP antibody (Cell Signalling), alexa fluor 680 conjugated goat anti-rabbit 
antibody (Invitrogen), anti-β-actin monoclonal antibody (Sigma-Aldrich), IRDye800 conjugated 
goat anti-mouse antibody (Rockland) and alkaline phosphatase (AP)-conjugated goat anti-rabbit 
IgG (Jackson ImmunoResearch) were purchased. 
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5.2.3 Plasmid construction 
Construction of plasmids pDR.bProt, pDR.hProt and pDR.pProt has been described earlier 
(Makadiya et al., 2015). Following plasmids were constructed using standard DNA manipulation 
techniques. 
i) pEY.pVIII.HA. PCR was performed using primers p8-c1-fwd +  p8-c1-Rev (Table 
5.2.1), and plasmid pUC304a+ (Du & Tikoo., 2010) DNA as template to amplify a 704bp 
DNA fragment. The restriction enzymes EcoRI and XhoI were used to digest the PCR 
product.  The XhoI-EcoRI digested PCR product was ligated to XhoI-EcoRI digested 
plasmid pEYFP-C1 (clontech) creating plasmid pEY.pVIII.HA. 
ii) pEY.pVIII.HA143A. First round of PCR was performed using primer pairs (p8-c1-fwd  
+ p8-143A-Rev) and (p8-143A-fwd + p8-c1-Rev) (Table 5.2.1) and plasmid pEY-pVIII-
HA DNA as template to generate 467bp and 281bp products, respectively. The PCR 
products of first round were mixed and used as templates with primers p8-c1-fwd + p8-
c1-Rev to amplify 704bp product by PCR. The restriction enzymes EcoRI and XhoI were 
used to digest the PCR product.  The XhoI-EcoRI digested final PCR product was ligated 
to XhoI-EcoRI digested plasmid pEYFP-C1creating plasmid pEY.pVIII.HA143A. 
iii) pEY.pVIII.HA108A. First round of PCR was performed using primer pairs (p8-c1-fwd 
+ p8-DM-Rev) and (p8-DM-fwd + p8-c1-Rev) (Table 5.2.1) and plasmid pEY.pVIII.HA  
DNA as template to generate 373bp and 386 bp products, respectively. The PCR products 
of first round were mixed and used as templates with primers p8-c1-fwd + p8-c1-Rev to 
amplify 704bp product by PCR. The restriction enzymes EcoRI and XhoI were used to 
digest the PCR product. The XhoI-EcoRI digested final PCR product was ligated to XhoI-
EcoRI digested plasmid pEYFP-C1creating plasmid pEY.pVIII.HA108A. 
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iv) pEY.pVIII.HA.DM. First round of PCR was performed using primer pairs (p8-c1-fwd + 
p8-DM-Rev) and (p8-DM-fwd + p8-c1-Rev) (Table 5.2.1) and plasmid 
pEY.pVIII.HA143A DNA as a template to generate 373bp and 386bp products, 
respectively. The PCR products of first round were mixed and used as templates with 
primers p8-c1-fwd +  p8-c1-Rev to amplify 704bp product by PCR. The restriction 
enzymes EcoRI and XhoI were used to digest the PCR product.  The XhoI-EcoRI digested 
final PCR product was ligated to XhoI-EcoRI digested plasmid pEYFP-C1creating 
plasmid pEY.pVIII.HA.DM. 
v) pMCS-108A. First round of PCR was performed using primer pairs (FWD –Reco-p8-
del) + Rev –p8-DM-Rev) and (p8-DM-fwd + Rev –Reco-p8-del)  and  plasmid  pMCS + 
pVIII DNA as template to generate 784bp and 991bp products, respectively. The PCR 
products of first round were mixed and used as templates with primers FWD –Reco-p8-
del + Rev –Reco-p8-del to amplify 1720 bp product by PCR. The restriction enzymes 
AscI and AfeI were used to digest the final PCR product. The AscI and AfeI digested PCR 
product was ligated to AscI and AfeI digested plasmid pMCS+pVIII creating plasmid 
pMCS-108A. 
vi)  pMCS-143A. First round of PCR was performed using primer pairs (FWD –Reco-p8-del 
+Rev–p8-143A-Rev) and (p8-143A-fwd + Rev –Reco-p8-del) and plasmid pMCS+pVIII 
DNA as template to generate 878bp and 886 bp products, respectively. PCR products of 
first round were mixed and used as templates with primers FWD –Reco-p8-del + Rev –
Reco-p8-del to amplify 1720bp product by PCR. The restriction enzymes AscI and AfeI 
were used to digest the final PCR product. The AscI and AfeI digested PCR product was 
ligated to AscI and AfeI digested plasmid pMCS+pVIII creating plasmid pMCS-143A. 
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vii) pMCS-DM. First round of PCR was performed using primer pairs (FWD –Reco-p8-del + 
Rev –p8-DM-Rev) and (p8-DM-fwd + Rev –Reco-p8-del) and plasmid  pMCS-143A 
DNA as template to generate 784bp and 991 bp products, respectively. The PCR products 
of first round were mixed and used as templates with primers FWD –Reco-p8-del + Rev 
–Reco-p8-del to amplify 1720 bp product by PCR. The restriction enzymes AscI and AfeI 
were used to digest the final PCR product. The AscI and AfeI digested PCR product was 
ligated to AscI and AfeI digested plasmid pMCS+pVIII creating plasmid pMCS-DM. 
viii) pUC304a-pVIII-108A. Restriction enzyme XcmI was used to isolate a 5446 bp DNA 
fragment from plasmid pMCS-108A. The isolated DNA fragment was used with SbfI 
digested plasmid pUC304a.dVIII DNA for homologous recombination in E. coli BJ5183 
to generate plasmid pUC304a-pVIII-108A. 
ix) pUC304a-pVIII-143A. Restriction enzyme XcmI was used to isolate a 5446 bp DNA 
fragment from plasmid pMCS-143A. The isolated DNA fragment was used with SbfI 
digested plasmid pUC304a.dVIII DNA for homologous recombination in E. coli BJ5183 
to generate plasmid pUC304a-pVIII-143A. 
x) pUC304a-pVIII-DM. Restriction enzyme XcmI was used to isolate a 5446 bp DNA 
fragment from plasmid pMCS-DM. The isolated DNA fragment was used with SbfI 
digested plasmid pUC304a.dVIII DNA for homologous recombination in E. coli BJ5183 
to generate plasmid pUC304a-pVIII-DM. 
5.2.4 Western blotting  
Proteins from purified virus, virus infected cell lysates or plasmid DNA transfected cell 
lysates were run on  SDS-PAGE, transferred to PVDF membrane (Bio-Rad) and probed by 
Western blot using protein specific anti-serum and Alexa Fluor 680, IRDye800 conjugated 
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antibodies or  alkaline phosphatase (AP)-conjugated goat anti-rabbit IgG (Sigma).The 
membranes probed with fluorophore-conjugated secondary antibody were scanned and analyzed 
by Odyssey
®
 CLx Imaging System (LI-COR). 
Table 5.2.1 List of primers 
Primer Name Primer sequence 
p8-c1-fwd TCAGATCTCGAGACATGAGCAAAGAAATTCCCAC 
 p8-c1-Rev 
ACTGCAGAATTCTCAAGCGTAATCTGGAACATCGTATGGGTAGCTATAACCGCTCA 
CAGAG 
p8-143A-fwd CAGATGGAGTCTTTCAACTAGCGGCCGCCTCGCGTTCATCTTTC 
p8-143A-Rev GAAAGATGAACGCGAGGCGGCCGCTAGTTGAAAGACTCCATCTG 
p8-DM-fwd CCTCACATGGCGCTCAAATCGCAGCTGCAGCCGCTGCGGGCGATTACTTTAAAAG 
p8-DM-Rev CTTTTAAAGTAATCGCCCGCAGCGGCTGCAGCTGCGATTTGAGCGCCATGTGAGG 
 
5.2.5 Isolation of mutant BAdV-3 
Monolayers of VIDO DT1 cells (cotton rat lung fibroblasts expressing I-SceI protein) (Du 
& Tikoo., 2010) in six- well plates were transfected with 4-6μg of individual plasmid DNA using 
Lipofectamine 2000 reagent (Invitrogen). At 4hrs post-transfection, the medium was replaced 
with MEM containing 2% FBS. The cells were observed daily for appearance of any cytopathic 
effect (CPE). On appearance of CPE, the cells were harvested and freeze thawed three times 
before using for reinfection of fresh MDBK cells. 
5.2.6 CsCl gradient centrifugation 
The CsCl gradient centrifugation was carried out as described earlier (Tollefson et al., 
2007). Briefly, confluent monolayers of MDBK cells were infected with wild-type or 
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recombinant virus. The cells showing more than 80% cells CPE were collected, pelleted by 
centrifugation and re-suspended in 5ml medium. The cell lysate was freeze thawed 5 times and 
was subjected to CsCl density gradient centrifugation at 35000 rpm for 1hr at 4°C. The band 
containing virus was collected and used for a second round of CsCl density gradient 
centrifugation at 35000 rpm for 16 hrs at 4°C. The virus was collected, dialyzed against three 
changes of dialysis buffer to remove traces of cesium chloride and stored in small aliquots at -
80°C. 
5.2.7 Virus growth kinetics 
MDBK cells in 24-well plates were infected with either BAdV304a or BAdV-108A or 
BAdV-143A at MOI of 1. Infected cells were then collected at different time points (0, 6, 12, 24, 
36, and 48 hrs) post-infection, freeze-thawed 3 times and virus in cell lysate was titrated by 
TCID50 in MDBK cells (Kulshrestha et al., 2004). 
5.2.8 Virus thermostability assay 
The virus thermostability assay was performed as described earlier (Zhao., 2016). Briefly, 
about 10
5
 purified virus particles were incubated at different temperatures (-80C, -20C, 4C, 
25C and 37C) for 3 days in PBS containing 10% glycerol.  Finally, the infectivity of viable 
virus was determined by TCID50. To further assess the thermostability, 10
5
 purified virus 
particles were incubated at different temperatures (-80C, 4C, 37C) for 0, 1, 3 and 7 days in 
PBS containing 10% glycerol and TCID50 assay was performed to determine the remaining 
infectivity. 
 109 
5.2.9 Transmission electron microscopy 
To analyze CsCl gradient purified BAdV-3 virions by TEM, three hundred mesh grids 
(Ted Pella, cat# G300) that were previously covered with 0.25% formvar followed by carbon 
coating (Denton Vacuum Inc.) were suspended for two minutes on to a twenty microliter droplet 
containing CsCl gradient purified virus particles and fixed with 5% electron microscopy grade 
glutaraldehyde (catalogue number 16316-10; Electron Microscopy Sciences). After three washes 
with water, the grids were suspended on a droplet of 0.5% Phosphotungstic Acid (J.B. Em 
Services Inc. Dorval QC) for one minute.  The excess solution was removed and the grids are 
allowed to dry. Finally, the grids with negatively stained virus particles were examined on an 
HT7700 transmission electron microscope (Hitachi Inc.) at 80 kv. 
To analyse BAdV-3 infected cells by TEM, the monolayers of MDBK cells were infected 
with either BAdV-304a or BAdV-3-d147-174. At 48 hrs post-infection, the cells were harvested 
and fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer at 4°C. Following fixation 
cells were pelleted in 1% Low melting point agarose, post fixed at room temperature in 1% OsO4 
in 0.1M sodium cacodylate buffer and en bloc stained with saturated Uranyl Acetate in 70% 
Ethanol. Dehydration was carried out with a graded ethanol series and finalized in propylene 
oxide (Electron Microscopy Sciences cat#20401). Dehydrated cells were infiltrated with 
Epon812/Araldite embedding medium by gradually increasing concentration in propylene oxide, 
and then polymerized in molds with pure Epon/araldite at 60C for 24 hrs. Finally, the pellet was 
sectioned with a Reichert ultracut ultramicrotome, each section stained with Reynolds lead 
citrate and 2% Uranyl acetate and viewed on a HT7700 transmission electron microscope 
(Hitachi Inc.) at 80 kv. 
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5.2.10 Fluorescent focus assay 
The monolayers of MDBK cells grown in 12 well plates were infected with individual 
viruses at a MOI of 2. After 18 hrs, GFP positive cells\foci were counted for each well using 
fluorescent microscope. The average number of GFP positive cells was quantified as fluorescent 
focus unit (FFU) per field. 
5.2.11 TEM analysis of subcellular distribution of purified viruses 
The monolayers of MDBK cells in one well of 6 well plate were incubated with individual 
viruses at a MOI of 10 at 4°C. After 1 hr of incubation, the cells were washed before incubating 
again at 37°C. After incubating for 30 mins, the cells were then processed for TEM analysis as 
described earlier (Kulshreshtha et al., 2004). 
5.2.12 Viral genome replication  
Viral genome replication was measured as described (Wu et al., 2012) with minor 
modifications. Briefly, MDBK cells were infected with BAdV304a, BAdV-108A or BAdV-
143A and harvested at indicated times post infection. The infected cells were pelleted, washed 
one time with phosphate-buffered saline (PBS) and then re-suspended in isotonic buffer. After 
incubating the cells on ice for 10 min, the nuclei were then pelleted by centrifugation at 2000 × g 
at 4°C for 5 min. The pelleted nuclei were suspended in 200 μl PBS and used for DNA 
extraction using a DNeasy blood and tissue kit (Qiagen) following manufacturer’s instructions. 
Finally, the DNA was re-suspended in double distilled water and subjected to quantitative PCR 
using Bio-Rad real time PCR system. The two sets of primers used for quantitative PCR were 
primer pair Q adeno Fwd and Q adeno Rev and primer pair Actin Fwd and Actin Rev (Table 
3.2.1). Genome replication was calculated as the value of viral genome copy number divided by 
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actin copy number. For comparison, the value of each virus was normalized to that of BAV304a 
at 6hpi and shown as relative viral genome copy number.  
5.2.13 Statistical analysis 
  All data were analyzed using GraphPad Prism version 6 (GraphPad Software, Inc., La 
Jolla, CA, USA). Statistical differences among the groups were calculated using unpaired t-test. 
Differences were considered significant at * p<0.05, ** p<0.01 and *** p<0.001. 
5.3 Results 
5.3.1 Analysis of the pVIII protein sequences for potential protease cleavage sites 
The adenovirus protease recognizes and cleaves at two consensus cleavage motifs 
(M/I/L)XGX-G and( M/I/L)XGG-X (where X is any amino acid) (Webster et al., 1989). Earlier, 
analysis of amino acid sequence of BAdV-3 pVIII (Ayalew et al., 2014)  revealed two potential 
adenoviral protease cleavage sites (Fig.5.3.1A), which are conserved with potential protease 
cleavage sites in pVIII encoded by human adenovirus 5 (HAdV-5) or porcine adenovirus 3 
(PAdV-3) (Fig.5.3.1B). In contrast, analysis of pVIII encoded by HAdV-5 and PAdV-3 revealed 
the presence of three potential protease cleavage sites (Fig.5.3.1B). 
5.3.2 Analysis of cleavage of BAdV-3 pVIII at potential protease cleavage site(s)  
To determine whether pVIII is cleaved at one or both potential protease cleavage sites, we 
constructed plasmid pEY.pVIII.HA (expressing EYFP and HA tagged pVIII) (Fig.5.3.2A). The 
293T cells were co-transfected with plasmids pEY.pVIII.HA + plasmid pDsRed-C1 DNAs or 
plasmid pEY.pVIII.HA + pDR.bProt (expressing DsRed tagged BAdV-3 protease) DNAs. After 
48 hrs post transfection, the cells were collected lysed and the lysates were analysed by Western 
blotting using anti-GFP serum. As seen in Fig.5.3.2 anti-GFP serum detected a protein of 52 kDa 
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Figure 5.3.1 Consensus Protease cleavage sites of pVIII. (A). Schematic diagram of BAdV-3 
pVIII showing the two potential protease cleavage sites (PPCS). PPCS1 (amino acid 108-112); 
PPCS2 (amino acids 143-147). Arrows depict the site of cleavage. (B). Conservation of PPCS 
in pVIII protein.  Black frames indicate the adenovirus protease consensus cleavage site present 
in pVIII protein of BAdV-3, PAdV-3 and HAdV-5 where as white frame indicate the AVP 
consensus cleavage site present in pVIII protein of PAdV-3 and HAdV-5 only. Sequences were 
downloaded from Uniprot (BAdV-3 Uniprot Accession # O92788; PADV-3# Q83453; HAdV-5 
#P24936) and aligned with TCofee (Notredame et al., 2000). The figure was created using 
JalView (Waterhouse et al., 2009). 
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Figure 5.3.2 Analysis of cleavage of BAdV-3 pVIII protein in transfected 293T cells. (A). 
Schematic diagram of plasmid DNAs. The name of the plasmids is indicated on the right of 
diagrams. The EYFP (enhanced yellow fluorescent protein), pVIII (BAdV-3), protease (BAdV-
3) and DsRed DNA are indicated. (B). Western blot. Cell lysates were prepared from 293T cells 
co-transfected with the indicated plasmid DNA. The proteins from the prepared lysates were run 
on 12 % SDS-PAGE, transferred to PVDF membrane and analysed by Western blotting using 
anti-GFP antibody. Solid arrows indicate uncleaved EY.pVIII.HA fusion protein and open 
arrows indicate the cleaved product. The molecular mass markers (M) in kDa are shown on the 
left. (C). Schematic diagram of plasmid DNAs showing potential protease cleavage sites. 
The origin of DNA is depicted. The amino acid sequence of potential protease cleavage sites is 
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depicted on the top of plasmid pEY.pVIII.HA. The glycine to alanine substitution in predicted 
protease cleavage sites are underlined and depicted on top of plasmids pEY.pVIII.HA108A, 
pEY.pVIIII.HA143A and pEY.pVIII.HA.DM. The name of the plasmid is on right. (D). 
Cleavage of BAdV-3 pVIII mutant proteins in transfected cells. Cell lysates were prepared 
from 293T cells co-transfected with the indicated plasmid DNA’s. The proteins from the 
prepared lysates were run on 12 % SDS-PAGE, transferred to PVDF membrane and analysed by 
Western blotting using anti-GFP antibody.  Solid arrows indicate uncleaved fusion protein and 
open arrows indicate the cleaved product. The molecular mass markers (M) in kDa are indicated 
on the left. 
 
 
  
 115 
 (corresponding to EYFP-pVIII-HA fusion protein) in the cells co-transfected with plasmid 
pEY.pVIII.HA + pDsRed-C1 DNAs. In contrast, anti-GFP serum detected proteins of 52 kDa, 
40 kDa (corresponding to cleavage product EYFP-pVIII amino acid 1 to 111 fusion protein) and 
43 kDa (corresponding to cleavage product EYFP-pVIII amino acid. 1 to 146 fusion protein) in 
the cells co-transfected with plasmid pEY.pVIII.HA + pDR.bProt DNAs, suggesting that pVIII 
is cleaved at both potential cleavage sites and that both sites are active.  
To further characterize the cleavage of pVIII by adenoviral protease, we constructed 
three additional plasmids (pEY.pVIII.HA.108A, pEY.pVIII.HA.143A and pEY.pVIII.HA.DM) 
(Fig.5.3.2C). Plasmid pEY.pVIII.HA.108A contain substitution of glycines at amino acid 
position 110, 111 and 112 of BAdV-3 pVIII to alanine; plasmid EY.pVIII.HA143A contain 
substitution of glycines at position 144, 145 and 146 of BAdV-3 pVIII to alanine and plasmid 
pEY.pVIII.HA.DM contain substitution of  glycines at position 110, 111, 112, 145 and 146 of 
BAdV-3 pVIII to alanine. Identity of these plasmid DNAs was confirmed by DNA sequencing.  
The 293T cells were co-transfected with each of these plasmids DNA along with either plasmid 
pDsRed-C1 DNA or plasmid pDR.bProt DNA. After 48 hrs post transfection, the cells were 
collected, lysed, and the lysates were analysed by Western blotting using anti-GFP serum. As 
seen in Fig.5.3.2D  anti-GFP serum detected a protein of 52 kDa in the lysates of the cells co-
transfected with plasmid pEY.pVIII.HA + pDsRed-C1 (lane 1), pEY.pVIII.HA.108A + pDsRed-
C1b(lane 3), pEY.pVIII.HA143A + pDsRed-C1 (lane 5),  pEY.pVIII.HA.DM + pDsRed-C1 and 
pEY. pVIII.HA.DM + pDR.bProt (lane 7) DNAs suggesting that pVIII is not cleaved in absence 
of protease. As seen earlier, anti-GFP serum detected proteins of 52 kDa, 43 kDa and 40 kDa in 
the lysates of cells co-transfected with plasmid pEY.pVIII.HA+ pDR.bProt DNAs (lane 2). 
However, anti-GFP serum detected proteins of 52 kDa and 43 kDa in the lysates of the cells co-
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transfected with plasmid pEY.pVIII.HA.108A + pDR.bProt DNAs DNA (lane 4). Similarly, 
anti-GFP serum detected two proteins of 52 kDa and 40 kDa in the lysates of the cells co-
transfected with plasmid pVIII.HA.143A + pDR.bProt DNAs (lane 6). In contrast, anti-GFP 
serum detected only a protein of 52 kDa in the lysates of the cells co-transfected with plasmid 
pEY.pVIII.HA.DM + pDR.bProt DNAs (lane 8). 
5.3.3 Cleavage of BAdV-3 pVIII by protease encoded by other Mastadenoviruses 
To determine if BAdV-3 pVIII protein can be cleaved by proteases encoded by other 
Mastadenoviruses, the 293T cells were co-transfected with plasmids pEY.pVIII.HA and either 
plasmid pDsRed-C1 or plasmid pDR.bProt (expressing BAdV-3 protease) or plasmid pDR.hProt 
(expressing human adenovirus 5 [HAdV-5] protease) or plasmid pDR.pProt (expressing porcine 
adenovirus 3 [PAdV-3] protease) DNAs. After 48 hrs post transfection, the cells were collected, 
lysed and the lysates were analysed by Western blotting using anti-GFP serum. As seen in 
Fig.5.3.3A, anti-GFP serum detected a protein of 52 kDa (uncleaved EYFP-pVIII-HA fusion 
protein) in the cells co-transfected with plasmid pEY.pVIII.HA and pDsRed-C1 DNAs (lane 1). 
In contrast, anti-GFP serum detected proteins of 52kDa (uncleaved  EYFP-pVIII-HA fusion  
protein), 43kDa (  cleavage product EYFP-pVIII amino acid 1 to 146 fusion protein) and 40kDa 
(cleavage product EYFP-pVIII amino acid 1 to 111 fusion protein ) in the cells co-transfected 
with plasmid pEY.pVIII.HA and either pDR.bProt (lane 2)  pDR.hProt ( lane 3) or pDR.pProt 
(lane 4)  DNAs, indicating that BAdV-3  pVIII can be cleaved at both potential cleavage sites by 
protease encoded by HAdV-5 and PAdV-3. 
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Figure 5.3.3 Cleavage of pVIII by different adenoviral proteases in transfected cells. (A-C). 
Cell lysates were prepared from 293T cells co-transfected with the indicated plasmid DNA’s. 
The proteins from the prepared lysates were run on 12 % SDS-PAGE, transferred to PVDF 
membrane and analysed by Western blotting using anti-GFP antibody. The cleavage of pVIII of 
(A) BAdV-3, (B) HAdV-5 and (C) PAdV-3 by different adenoviral proteases was analysed. 
Solid arrows indicate uncleaved fusion protein and open arrows indicate the cleaved product. 
The molecular mass markers (kDa) are indicated on the left of each panel. 
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5.3.4 Cleavage of pVIII protein encoded by other Mastadenoviruses 
Analysis of amino acid sequence of pVIII of HAdV-5 and PAdV-3 revealed three potential 
protease cleavage sites. To analyze the cleavage of pVIII protein of   HAdV-5 and PAdV-3, we 
constructed plasmids expressing pVIII protein of HAdV-5 (pEY.hpVIII.HA) or PAdV-3 
(pEY.ppVIII.HA) as EYFP fusion protein. The 293T cells were co-transfected with DNA’s from 
plasmid pEY.hpVIII.HA and plasmid pDsRed-C1 (control), pDR.bProt (expressing BAdV-3 
protease), pDR.hProt (expressing HAdV-5 protease) or pDR.pProt (expressing PAdV-3 
protease). After 48 hrs post transfection, the cells were collected, lysed and the cell lysate were 
analysed by Western blotting using anti-GFP serum. As seen in Fig.5.3.3B anti-GFP serum 
detected a protein of 53 kDa (uncleaved EYFP-hpVIII-HA fusion protein) in the cells co-
transfected with plasmid pEY.hpVIII.HA and pDsRed-C1 DNAs (lane 1). In contrast, proteins of 
53 kDa, 40 kDa (cleavage product EYFP-hpVIII amino acids 1 to 111 fusion protein ), 42 kDa 
(cleavage product EYFP-hpVIII amino acids 1 to 131 fusion protein) and 45 kDa (cleavage 
product EYFP-hpVIII  amino acids 1 to 157 fusion protein) were detected in the lysates of the 
cells co-transfected with plasmid pEY.hpVIII.HA and either pDR.bProt (lane 2)or  pDR.hProt 
(lane 3) or pDR.pProt (lane 4)  DNAs, indicating that HAdV-5  pVIII can be cleaved at all three 
potential cleavage sites by protease encoded by HAdV-5 , BAdV-3 or PAdV-3.  Interestingly, 
the 45kDa band and 40 kDa bands were thicker than 42 kDa band in pEY.hpVIII.HA and 
pDR.bProt co-transfected cells (Fig.5.3.3B, lane2). Similarly, the 45kDa band was thicker than 
the 42kDa and 40kDa band in pEY.hpVIII.HA and pDR.pProt co-transfected cells (Fig.5.3.3B, 
lane 4). However, the 42kDa band was thicker than both 45kDa and 40kDa bands in 
pEY.hpVIII.HA and pDR.hProt co-transfected cells (Fig.5.3.3B, lane 3). 
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Similarly, anti-GFP serum detected a protein of 53 kDa (uncleaved EYFP-ppVIII-HA 
fusion protein) in the cells co-transfected with plasmid pEY.ppVIII.HA and pDsRed-C1 DNAs 
(lane 1). In contrast,  proteins of 53 kDa, 40 kDa (cleavage product EYFP-ppVIII amino acids1 
to 111 fusion protein ), 42 kDa (cleavage product EYFP-ppVIII  amino acids 1 to 131 fusion 
protein) and 45 kDa (cleavage product EYFP-ppVIII amino acids 1 to 157 fusion protein) were 
detected in lysate of  the cells co-transfected with plasmid pEY.ppVIII.HA and either plasmid 
pDR.bProt (lane 2) or  plasmid pDR.hProt (lane 3) or plasmid pDR.pProt (lane 4)  DNAs, 
indicating that PAdV-3  pVIII can also be cleaved at all three potential cleavage sites by protease 
encoded by HAdV-5 , BAdV-3 or PAdV-3 (Fig.5.3.3C).  
5.3.5 Construction of BAdV-3 expressing pVIII protein with altered protease cleavage 
site(s)  
To determine the role of cleavage of pVIII protein in BAdV-3 replication, we decided to 
generate recombinant BAdV-3 expressing protease cleavage site(s) mutant pVIII protein. To 
achieve this, we constructed three different plasmids containing mutant full length genomic 
clone of BAdV-3 (Fig.5.3.4A). The plasmid pUC304a-pVIII-108A contained a BAdV-3 pVIII 
gene with substitution of amino acid 110, 111 and 112 from glycine to alanine in potential 
protease cleavage site I of the protein. The plasmid pUC304a-pVIII-143A contained a BAdV-3 
pVIII gene with substitution of amino acid 144, 145 and 146 from glycine to alanine in potential 
protease cleavage site II of the protein. Similarly, plasmid pUC304a-pVIII-DM, contained 
BAdV-3 pVIII gene with substitution of amino acid 110, 111, 112, 144, 145 and 146 from 
glycine to alanine in potential protease cleavage site I and site II of the protein.  
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Figure 5.3.4 Isolation and characterization of mutant BAdV-3. (A). Schematic 
representation of plasmids. The BAdV-3 sequence is represented by hollow box. The thin line 
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represents deleted E3 region (Zakhartchouk et al., 1998b). The alanines substituted for glycines 
are underlined. The numbers indicate the amino acids of BAdV-3 pVIII, CMV (human 
cytomegalo virus immediate early promoter); EYFP (enhanced yellow fluorescent protein). 
Arrows indicate the direction of the transcription. The black box represents the nucleotide 
sequence of BAdV-3 pVIII.  (B). Direct fluorescence. Monolayer of VIDO DT1 cells (Du & 
Tikoo., 2010) were transfected with 4-6 μg of plasmid DNA; pUC304a (BAV304a), pUC304a-
pVIII-108A (BAdV-108A), pUC304a-pVIII-143A (BAdV-143A, or pUC304a-pVIII-DM 
(BAdV-DM) and visualized at indicated times post transfection for the expression of EYFP and 
development of cytopathic effects using fluorescent microscope TCS SP5 (Leica). Increase in 
green fluorescence indicating virus production could be seen after 9th day post transfection. (C). 
CsCl  purification. Virus was purified from infected cell lysates by CsCl2 density gradient 
purification. Mature virion bands after double CsCl density gradient centrifugation are shown. 
(D). Western blot. Proteins from purified BAV304a (lane 1), BAdV-108A (lane 2) or BAdV-
143A (lane 3) were run on 4-20% gradient SDS-PAGE, transferred to PVDF and probed in 
Western blot using anti-pVIII serum (Ayalew et al., 2014).  (E). Virus growth kinetics. The 
infected MDBK cells were collected at indicated times post infection, freeze-thawed and virus 
was titrated on MDBK cells. BAV304a (), BAdV-108A (), BAdV-143A (). 
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To isolate mutant BAdV-3s, VIDO DT1 cells (cotton rat lung fibroblasts expressing I-SceI 
protein) (Du & Tikoo., 2010) were transfected with individual plasmid (pUC304a-pVIII-108A,  
pUC304a-pVIII-143A or pUC304a-pVIII-DM) DNAs using lipofectamine 2000 reagent. The 
transfected cells were observed daily for development of the cytopathic effects (CPE). The cells 
transfected with either plasmid pUC304a-pVIII-108A or pUC304a-pVIII-143A DNAs showed 
increase in green fluorescence 9th day post transfection indicating virus production (Fig.5.3.4B). 
The cells showing cytopathic effects were harvested 25 day post transfection, freeze thawed 
three times and used to purify virus using CsCl density gradient (Tollefson et al., 2007). The 
recombinant viruses were named BAdV-108A (pUC304a-pVIII-108A) and BAdV-143A 
(pUC304a-pVIII-143A).  
Although fluorescent focus forming units could be observed after 9 day post transfection in 
VIDO DT1 cells transfected with plasmid pUC304a-pVIII-DM DNA, however, these fluorescent 
foci gradually disappeared without showing any observable cytopathic effect (Fig.5.3.4B). 
The BAV304a, BAdV-108A and BAdV-143A were propagated in MDBK cells and 
purified by double CsCl density gradients (Fig.5.3.4C). The number of MDBK cells used to 
purify BAdV-108A and BAdV-143A was twice the number of MDBK cells used to purify 
BAV304a. To determine the incorporation of pVIII in purified virions, proteins from purified 
virions were separated by 4-20% gradient SDS-PAGE, transferred to PVDF and probed in 
Western blot using anti-VIIIb serum. As expected (Fig.5.3.4D), anti pVIIIb detected a protein of 
8 kDa in purified BAV304a (lane 1) and BAdV-108A (lane 2), and a protein of 12 kDa in 
purified BAdV-143A (lane 3).  
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5.3.6 Virus growth kinetics  
To determine if the mutation of protease cleavage sites of pVIII affects BAdV-3 
replication, we compared the growth kinetics of BAdV-304a, BAdV-108A and BAdV-143A. 
The monolayers of MDBK cells in 24-well plates were infected with either CsCl purified 
BAV304a, BAdV-108A or BAdV-143A at MOI of 1. At different times post infection (6, 12, 24, 
36, 48 hrs), the infected cells were collected, freeze-thawed three times and virus in cell lysate 
was titrated by TCID50 in MDBK cells (Kulshreshtha et al., 2004). As seen in Fig.5.3.4E, 
BAV304a grew to a titer of 10
8.4 
TCID50/ml. However, BAdV-108A and BAdV-143A could only 
grow to a titer of 10
5.75 
and 10
5.6
 TCID50/ ml, respectively. 
5.3.7 Virus infectivity and genome replication 
To determine the infectivity of mutant viruses, GFP expression was used as an indicator to 
determine the virus particles infectivity in a single round infection assay.  As seen in Fig.5.3.5A, 
there was no significant difference in the number of GFP expressing cells when MDBK cells 
infected with equal amount of infectious virus were analysed after 18 hrs post infection.  
To determine if the alteration of protease cleavage of pVIII modulate the replication of 
mutant viruses, we determined the mutant viral DNA replication by quantitative real time PCR 
as described in materials and methods. As seen in Fig.5.3.5B during the early phase of infection 
(6hpi and 12hpi) virus genome replication appeared similar in different viruses. However, during 
late phase of infection (24hpi and 36hpi) BAV-304a and BAdV-108A replicated marginally 
better than BAV304a or BAdV-143A. Similarly, BAV304 replicated marginally better than 
BAdV-143A.   
To determine if alteration of protease cleavage of pVIII modulate the release of the virus 
from endosomes, MDBK cells infected with equal amounts of individual infectious viruses were  
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Figure 5.3.5 Analysis of mutant BAdV-3s. (A). Virus infectivity.  The MDBK cells were 
infected with equivalent amounts of infectious particles of indicated virus. The infected cells 
were visualized for the expression of GFP at 18 hrs post infection by fluorescent microscope 
TCS SP5 (Leica). (B). Viral genome replication. The MDBK cells were infected with 
equivalent amounts of infectious particles of indicated virus in triplicate. At indicated times post 
infection, cells were harvested, and genomic DNA was isolated. The viral genome copy number 
was determined by quantitative PCR and divided by actin copy number for normalization. For 
comparison the normalized genome copy number values for each virus at each time point were 
compared to that of BAV304a virus at 6hpi  C). Sub cellular distribution of BAdV-3.  
Monolayers of MDBK cells (1 × 10
6
 cells/well) were incubated with 1.4 × 10
7 
purified virions at 
4
°
C. After 1 hr of incubation, the cells were incubated at 37
°
C for 30 min. Finally, the cells were 
processed and visualized by transmission electron microscopy. For each virus ten cells were 
selected randomly and virus particles in endosomes, cytoplasm and at plasma membrane were 
counted. BAV304a (panel 1-3), BAdV-108A (panel 4-6), BAdV-143A (panel 7-9). 
BAdV-304a 
BAdV-108A 
BAdV-143A 
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analyzed by TEM after 90 min of infection. As seen in Fig.5.3.5C, no significant difference 
could be observed in the number of virus particles in the endosome or cytosol between 
BAV304a, BAdV-108A or BAdV-143A at 90 min pi.  
5.3.8 Thermostability of virus 
To determine if mutation of protease cleavage site of pVIII protein alters the stability of 
mutant BAdV-3, we compared the thermostability of BAdV-304a and BAdV-108A and BAdV-
143A.  About 10
5
 purified virus particles were incubated at different temperatures (-80C, -20C, 
4C, 25C and 37C) for 3 days in PBS containing 10% glycerol.  Finally, the infectivity of 
viable virus was determined by TCID50. As seen in Fig.5.3.6A., there was not much decrease in 
virus titer when viruses were incubated at -80C, -20C, 4C and 25C for 3 days. However, the 
virus titers decreased significantly when viruses were incubated at 37C for 3 days. Compared 
with BAdV-304a, the drop in the titre was more for BAdV-108A and BAdV-143A (Fig.5.3.6A).  
To further assess the thermostability, 10
5
 purified virus particles were incubated at different 
temperatures (-80C, 4C, 37C) for 0, 1, 3 and 7 days in PBS containing 10% glycerol 
measuring the remaining infectivity by TCID50. As seen in Fig.5.3.6B, C and D, when incubated 
at 37C more rapid loss of infectivity was observed for BAdV-108A and BAdV-143A. While 
BAdV-108A and BAdV-143A lost the infectivity within 5 days BAV-304a lost the infectivity 
only after 7days incubation at 37C. 
5.3.9 Analysis of protein expression in infected cells  
To analyze if there is any difference in expression of viral protein, MDBK cells were 
infected with either BAV-304a or BAdV-108A or BAdV-143A. After 24 hrs post infection, the 
cells were collected, lysed and the lysates were analysed by Western blotting using protein  
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Figure 5.3.6 Thermostability of mutant virions. (A). Purified virions grown in MDBK cells 
(10
5
 infectious virus particles (TCID50) were incubated at various temperatures for 3 days in 
PBS containing 10% glycerol and the residual viral infectivity was determined by titration on 
MDBK cells. (B) Purified BAV304a (10
5
 TCID50) grown in MDBK cells were incubated at 
different temperatures for indicated periods of time in PBS containing 10% glycerol and the 
residual viral infectivity was determined by titration on MDBK cells. (C). Purified BAdV-108A 
(10
5
 TCID50) grown in MDBK cells were incubated at different temperatures for indicated 
periods of time in PBS containing 10% glycerol and the residual viral infectivity was determined 
by titration on MDBK cells. (D). Purified BAdV-143A (10
5
 TCID50) grown in MDBK cells 
were incubated at different temperatures for indicated periods of time in PBS containing 10% 
glycerol and the residual viral infectivity was determined by titration on MDBKcells. The data is 
representative of two independent experiments. 
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Figure 5.3.7 Analysis of viral protein expression in infected cells. Cell lysates were prepared 
from infected MDBK cells. Proteins from the prepared cell lysates were run on  4-20% gradient 
SDS-PAGE, transferred to PVDF membranes and probed by Western blot using anti-DNA 
binding protein (DBP) (Zhou et al., 2001b), anti-pVII (Anand et al., 2014), anti-proteinV 
(Kulshreshtha & Tikoo., 2008), anti- hexon (Patel & Tikoo., 2006) and anti-100K (Makadiya et 
al., 2015) sera followed by Alexa Fluor 680 conjugated goat anti-rabbit antibody (Invitrogen). β-
actin (G) was detected by Western blot using mouse anti-β-actin monoclonal antibody (Sigma-
Aldrich) followed by IRDye800 conjugated goat anti-mouse antibody (Rockland). The name of 
the proteins is depicted on the right of the panel. DBP (DNA binding protein). Early (E), Late 
(L). (b) The results were analyzed by using Odyssey Infrared Imaging System. Values represent 
averages from two independent repeats and error bars indicate the standard deviations. 
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specific rabbit antisera. As seen in Fig.5.3.7A, B no appreciable decrease could be detected in the 
expression of viral proteins in BAdV-108A infected cells compared to BAV-304a infected cells. 
Interestingly, expression of all tested proteins appeared increased in BAdV-108A infected cells. 
In contrast compared to BAV304a, though expression of early viral protein (DBP) and late 
protein fiber appears increased in BAdV-143A infected cells, the expression of some of the viral 
late proteins (pVII, 100K and hexon) appears reduced in BAdV-143A infected cells. 
5.3.10 Analysis of protein incorporation in viral particles 
To analyse the incorporation of viral protein in the progeny virions, the proteins from 
purified virions were run on SDS-PAGE, transferred to PVDF membrane and probed in Western 
blot using viral protein specific serum. As seen in Fig.5.3.8A, B, compared to BAV304a, no 
significant decrease could be observed in the incorporation of the viral proteins in purified 
BAdV-108A or BAdV-143A virions.  
5.3.11 Transmission Electron Microscopy 
To assess whether mutation of single protease cleavage site of pVIII protein has any effect 
on virus structure BAV304a , BAdV-108A or BAdV-143A were propagated in MDBK cells and 
purified by CsCl2 density gradient (Fig.5.3.9A) as described in materials and methods. The virus 
particles were then observed by negative-staining electron microscopy. As seen in Fig.5.3. 9A 
the BAV304a particles (panel 1-2) had typical icosahedral structure and most of them were 
intact. However, unlike the BAV304a particles, BAdV-108A (panel 3 -4) or BAdV-143A (panel 
5-6) virus particles appeared more rounded disrupted capsids and lacking capsid fragments. 
To further assess if the mutation of single protease cleavage site of pVIII protein affect the 
formation of BAdV-3 particles, transmission electron microscopy was done on MDBK cells 
infected with BAdV304a, BAdV-108A or BAdV-143A. The infected cells were harvested 
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Figure 5.3.8 Analysis of viral protein incorporation in purified virions.  Proteins from double 
CsCl2 purified BAV304a, BAdV-108A or BAdV-143A virions were run on 4-20% gradient 
SDS-PAGE, transferred to PVDF membrane and probed in Western blot using protein specific 
antisera. The name of the detected protein is indicated on the right of the panel. 
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Figure 5.3.9 Electron microscopic analysis. (A). Purified BAV304a (panel 1), BAdV-108A 
(panel 3) or BAdV-143A (panel 5) (Magnification 30000×). The arrows depict the enlargement 
of selected boxed region of panel 1 (panel 2), panel 3 (panel 4) and panel 5 (panel 6) 
(Magnification 1000000×). (B). BAV304a infected (panel 1) or BAdV-108A infected (panel 3) 
and BAdV-143A (panel 5) infected MDBK cells (magnification 10000×). The arrows depict the 
enlargement of selected boxed region of panel 1 (panel2), panel 3 (panel 4) and panel 5 (panel 6) 
(Magnification 30000×).  
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48 hrs post infection and examined by transmission electron microscopy. As seen in Fig.5.3.9B 
BAV304a particles were uniformly distributed and loosely arranged (panel1-2). However, 
BAdV-108A (panel 3-4) and BAdV-143A (panel 5-6) particles were clustered together in groups 
and appeared tightly organized in rows. 
5.3.12 BAdV-3 pVIII complements the defect of BAV.pVIIIDM 
In order to determine if cleavage of pVIII at both potential protease consensus sites is essential 
for viral replication, we performed complementation assay. VIDO DT1 cells in 6 well plates 
were co-transfected with plasmid (pUC304a-pVIII-DM + pC-pVIII; or pUC304a-pVIII-DM + 
pCDNA3) DNAs (Fig.5.3.10A). The transfected cells were observed under fluorescent 
microscope daily for the appearance of fluorescent focus forming units. As seen in Fig.5.3.10B 
Co-transfection of VIDO DT1 cells with plasmid pUC304a-pVIII-DM and pCDNA3 DNAs did 
not resulted in progeny virus production as indicated by absence of any increase in the number of 
FFU from day 5 to day 11 post transfection (Fig.5.3.10B). However, co-transfection of VIDO 
DT1 cells with plasmid pUC304a-pVIII-DM and pC-pVIII DNAs resulted in production of 
progeny virus as indicated by significant increase in number of FFU from day 5 to day 11 post 
transfection (Fig.5.3.10B). 
5.4 Discussion 
The final step in adenovirus morphogenesis involves the maturation of immature virus 
particle by proteolytic cleavage of three minor capsid proteins, three core proteins and one non-
structural protein (Mangel & San Martín., 2014). The major player in this complex process is 23 
kDa adenovirus protease, which recognizes consensus motifs (M/I/L)XGX-G and (M/I/L)XGG-
X in precursor proteins (Webster et al., 1989). Much of the knowledge about the requirement of 
proteolytic cleavage of some precursor proteins for maturation of adenovirus has come from the  
 133 
 
 
 
Figure 5.3.10 Complementation assay. (A). Schematic representation of plasmid pUC304a-
DM. The dotted line represents the plasmid sequence. The BAdV-3 sequence is represented by 
hollow box. The thin line represents deleted E3 region (Zakhartchouk et al., 1998b). The 
alanines substituted for glycines are underlined. The numbers indicate the amino acids of BAdV-
3 pVIII; CMV (human cytomegalo virus immediate early promoter); EYFP (enhanced yellow 
fluorescent protein). Arrows indicate the direction of the transcription. The black box represents 
the nucleotide sequence of BAdV-3 pVIII. The dotted line represents the nucleotide sequence of 
plasmid DNA. (B). Plasmid DNA from indicated plasmids was used to transfect the VIDO DT1 
cells. At indicated days post transfection (denoted on X axis) fluorescent focus forming units 
were counted. Values represent averages from two independent repeats and error bars indicate 
the standard deviations.  Statistical differences among the groups were calculated using unpaired 
t-test. Differences were considered significant at * p<0.05, ** p<0.01 and *** p<0.001. 
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studies involving a temperature sensitive mutant of HAdV-2 (Weber., 1976). However, the 
importance of cleavage of each precursor protein in determining the infectivity of progeny virus 
is not clear (Mangel & San Martín., 2014). A recent study has demonstrated the importance of 
N-terminal cleavage of pVI in cell entry and capsid assembly (Moyer et al., 2015). Thus, a better 
understanding of this complex process of proteolytic maturation of adenovirus needs further 
investigation. Here, we have analysed the role of cleavage of pVIII in BAdV-3 virus assembly, 
stability and infection. To our knowledge, this is the first study to investigate the role of 
proteolytic cleavage of pVIII in adenoviral life cycle. 
Analysis of the BAdV-3 pVIII amino acid sequence revealed two potential protease 
cleavage sites (
108
IAGG-G
112
) (
143
LGGG-S
147
). Our results suggest that BAdV-3 protease cleaves 
BAdV-3 pVIII at both potential protease cleavage sites, which appears specific as mutation of 
protease cleavage sites abrogated the cleavage of pVIII. Moreover, cleavage at both potential 
sites does not appear to be sequential since mitigating cleavage at 
108
IAGG-G
112
 motif does not 
block cleavage at 
143
LGGG-S
147
 motif and vice versa. Earlier report has suggested the usage of 
only one potential protease cleavage site (
143
LGGG-S
147
) of pVIII (Ayalew et al., 2014). The 
difference could be due to use of different approach. Similarly, analysis of HAdV-5 pVIII 
revealed three potential adenoviral protease cleavage sites (amino acids 111, 131 and 157). Our 
results suggest that HAdV-5 protease can cleave pVIII at all three potential protease cleavage 
sites. Earlier studies have suggested the usage of only two potential cleavage sites at amino acid 
111 and amino acid 157 of HAdV-5 pVIII (Blanche et al., 2001,Chelius et al., 2002,Lehmberg et 
al., 1999,Liu et al., 2003). 
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  Analysis of the amino acid sequence revealed high degree of homology between proteases 
encoded by BAdV-3, HAdV-2 and PAdV-3 (Reddy et al., 1998). Moreover, the conservation of 
residues involved in the catalytic activity among proteases encoded by BAdV-3, HAdV-5 and 
PAdV-3 (Reddy et al., 1998) suggested that mechanism of cleavage of proteins harboring the 
potential cleavage site(s) might be conserved in Mastadenoviruses. Interestingly, detection of 
cleavage of pVIII encoded by BAdV-3, HAdV-5 or PAdV-3 by individual protease encoded by 
BAdV-3, HAdV-5 and PAdV-3 at potential protease cleavage sites provides evidence that the 
mechanism of cleavage of proteins appears conserved in members of Mastadenoviruses. 
However, we detected differences in the efficiency of usage of protease cleavage sites between 
HAdV-5, BAdV-3 and PAdV-3 protease. Earlier reports have suggested that efficiency of 
cleavage by adenovirus protease is dependent upon amino acid sequence at the cleavage site. The 
cleavage site sequence that conforms to GX-G type is cleaved more efficiently compared to 
cleavage site sequence that conforms to GG-X type (Diouri et al., 1996). Moreover, the four 
amino acids on either side of scissile bond determine the specificity of adenovirus protease 
mediated cleavage (Ruzindana-Umunyana et al., 2002,Webster et al., 1989). Our results confirm 
these findings as BAdV-3 pVIII was cleaved more efficiently at PPCS1 (GX-G type) than 
PPCS2 (GG-X type). Interestingly, there appears to be some difference in preference of cleavage 
site between HAdV-5, BAdV-3 and PAdV-3 protease as each of them cleaved different HAdV-5 
pVIII cleavage sites with different efficiency.  
Although abrogation of protease cleavage at either potential cleavage site (PPCS1 or 
PPCS2) affects the efficient production of infectious progeny virions, the protease cleavage at 
individual sites does not appear to be essential for the production of progeny BAdV-3. However, 
alteration of both protease cleavage sites (PPCS1 [amino acid 110-112] and PPCS2 [amino acids 
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146-148)] of BAdV-3 pVIII by substitution of glycines with alanines obviated the production of 
progeny virus suggesting that the absence of protease cleavage of pVIII is lethal for the 
production of progeny BAdV-3. These results are consistent with the suggestion that the function 
of the each protease cleavage site of BAdV-3 pVIII in viral replication may be redundant. 
The cleavage of few precursor proteins including pVIII has been postulated to be 
required for the production of infectious progeny virions (Greber et al., 1996). Absence of 
cleavage of these precursor proteins appear to make virions non-infectious as it partially alter the 
uncoating and release of  virions  from the  endosome (Cotten & Weber., 1995,Gastaldelli et al., 
2008,Perez-Berna et al., 2012). Mutant viruses produced significantly less infectious particles 
than wild-type virus when cells were infected with equal number of infectious virus particles.  
The defect could be in different steps of virus gene expression (receptor binding to virus 
assembly) including endosome escape. Several lines of evidence suggest that the capsid 
formation and virus assembly is occurring in mutant viruses. First, our quantitative TEM analysis 
suggests that the inability of cleavage at individual protease cleavage site of BAdV-3 pVIII does 
not appear to impair the release of partially uncoated BAdV-3 from the endosome(s).  Second, 
there is no significant difference in the replication of mutant virus genomes. Third, alteration of 
individual protease cleavage site does not significantly affect the incorporation of proteins in 
mutant virus capsids. Finally, capsid formation and virus assembly appeared to occur as progeny 
virions produced in infected cells banded at CsCl gradient density, which is consistent with the 
formation of mature virions.  
Earlier structural studies have revealed that mature HAdV-5 virion contain N- terminus 
(112 residues) and C-terminus (70 residues) proteolytic fragments of pVIII, which interact with 
the hexons (Reddy & Nemerow., 2014). While the ternary complex of V-VI-VIII  stabilizes the 
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peripentonal hexons, the binary complex VIII- VIB contributes to the stabilization of group of 
nine hexons (GONs) (Reddy & Nemerow., 2014) providing help in maintaining the integrity of 
the capsids.  Thus, significant decrease in the production of infectious BAdV-108A and BAdV-
143A viruses could be due to the production of less stable virions. Indeed our results confirm the 
role of VIII in stabilization of virion capsid. First, the altered proteolytic processing  of pVIII of      
BAdV-108A or BAdV-143A virus resulted in the production of  thermolabile virions with fragile 
capsids, which may be disrupted by CsCl \TEM leading to the production of significant number 
of broken capsids. Secondly, cleavage of pVIII at both potential cleavage sites appears essential 
for maintaining the integrity and stability of BAdV-3 virion. 
In conclusion, we have demonstrated that mitigation of both protease cleavage sites of 
pVIII is detrimental for progeny virus production. Moreover, single pVIII protease cleavage site 
mutants assemble virus particles. However, these thermolabile virus particles may lead to the 
production of non-infectious virions with broken capsids.   
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6.0 GENERAL DISCUSSION AND CONCLUSION 
To understand the basic biology of BAdV-3 it is necessary to study the biological functions  
of the various structural and non-structural viral proteins. This study is continuation of our earlier 
work on characterizing one of the structural protein pVIII of BAdV-3 which is also one of the 
least characterized adenovirus proteins. 
 Protein-protein interactions influence every cellular process. Similarly, the interaction of 
viral proteins and host cell proteins is essential for virus replication, growth and survival. Earlier, 
we demonstrated that BAdV-3 pVIII a) is expressed as 24 kDa protein in BAdV-3 infected or 
gene transfected cells and is localized both in the nucleus and the cytoplasm, b) N-terminal 
region (amino acids 57-72) of pVIII is involved in nuclear transport of pVIII by interacting 
preferentially with importin α-3 (Ayalew et al., 2014), and  c)  interacts with cellular factor 
DDX3, which alters the cap dependent translation by excluding eIF’s from cap binding complex 
(Ayalew., 2015). 
 Using yeast two-hybrid analysis, we observed that pVIII may also interact with cellular 
protein eIF6. This pVIII-eIF6 interaction was confirmed in-vitro and in-vivo using GST pull-
down, BiFC and co-immunoprecipitation assays. 
The eIF6 is a 245 amino acid long protein that is highly conserved (Si et al., 1997,Si & 
Maitra., 1999). eIF6 has a dual role and is important both for ribosome biogenesis and protein 
translation. It is associated with 60S subunit, which helps to prevent joining of 40S subunit and 
immature 60S subunit. After maturation of 60S subunit, eIF6 is released from the 60S subunit, 
which allows joining of 60S and 40S subunits leading to the formation of functional 80S 
ribosome (Gartmann et al., 2010,Russell & Spremulli., 1979,Valenzuela et al., 1982).  
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Using polysome profile analysis of BAdV-3 infected cells and pVIII expressing cell line 
we demonstrate that the presence of pVIII impairs joining of 40S and 60S subunits which 
consequently leads to reduction in formation of functional 80S subunits. We speculate that this 
impairment of formation of functional 80S unit may be because of inhibition of release of eIF6 
from mature 60S subunit, thus altering the cellular mRNA synthesis.  
Viruses do not have their own metabolic machinery so they depend completely on their 
host for translation of their transcripts. Many viruses globally interfere with the host translation 
by inhibiting cap dependent ribosome recruitment to host mRNA (Firth & Brierley., 2012,Gale et 
al., 2000). Earlier studies have reported inhibition of cellular protein synthesis during adenovirus 
infection particularly during late times post infection (Dolph et al., 1988,Huang & Schneider., 
1991) indicating that one or more late adenoviral proteins inhibit cap dependent translation of 
cellular mRNAs. Earlier studies have implicated 100K protein for inhibiting cellular protein 
synthesis (Cuesta et al., 2004). However, it is possible that viruses may employ more than one 
mechanism to control the complex process of translation and hence more than one viral protein 
may be involved in inhibiting cellular protein synthesis. 
It is possible that interaction of pVIII and eIF6 may have a role in preferential translation 
of late viral mRNAs. Support for this comes from the fact that abrogating the interaction of 
pVIII-eIF6 results in decreased production of progeny virus BAdV-3-d147-174 because of 
significant decrease in the production of late viral proteins. It is possible that interaction of 
pVIII-eIF6 allows availability of free 40S and 60Sribosome subunits, which  may allow the 
recruitment of free 40S and 60S ribosomal units to late viral mRNA that contain tripartite leader 
sequence (TPL) leading to their preferential translation. Alternatively, it is possible that 
inhibition of cellular mRNA translation at late times post infection by different mechanisms 
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involving BAdV-3 100K (Cuesta et al., 2004) and pVIII may indirectly help the translation of 
late viral mRNAs by independent mechanism (Yueh & Schneider., 1996). However, the exact 
mechanism by which pVIII-eIF6 interaction modulates late viral protein synthesis remains to be 
determined.  
The second part of the thesis determined the role of proteolytic cleavage in the maturation 
of progeny infectious BAdV-3. The maturation of immature adenovirus involving proteolytic 
processing of precursor proteins by adenovirus protease is an important step in adenovirus life 
cycle (Mangel & San Martín., 2014,Moyer et al., 2015). However, this complex process is still 
not fully understood especially how these individual proteolytic events affect adenovirus 
assembly stability and infectivity is not known.  
Based on our experimental approach, earlier we reported that BAdV-3 pVIII is only 
cleaved at its C-terminal potential cleavage site 
143LGGG↓S147 (Ayalew et al., 2014). However, 
using a different approach here we demonstrated that BAdV-3 pVIII is cleaved at its both 
potential adenovirus protease cleavage sites. Further our results indicate that usage of at least one 
cleavage site is essential for the production of progeny BAdV-3 virions as glycine to alanine 
mutation of both protease cleavage sites appears lethal for the production of progeny virions.  
Interestingly, cleavage of pVIII at both potential cleavage sites appears essential for the 
production of stable BAdV-3 virions as BAdV-3 expressing pVIII containing glycine to alanine 
mutation of either of the potential cleavage site are thermolabile  and may lead to production of 
non- infectious virions with disrupted capsids. 
Earlier structural studies have suggested that pVIII stabilize peripentonal and group of 
nine hexons (GONs) (Reddy & Nemerow., 2014). Indeed, our results confirm these findings as 
mutation of individual cleavage site of pVIII resulted in production of thermolabile and fragile 
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virions. It is possible that mutation of individual cleavage site of pVIII resulted in generation of 
pVIII fragments that does not fit well in the virion structure and hence can no longer interact and 
stabilize hexons resulting in production of fragile and increased number of non-infectious 
particles. Alternatively, it is possible that alteration of cleavage sites results in generation of 
pVIII fragments that fold differently and are unable to form complexes with other structural 
proteins thereby affecting the stability of the virus particle. 
The results of characterization of BAdV-3 pVIII carried out in this study provide 
evidence that pVIII is an important protein in adenoviral life cycle. The pVIII-eIF6 interaction 
inhibits cellular protein synthesis and diverts the cellular resources for preferential translation of 
late adenovirus mRNAs. Moreover, we provide evidence that cleavage of pVIII at atleast one 
potential cleavage sites appears essential for the formation and production of mature virions. To 
our knowledge, this is the first study to investigate the role of proteolytic cleavage of pVIII in 
adenoviral life cycle.  
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7.0 FUTURE DIRECTIONS 
 In the present study, we characterized interaction of BAdV-3 pVIII with cellular protein 
eIF6. Our polysome profile results indicate that in the presence of BAdV-3 pVIII the formation 
of functional 80S ribosome is inhibited. We speculate that this might be because of inhibition of 
release of eIF6 from 60S subunit. So future work could focus on determining the mechanism by 
which pVIII inhibit release of eIF6 from 60S subunit. 
 Secondly, our results of polysome profile indicate that free 40S subunits are diminished 
significantly in BAdV-3 infected cells compared to free 40S subunits in mock infected cells 
suggesting that some adenoviral protein(s) affects 40S ribosome biogenesis. So experiments can 
be performed to determine the adenoviral protein that affects the 40S ribosome biogenesis. 
 Thirdly, the fate of cleaved middle fragment (amino acid 112 to 146) of BAdV-3 pVIII is 
still not known. A recombinant virus can be made with a tag inserted just after the first protease 
cleavage site of BAdV-3 pVIII or just before the second cleavage site of BAdV-3 pVIII and 
experiments can be done with this recombinant virus to determine whether the cleaved middle 
fragment of BAdV-3 pVIII is incorporated in the mature virus particle or not.  Alternatively, an 
antibody can be generated that specifically detects the cleaved middle fragment (amino acid 112 
to 146) and can be used to detect presence or absence of amino acid 112 to 146 of pVIII in 
mature virus. 
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